• Aagaard CS, Hoang TT, Vingsbo-Lundberg C, Dietrich J, Andersen P. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis. J. Immunol. 183: 2659-2668 (2009).

• Abdallah AM, Savage ND, van Zon M, Wilson L, Vandenbroucke-Grauls CM, van der Wel NN, Ottenhoff TH, Bitter W. The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response. J. Immunol. 181: 7166-7175 (2008). *

• Abebe F, Mustafa T, Nerland AH, Bjune GA. Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease. Clin. Exp. Immunol. 143: 180-192 (2006). *

• Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169: 3155-3162 (2002). *

• Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).

• Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm. Bowel Dis. 14: 401-410 (2008). *

• Abubakar I, Myhill DJ, Hart AR, Lake IR, Harvey I, Rhodes JM, Robinson R, Lobo AJ, Probert CS, Hunter PR. A case-control study of drinking water and dairy products in Crohn's disease - further investigation of the possible role of Mycobacterium avium paratuberculosis. Am. J. Epidemiol. 165: 776-783 (2007). *

• Achkar JP, Duerr R. The expanding universe of inflammatory bowel disease genetics. Curr. Opin. Gastroenterol. 24: 429-434 (2008). *

• Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrob. Agents Chemother. 51: 3104-3110 (2007). *

• Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646 (2007). *

• Adams JS, Chen H, Chun R, Ren S, Wu S, Gacad M, Nguyen L, Ride J, Liu P, Modlin R, Hewison M. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J. Bone Miner. Res. 22 Suppl. 2: V20-V24 (2007). *

• Afdhal NH, Long A, Lennon J, Crowe J, O'Donoghue DP. Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo. Dig. Dis. Sci. 36: 449-453 (1991).

• Agarwal R, Singh N, Aggarwal AN. An unusual association between Mycobacterium tuberculosis and Aspergillus fumigatus. Monaldi Arch. Chest Dis. 69: 32-34 (2008).

• Agger EM, Cassidy JP, Brady J, Korsholm KS, Vingsbo-Lundberg C, Andersen P. Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection. Immunology 124: 175-185 (2008). *

• Aho AD, McNulty AM, Coussens PM. Enhanced expression of interleukin-1alpha and tumor necrosis factor receptor-associated protein 1 in ileal tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis. Infect. Immun. 71: 6479-6486 (2003). *

• Ahuja V. Crohn's disease and mycobacteria: 'the Thomson brothers' or 'back to the future'. Trop. Gastroenterol. 25: 151-155 (2004).

• Akobeng AK. Review article: the evidence base for interventions used to maintain remission in Crohn's disease. Aliment. Pharmacol. Ther. 27: 11-18 (2008). *

• Akobeng AK. Anti-mycobacterials and Crohn's disease: author's reply. Aliment. Pharmacol. Ther. 28: 374-375 (2008). *

• Aktas E, Ciftci F, Bilgic S, Sezer O, Bozkanat E, Deniz O, Citici U, Deniz G. Peripheral immune response in pulmonary tuberculosis. Scand. J. Immunol. 70: 300-308 (2009). *

• Al-Attiyah R, Mustafa AS. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect. Immun. 76: 4190-4198 (2008). *

• Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol. 122: 1043-1051 (2008). *

• Al-Shamali M, Khan I, Al-Nakib B, Al-Hassan F, Mustafa AS. A multiplex polymerase chain reaction assay for the detection of Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Scand. J. Gastroenterol. 32: 819-823 (1997).

• Albrecht H, Rusch-Gerdes S, Stellbrink HJ, Greten H, Jackle S. Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin. Infect. Dis. 25: 742-743 (1997).

• Aleman M, Schierloh P, De La Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E, Sasiain MC. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving Toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect. Immun. 72: 5150-5158 (2004). *

• Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173: 3287-3296 (2004). *

• Ali Z, Yan L, Plagman N, Reichenberg A, Hintz M, Jomaa H, Villinger F, Chen ZW. gammadelta T cell immune manipulation during chronic phase of Simian HIV infection confers immunological benefits. J. Immunol. 183: 5407-5417 (2009).

• Allie N, Alexopoulou L, Quesniaux VJ, Fick L, Kranidioti K, Kollias G, Ryffel B, Jacobs M. Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection. Immunology 125: 522-534 (2008). *

• Alluwaimi AM. The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Saudi Med. J. 28: 1479-1484 (2007).

• Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am. J. Gastroenterol. 104: 1003-1012 (2009). *

• Almeida PE, Silva AR, Maya-Monteiro CM, Torocsik D, Avila HD, Dezso B, Magalhaes KG, Castro-Faria-Neto HC, Nagy L, Bozza PT. Mycobacterium bovis Bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 183: 1337-1345 (2009).

• Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla I, Garrido JM, Juste RA. Isolation of Mycobacterium avium subsp. paratuberculosis from muscle tissue of naturally infected cattle. Foodborne Pathog. Dis. 6: 513-518 (2009).

• Alter A, de Leseleuc L, Van Thuc N, Thai VH, Huong NT, Ba NN, Cardoso CC, Grant AV, Abel L, Moraes MO, Alcais A, Schurr E. Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum. Genet. Dec 25 [Epub ahead of print] (2009). *

• Alvarado-Navarro A, Montoya-Buelna M, Munoz-Valle JF, Lopez-Roa RI, Guillen-Vargas C, Fafutis-Morris M. The 3'UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol. Lett. 118: 148-151 (2008).

• Amicosante M, Puxeddu E, Saltini C. Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. Am. J. Respir. Crit. Care Med. 180: 685 (2009). *

• Anand PK, Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiol. Lett. 250: 137-144 (2005). *

• Anand PK, Kaul D, Sharma M. Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J. Microbiol. Immunol. Infect. 41: 17-25 (2008). *

• Anand SP, Selvaraj P. Effect of 1,25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. Clin. Immunol. 133: 126-131 (2009). *

• Andresen D. Microbiological diagnostic procedures in respiratory infections: mycobacterial infections. Paediatr. Respir. Rev. 8: 221-230 (2007).

• Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223-227 (2005). *

• Andus T, Gross V. Etiology and pathophysiology of inflammatory bowel disease - environmental factors. Hepatogastroenterology 47: 29-43 (2000).

• Anes E, Jordao L. Trick-or-treat: dietary lipids and host resistance to infectious disease. Mini Rev. Med. Chem. 8: 1452-1458 (2008).

• Angelo LS, Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin. Cancer Res. 13: 2825-2830 (2007). *

• Ano H, Matsumoto T, Suetake T, Nagai T, Tamura Y, Takamatsu I, Iwasaki T, Matsuoka H, Sasada S, Tetsumoto S, Tsuyuguchi I, Kusunoki Y, Takashima T. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Int. J. Tuberc. Lung Dis. 12: 1300-1305 (2008).

• Aoshi T, Nagata T, Suzuki M, Uchijima M, Hashimoto D, Rafiei A, Suda T, Chida K, Koide Y. Identification of HLA-A*0201-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening. Infect. Immun. 76: 1565-1571 (2008). *

• Araujo Z, Acosta M, Escobar H, Banos R, Fernandez de Larrea C, Rivas-Santiago B. Immunitary response in tuberculosis and the role of Mycobacterium tuberculosis secretion antigens in its protection, pathology and diagnosis. Review. Invest. Clin. 49: 411-441 (2008).

• Arcila ML, Sanchez MD, Ortiz B, Barrera LF, Garcia LF, Rojas M. Activation of apoptosis, but not necrosis, during Mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-alpha, IL-10, caspases and phospholipase A2. Cell. Immunol. 249: 80-93 (2007). *

• Arcus VL, Lott JS, Johnston JM, Baker EN. The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov. Today 11: 28-34 (2006).

• Arend SM, Breedveld FC, van Dissel JT. TNF-alpha blockade and tuberculosis: better look before you leap. Neth. J. Med. 61: 111-119 (2003). *

• Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT. A patient with de novo tuberculosis during anti-tumor necrosis factor- alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin. Infect. Dis. 45: 1470-1475 (2007). *

• Aries PM, Witte T, Lamprecht P. Report on the 34th Meeting of the German Clinical Immunology Workgroup, Frankfurt, 03.-04.11.2006. Z. Rheumatol. 66: 63-64 (2007).

• Arko-Mensah J, Julian E, Singh M, Fernandez C. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages. Scand. J. Immunol. 65: 148-157 (2007). *

• Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J. Clin. Immunol. 28: 232-236 (2008). *

• Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377-382 (2007). *

• Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, Giese T, Loffler T, Buchler MW, Schmidt J. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut 54: 944-949 (2005). *

• Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, Maeurer MJ. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8(+) T-cell responses. Immunology Dec 14 [Epub ahead of print] (2009). *

• Aytekin C, Dogu F, Tanir G, Guloglu D, Santisteban I, Hershfield MS, Ikinciogullari A. Purine nucleoside phosphorylase deficiency with fatal course in two sisters. Eur. J. Pediatr. Aug 6 [Epub ahead of print] (2009).

• Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, Duncan K, van Helden P, Hoal EG. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87: 295-302 (2007).

• Babu S, Bhat SQ, Kumar NP, Jayantasri S, Rukmani S, Kumaran P, Gopi PG, Kolappan C, Kumaraswami V, Nutman TB. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J. Infect. Dis. 200: 288-298 (2009). *

• Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J. Infect. Dis. 201: 20-31 (2010). *

• Badr MZ, Shnyra A, Zoubine M, Norkin M, Herndon B, Quinn T, Miranda RN, Cunningham ML, Molteni A. Phthalate-induced liver protection against deleterious effects of the Th1 response: a potentially serious health hazard. PPAR Res. 2007: 49671 (2007). *

• Bakker D, Willemsen PT, van Zijderveld FG. Paratuberculosis recognized as a problem at last: a review. Vet. Q. 22: 200-204 (2000).

• Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC, Dunn JC. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod. Pathol. 17: 1289-1294 (2004). *

• Balkowiec-Iskra E, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Muszynska A, Przybylkowski A, Czlonkowska A, Czlonkowski A. MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice. Inflamm. Res. 56: 311-317 (2007). *

• Bang PD, Suzuki K, Phuong le T, Chu TM, Ishii N, Khang TH. Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy. J. Dermatol. 36: 269-276 (2009). *

• Bannantine JP, Barletta RG, Stabel JR, Paustian ML, Kapur V. Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen. Foodborne Pathog. Dis. 1: 3-15 (2004).

• Bansal K, Elluru SR, Narayana Y, Chaturvedi R, Patil SA, Kaveri SV, Bayry J, Balaji KN. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J. Immunol. Feb 22 [Epub ahead of print] (2010).

• Bansal K, Narayana Y, Balaji KN. Inhibition of TNF-alpha-induced cyclooxygenase-2 expression by Mycobacterium bovis BCG in human alveolar epithelial A549 cells. Scand. J. Immunol. 69: 11-19 (2009). *

• Barlan I, Bahceciler NN, Akdis M, Akdis CA. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases. Immunol. Allergy Clin. North Am. 26: 365-377 (2006).

• Barroso Pereira JC. Systemic lupus erythematosus association with tuberculosis - critical review. Rev. Port. Pneumol. 14: 843-855 (2008).

• Barta Z, Csipo I, Mekkel G, Zeher M, Majoros L, Bernstein CN, Collins MT. Seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease. J. Clin. Microbiol. 42: 5432-5433 (2004). *

• Basler T, Geffers R, Weiss S, Valentin-Weigand P, Goethe R. Mycobacterium avium subspecies induce differential expression of pro-inflammatory mediators in a murine macrophage model: Evidence for enhanced pathogenicity of Mycobacterium avium subspecies paratuberculosis. Immunobiology 213: 879-888 (2008).

• Basler T, Holtmann H, Abel J, Eckstein T, Baumer W, Valentin-Weigand P, Goethe R. Reduced transcript stabilization restricts TNF-alpha expression in RAW264.7 macrophages infected with pathogenic mycobacteria: evidence for an involvement of lipomannan. J. Leukoc. Biol. Oct 22 [Epub ahead of print] (2009). *

• Basler T, Jeckstadt S, Valentin-Weigand P, Goethe R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages. J. Leukoc. Biol. 79: 628-638 (2006). *

• Basu S, Pathak SK, Banerjee A, Pathak S, Bhattacharyya A, Yang Z, Talarico S, Kundu M, Basu J. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J. Biol. Chem. 282: 1039-1050 (2007). *

• Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. Effect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 149: 501-503 (2005).

• Bauerova K, Paulovicova E, Mihalova D, Svik K, Ponist S. Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan(R) in adjuvant arthritis. Toxicol. Ind. Health 25: 329-335 (2009).

• Bauerova K, Ponist S, Ondrejickova O, Komendova D, Mihalova D. Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuro. Endocrinol. Lett. 27: S172-S175 (2006).

• Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi RH, Wiedmann M, McDonough P, Kim SG, Berg D, Schukken Y, Scherl E, Simpson KW. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 1: 403-418 (2007). *

• Beckler DR, Elwasila S, Ghobrial G, Valentine JF, Naser SA. Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J. Gastroenterol. 14: 2723-2730 (2008). *

• Begg DJ, O'Brien R, Mackintosh CG, Griffin JF. Experimental infection model for Johne's disease in sheep. Infect. Immun. 73: 5603-5611 (2005). *

• Begum D, Umemura M, Yahagi A, Okamoto Y, Hamada S, Oshiro K, Matsuzaki G. Accelerated induction of mycobacterial antigen-specific CD8(+) T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guerin. Immunology 128: 556-563 (2009). *

• Behr MA. The path to Crohn's disease: is mucosal pathology a secondary event? Inflamm. Bowel Dis. Nov 18 [Epub ahead of print] (2009). *

• Behr MA, Hanley J. Antimycobacterial therapy for Crohn's disease: a reanalysis. Lancet Infect. Dis. 8: 344 (2008).

• Behr MA, Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr. Opin. Gastroenterol. 24: 17-21 (2008). *

• Behr MA, Schurr E. Mycobacteria in Crohn's disease: a persistent hypothesis. Inflamm. Bowel Dis. 12: 1000-1004 (2006). *

• Behr MA, Semret M, Poon A, Schurr E. Crohn's disease, mycobacteria, and NOD2. Lancet Infect. Dis. 4: 136-137 (2004).

• Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 4: 4-11 (2003). *

• Bellofiore B, Matarese A, Balato N, Gaudiello F, Scarpa R, Atteno M, Bocchino M, Sanduzzi A. Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. J. Rheumatol. Suppl. 83: 76-77 (2009).

• Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J. Immunol. 183: 6883-6892 (2009). *

• Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11: 625-626 (2004). *

• Bene L, Fust G, Huszti Z, Hernadi Z, Fekete B, Meszaros M, Veres A, Kovacs A, Miklos K, Singh M, Romics L, Prohaszka Z. Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease. Dig. Dis. Sci. 47: 1432-1437 (2002). *

• Bentley RW, Keenan JI, Gearry RB, Kennedy MA, Barclay ML, Roberts RL. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn's disease and control subjects. Am. J. Gastroenterol. 103: 1168-1172 (2008). *

• Berg PA, Klein R. Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis? J. Hepatol. 23: 103 (1995). *

• Berger S, Hinz D, Bannantine JP, Griffin JF. Isolation of high-affinity single-chain antibodies against Mycobacterium avium subsp. paratuberculosis surface proteins from sheep with Johne's disease. Clin. Vaccine Immunol. 13: 1022-1029 (2006). *

• Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 42: 1129-1135 (2004). *

• Bernstein CN, Nayar G, Hamel A, Blanchard JF. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J. Clin. Microbiol. 41: 4986-4990 (2003). *

• Bernstein CN, Wang MH, Sargent M, Brant SR, Collins MT. Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J. Clin. Microbiol. 45: 968-971 (2007). *

• Bertholet S, Ireton GC, Kahn M, Guderian J, Mohamath R, Stride N, Laughlin EM, Baldwin SL, Vedvick TS, Coler RN, Reed SG. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis. J. Immunol. 181: 7948-7957 (2008). *

• Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J. Clin. Immunol. 27: 347-362 (2007). *

• Bhatt K, Uzelac A, Mathur S, McBride A, Potian J, Salgame P. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection. J. Immunol. 182: 3793-3800 (2009).

• Bhide MR, Mucha R, Mikula I Jr, Kisova L, Skrabana R, Novak M, Mikula I Sr. Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection. BMC Genet. 10: 21 (2009). *

• Biet F, Boschiroli ML, Thorel MF, Guilloteau LA. Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC). Vet. Res. 36: 411-436 (2005). *

• Bigbee CL, Gonchoroff DG, Vratsanos G, Nadler SG, Haggerty HG, Flynn JL. Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice. Arthritis Rheum. 56: 2557-2565 (2007). *

• Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr. Opin. Pulm. Med. 14: 595-599 (2008).

• Binder RJ. CD40-independent engagement of mammalian hsp70 by antigen-presenting cells. J. Immunol. 182: 6844-6850 (2009).

• Bird L. Human TH17 cells take centre stage. Nat. Rev. Immunol. 7: 413 (2007). *

• Birnbaum G, Kotilinek L. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann. N. Y. Acad. Sci. 835: 157-167 (1997). *

• Birnbaum G, Kotilinek L. Immunity to heat shock proteins and neurological disorders of women. Infect. Dis. Obstet. Gynecol. 7: 39-48 (1999).

• Biswas D, Gupta SK, Sindhwani G, Patras A. TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden of tuberculosis in Indian patients. BMC Res. Notes 2: 162 (2009). *

• Blackwell JM. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol. Med. Today 2: 205-211 (1996).

• Blakelock RT, Beasley SW. Infection and the gut. Semin. Pediatr. Surg. 12: 265-274 (2003).

• Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87: 888-894 (1984).

• Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr. Mol. Med. 9: 15-22 (2009).

• Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Santoro G, Balato N, Castiglione F, Scarpa R, Perna F, Signoriello G, Galati D, Ponticiello A, Sanduzzi A. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur. J. Clin. Microbiol. Infect. Dis. 27: 907-913 (2008). *

• Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170: 3451-3454 (2003). *

• Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 42: 458-465 (2005). *

• Bogdanos DP, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, Burroughs AK, Rodes J, Vergani D. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J. Autoimmun. 22: 353-362 (2004).

• Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin. Rev. Allergy Immunol. 36: 30-39 (2009). *

• Bonar A, Chmiela M, Rudnicka W, Rozalska B. Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro. Arch. Immunol. Ther. Exp. (Warsz.) 53: 437-441 (2005).

• Bonfioli AA, de Miranda SS, Campos WR, Orefice F. Tuberculosis. Semin. Ophthalmol. 20: 169-175 (2005).

• Bonilla DL, Fan YY, Chapkin RS, McMurray DN. Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice. J. Infect. Dis. Jan 6 [Epub ahead of print] (2010). *

• Boot EP, Koning GA, Storm G, Wagenaar-Hilbers JP, van Eden W, Everse LA, Wauben MH. CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis. Arthritis Res. Ther. 7: R604-R615 (2005). *

• Borgaonkar MR, MacIntosh DG, Fardy JM. A meta-analysis of antimycobacterial therapy for Crohn's disease. Am. J. Gastroenterol. 95: 725-729 (2000). *

• Borody TJ, Bilkey S, Wettstein AR, Leis S, Pang G, Tye S. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Dig. Liver Dis. 39: 438-444 (2007).

• Borody TJ, Heifets LB. Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy. Gut 55: 1211 (2006). *

• Borody TJ, Leis S, Warren EF, Surace R. Treatment of severe Crohn's disease using antimycobacterial triple therapy - approaching a cure? Dig. Liver Dis. 34: 29-38 (2002).

• Borras SG, Cotorruelo C, Racca L, Recarte M, Garcías C, Biondi C, Bottasso O, Racca A. Association of leprosy with HLA-DRB1 in an Argentinean population. Ann. Clin. Biochem. 45: 96-98 (2008).

• Botsios C, Ostuni P, Sfriso P, Furlan A, Fiocco U, Sgarabotto D, Todesco S. Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects. Reumatismo 55: 224-235 (2003).

• Boukouvala S, Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab. Rev. 37: 511-564 (2005).

• Boulkroun S, Guenin-Mace L, Thoulouze MI, Monot M, Merckx A, Langsley G, Bismuth G, Di Bartolo V, Demangel C. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J. Immunol. Dec 30 [Epub ahead of print] (2009).

• Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, Abgrall S, Delcey V, Vicaut E, Sereni D, Autran B; PARADOX Study Group. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J. Immunol. 183: 3915-3923 (2009).

• Bower K, Begg DJ, Whittington RJ. Optimisation of culture of Mycobacterium avium subspecies paratuberculosis from blood samples. J. Microbiol. Methods Nov 20 [Epub ahead of print] (2009).

• Breza TS Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J. Cutan. Pathol. 33: 512-515 (2006). *

• Britton WJ, Lockwood DN. Leprosy. Lancet 363: 1209-1219 (2004). *

• Bronner MP. Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 21: 98-107 (2004).

• Broome U, Scheynius A, Hultcrantz R. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 18: 298-303 (1993).

• Broxmeyer L. Is mad cow disease caused by a bacteria? Med. Hypotheses 63: 731-739 (2004).

• Brucato A, Maestroni S, Cumetti D, Thiella G, Alari G, Brambilla G, Imazio M, Doria A, Palmieri G, Adler Y. Recurrent pericarditis: infectious or autoimmune? Autoimmun. Rev. 8: 44-47 (2008).

• Brugere-Picoux J. Crohn disease: uncertainty about the etiologic role of Mycobacterium paratuberculosis. Bull. Acad. Natl. Med. 182: 823-829 (1998).

• Brunello F, Pera A, Martini S, Marino L, Astegiano M, Barletti C, Gastaldi P, Verme G, Emanuelli G. Antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig. Dis. Sci. 36: 1741-1745 (1991).

• Bruns H, Meinken C, Schauenberg P, Harter G, Kern P, Modlin RL, Antoni C, Stenger S. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119: 1167-1177 (2009). *

• Buback F, Renkl AC, Schulz G, Weiss JM. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp. Dermatol. 18: 750-759 (2009).

• Buchan GS, Lee R, Wilson M, Slobbe L, Buddle BM, Young SL. Strains of Mycobacterium avium differentially activate human dendritic cells. Immunol. Cell Biol. Aug 4 [Epub ahead of print] (2009). *

• Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G,. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J. Clin. Microbiol. 41: 2915-2923 (2003). *

• Bulte M, Schonenbrucher H, Abdulmawjood A. From farm to fork - Mycobacterium avium ssp. paratuberculosis (MAP) as zoonotic agent? Berl. Munch. Tierarztl. Wochenschr. 118: 377-385 (2005).

• Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, Singh M, Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 280: 20961-20967 (2005). *

• Burnham WR, Lennard-Jones JE, Stanford JL, Bird RG. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 2: 693-696 (1978).

• Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, Casanova JL. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr. Opin. Immunol. 20: 39-48 (2008). *

• Cachafeiro-Vilar A, Garcia-Padilla C, Reyes E, Hernandez-Molina G. Polyarticular arthritis secondary to Mycobacterium bovis infection: an unusual clinical presentation. Joint Bone Spine 74: 107-109 (2007). *

• Cai X, Wong YF, Zhou H, Liu ZQ, Xie Y, Jiang ZH, Bian ZX, Xu HX, Liu L. Manipulation of the induction of adjuvant arthritis in Sprague-Dawley rats. Inflamm. Res. 55: 368-377 (2006). *

• Cai X, Wong YF, Zhou H, Xie Y, Liu ZQ, Jiang ZH, Bian ZX, Xu HX, Liu L. The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn. Schmiedebergs. Arch. Pharmacol. 373: 140-147 (2006). *

• Calabrese L. The yin and yang of tumor necrosis factor inhibitors. Cleve. Clin. J. Med. 73: 251-256 (2006). *

• Calabuig E, Salavert M. Infectious risk. Actas Dermosifiliogr. 99 Suppl. 4: 14-22 (2008).

• Cancino-Diaz ME, Perez-Salazar JE, Dominguez-Lopez L, Escobar-Gutierrez A, Granados-Arreola J, Jimenez-Zamudio L, Burgos-Vargas R, García-Latorre E. Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J. Rheumatol. 25: 1756-1764 (1998).

• Canonne-Hergaux F, Gruenheid S, Govoni G, Gros P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111: 283-289 (1999).

• Cappell MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am. J. Gastroenterol. 86: 1-15 (1991).

• Carrada-Bravo T. Miliary tuberculosis involving the central nervous system. Neurologia 20: 426-429 (2005). *

• Carvalho IA, Silva A Jr, Campos VE, Moreira MA. Short communication: detection of Mycobacterium avium subspecies paratuberculosis by polymerase chain reaction in bovine milk in Brazil. J. Dairy Sci. 92: 5408-5410 (2009).

• Castellanos E, Aranaz A, Gould KA, Linedale R, Stevenson K, Alvarez J, Dominguez L, de Juan L, Hinds J, Bull TJ. Discovery of stable and variable differences in the Mycobacterium avium subspecies paratuberculosis Types I, II and III genomes by pan-genome microarray analysis. Appl. Environ. Microbiol. 75: 676-686 (2009). *

• Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, Dannhoffer L, Chinet T, Morand P, Poyart C, Heym B, Rottman M, Gaillard JL, Herrmann JL. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J. Clin. Microbiol. 47: 271-274 (2009). *

• Cattan D. MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. Curr. Drug Targets Inflamm. Allergy 4: 105-112 (2005).

• Cavalcanti YV, Pereira VR, Reis LC, Ramos AL, Luna CF, Nascimento EJ, Lucena-Silva N. Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases. J. Clin. Lab. Anal. 23: 57-62 (2009). *

• Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR Jr, Letvin NL. Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. J. Virol. 80: 1645-1652 (2006). *

• Cellier C, De Beenhouwer H, Berger A, Penna C, Carbonnel F, Parc R, Cugnenc PH, Le Quintrec Y, Gendre JP, Barbier JP, Portaels F. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol. Clin. Biol. 22: 675-678 (1998).

• Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55: 301-305 (2006).

• Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents against tumor necrosis factor-alpha - California, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 53: 683-686 (2004).

• Chackerian AA, Chen SJ, Brodie SJ, Mattson JD, McClanahan TK, Kastelein RA, Bowman EP. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect. Immun. 74: 6092-6099 (2006). *

• Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58: 329-363 (2004). *

• Chaitra MG, Shaila MS, Nayak R. Detection of interferon gamma-secreting CD8(+) T lymphocytes in humans specific for three PE/PPE proteins of Mycobacterium tuberculosis. Microbes Infect. 10: 858-867 (2008). *

• Chaitra MG, Shaila MS, Nayak R. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. J. Med. Microbiol. 56: 466-474 (2007). *

• Chakravarty SD, Zhu G, Tsai MC, Mohan VP, Marina S, Kirschner DE, Huang L, Flynn J, Chan J. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76: 916-926 (2008). *

• Chamberlin W, Ghobrial G, Chehtane M, Naser SA. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. Am. J. Gastroenterol. 102: 689-691 (2007). *

• Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment. Pharmacol. Ther. 15: 337-346 (2001). *

• Chamberlin W, Hulten K, Graham DY. Antibiotics as primary therapy for Crohn's disease. Drugs Today (Barc.) 36: 667-678 (2000).

• Chamberlin WM, Naser SA. Integrating theories of the etiology of Crohn's disease on the etiology of Crohn's disease: questioning the hypotheses. Med. Sci. Monit. 12: RA27-RA33 (2006). *

• Chamberlin WM, Shafran I. Anti-mycobacterials and Crohn's disease. Aliment. Pharmacol. Ther. 28: 373-374 (2008). *

• Chamberlin WM, Shafran I. Anti-mycobacterials and Crohn's disease. Aliment. Pharmacol. Ther. 28: 373-374 (2008). *

• Chan AC, Lo CM, Ng KK, Chan SC, Fan ST. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int. 27: 81-85 (2007). *

• Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110: 2-12 (2004).

• Chan MM, Cheung BK, Li JC, Chan LL, Lau AS. A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction. J. Leukoc. Biol. 86: 283-291 (2009). *

• Cheepsattayakorn A, Cheepsattayakorn R. Human genetic influence on susceptibility of tuberculosis: from infection to disease. J. Med. Assoc. Thai. 92: 136-141 (2009).

• Chen X, Zhang M, Liao M, Graner MW, Wu C, Yang Q, Liu H, Zhou B. Reduced Th17 response in patients with tuberculosis correlate with IL-6R expression on CD4+ T cells. Am. J. Respir. Crit. Care Med. Dec 17 [Epub ahead of print] (2009). *

• Chen X, Zhang M, Zhu X, Deng Q, Liu H, Larmonier N, Graner MW, Zhou B. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy. J. Infect. Dis. 200: 399-408 (2009). *

• Cheung BK, Yim HC, Lee NC, Lau AS. A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1. BMC Immunol. 10: 64 (2009). *

• Cheung TC. Modulation of T cell proliferation through LIGHT-HVEM-BTLA cosignaling pathway. Recent Pat. DNA Gene Seq. 3: 177-182 (2009).

• Chiappini E, de Martino M, Mangiantini F, Lionetti P. Crohn disease and mycobacterial infection in children: an intriguing relationship. J. Pediatr. Gastroenterol. Nutr. 49: 550-558 (2009).

• Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease. J. Gastroenterol. 33: 482-487 (1998).

• Chiba M, Kono M, Hoshina S, Komatsu M, Kitagawa Y, Iizuka M, Watanabe S. Presence of bacterial 16S ribosomal RNA gene segments in human intestinal lymph follicles. Scand. J. Gastroenterol. 35: 824-831 (2000). *

• Chiodini RJ. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin. Microbiol. Rev. 2: 90-117 (1989). *

• Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR Jr, Coutu JA. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J. Clin. Microbiol. 20: 966-971 (1984). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J. Clin. Microbiol. 24: 357-363 (1986). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA, Merkal RS. In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease. Antimicrob. Agents Chemother. 26: 930-932 (1984). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig. Dis. Sci. 29: 1073-1079 (1984).

• Choi SW, Ahn JJ, Hwang YT, Koh SH, Cho SD. A case of tuberculous arthritis following the use of etanercept. Korean J. Intern. Med. 24: 397-401 (2009).

• Chou YH, Hsu MS, Sheng WH, Chang SC. Disseminated Mycobacterium kansasii infection associated with hemophagocytic syndrome. Int. J. Infect. Dis. Aug 3 [Epub ahead of print] (2009).

• Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am. J. Gastroenterol. 102: 1510-1517 (2007). *

• Cirone K, Morsella C, Romano M, Paolicchi F. Mycobacterium avium subsp. paratuberculosis in food and its relationship with Crohn's disease. Rev. Argent Microbiol. 39: 57-68 (2007).

• Clancy R, Ren Z, Turton J, Pang G, Wettstein A. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion. Dig. Liver Dis. 39: 445-451 (2007).

• Clark LN, Lebwohl M. Recent advances in medical dermatology. Int. J. Dermatol. 46: 1005-1010 (2007). *

• Clark-Curtiss JE, Haydel SE. Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu. Rev. Microbiol. 57: 517-549 (2003). *

• Clarkston WK, Presti ME, Petersen PF, Zachary PE Jr, Fan WX, Leonardi CL, Vernava AM 3rd, Longo WE, Kreeger JM. Role of Mycobacterium paratuberculosis in Crohn's disease: a prospective, controlled study using polymerase chain reaction. Dis. Colon Rectum 41: 195-199 (1998).

• Clay H, Volkman HE, Ramakrishnan L. Tumor necrosis factor signaling mediates resistance to Mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29: 283-294 (2008). *

• Click RE, Van Kampen CL. Short communication: progression of Johne's disease curtailed by a probiotic. J. Dairy Sci. 92: 4846-4851 (2009). *

• Cohavy O, Harth G, Horwitz M, Eggena M, Landers C, Sutton C, Targan SR, Braun J. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect. Immun. 67: 6510-6517 (1999). *

• Cohen RD. Mycobacterium in Crohn's: something to ruminate about? Gastroenterology 128: 2167-2168 (2005). *

• Cole DE, Olivier KN. The challenge of nontuberculous mycobacteria in patients with cystic fibrosis. South Med. J. 98: 964 (2005).

• Collins MT. Mycobacterium paratuberculosis: a potential food-borne pathogen? J. Dairy Sci. 80: 3445-3448 (1997). *

• Collins MT, Lisby G, Moser C, Chicks D, Christensen S, Reichelderfer M, Hoiby N, Harms BA, Thomsen OO, Skibsted U, Binder V. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J. Clin. Microbiol. 38: 4373-4381 (2000). *

• Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest Oct 26 [Epub ahead of print] (2009).

• Connolly SF, Kusner DJ. The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens. Immunol. Res. 39: 115-127 (2007).

• Cook LS. A causal role for Mycobacterium avium subspecies paratuberculosis in Crohn's disease? Can. J. Gastroenterol. 14: 479-480 (2000).

• Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 174: 339-343 (2006). *

• Cooper AM. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27: 393-422 (2009). *

• Cooper AM. T cells in mycobacterial infection and disease. Curr. Opin. Immunol. 21: 378-384 (2009).

• Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226: 191-204 (2008). *

• Cooper AM, Khader SA. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28: 33-38 (2007). *

• Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168: 1322-1327 (2002). *

• Corti S, Stephan R. Detection of Mycobacterium avium subspecies paratuberculosis specific IS900 insertion sequences in bulk-tank milk samples obtained from different regions throughout Switzerland. BMC Microbiol. 2: 15 (2002). *

• Cosma CL, Sherman DR, Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57: 641-676 (2003). *

• Coulombe F, Divangahi M, Veyrier F, de Leseleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med. 206: 1709-1716 (2009). *

• Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, Brytting M, Egeler RM, Rabourdin-Combe C, Henter JI, Arico M, Delprat C. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 14: 81-87 (2008). *

• Coussens A, Timms PM, Boucher BJ, Venton TR, Ashcroft AT, Skolimowska KH, Newton SM, Wilkinson KA, Davidson RN, Griffiths CJ, Wilkinson RJ, Martineau AR. 1alpha,25-Dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 127: 539-548 (2009). *

• Coussens PM. Mycobacterium paratuberculosis and the bovine immune system. Anim. Health Res. Rev. 2: 141-161 (2001).

• Cox KL, Cox KM. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 27: 580-583 (1998). *

• Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177: 1416-1420 (2006). *

• Cummins RE, Mullins D, Smith LJ, Ford MJ. Metastatic Crohn's disease: a case report. Pediatr. Dermatol. 13: 25-28 (1996).

• Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185 (2009). *

• Cush JJ, Yazici Y. Laboratory monitoring of biologic therapies. Clin. Exp. Rheumatol. 23: S90-S92 (2005).

• D'Amore M, Lisi S, Sisto M, Cucci L, Dow CT. Molecular identification of Mycobacterium avium subspecies paratuberculosis in an Italian patient with Hashimoto's thyroiditis and Melkersson-Rosenthal syndrome. J. Med. Microbiol. 59: 137-139 (2010).

• D'Haens G. Risks and benefits of biologic therapy for inflammatory bowel diseases. Gut 56: 725-732 (2007). *

• Dai YS, Liang MG, Gellis SE, Bonilla FA, Schneider LC, Geha RS, Orange JS. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J. Am. Acad. Dermatol. 51: 718-722 (2004).

• Daigeler A, Lehnhardt M, Helwing M, Steinstraesser L, Homann HH, Steinau HU, Druecke D. Differential diagnosis of "sterile" phlegmonous hand infections. Chirurg. 77: 1040-1045 (2006).

• Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Ann. Rheum. Dis. 63: 718-722 (2004). *

• Dao DN, Sweeney K, Hsu T, Gurcha SS, Nascimento IP, Roshevsky D, Besra GS, Chan J, Porcelli SA, Jacobs WR. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog. 4: e1000081 (2008). *

• Dassopoulos T. Diagnostic methodologies: serology, endoscopy, and radiology. Curr. Gastroenterol. Rep. 3: 491-499 (2001).

• Daum S, Moos V, Loddenkemper C, Schurmann C, Marker-Hermann E, Stein H, Zeitz M, Schneider T. Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis. Z. Rheumatol. 67: 277-283 (2008).

• Davidson RS, Marion G, White PC, Hutchings MR. Use of host population reduction to control wildlife infection: rabbits and paratuberculosis. Epidemiol. Infect. 137: 131-138 (2009).

• Davila H, Almeida PE, Roque NR, Castro-Faria-Neto HC, Bozza PT. Toll-like receptor-2 mediated CCR3/eotaxin-driven eosinophil influx induced by Mycobacterium bovis BCG pleurisy. Infect. Immun. 75: 1507-1511 (2007). *

• Davila S, Hibberd ML, Hari Dass R, Wong HE, Sahiratmadja E, Bonnard C, Alisjahbana B, Szeszko JS, Balabanova Y, Drobniewski F, van Crevel R, van de Vosse E, Nejentsev S, Ottenhoff TH, Seielstad M. Genetic association and expression studies indicate a role of Toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 4: e1000218 (2008). *

• Davis AS, Vergne I, Master SS, Kyei GB, Chua J, Deretic V. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathog. 3: e186 (2007). *

• de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Janniere L, Fieschi C, Stephan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205: 1543-1550 (2008). *

• de Boer T, van Dissel JT, Kuijpers TW, Rimmelzwaan GF, Kroon FP, Ottenhoff TH. Influenza vaccination induces interleukin-12/23 receptor beta1-independent production of interferon-gamma: cellular and humoral immune response to influenza vaccine in patients with genetic deficiency in IL-12/23Rbeta1 or IFN-gammaRI. Clin. Vaccine Immunol. 15: 1171-1175 (2008).

• De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14 (2004). *

• de la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maitre B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G. Assistance of microbial glycolipid antigen processing by CD1e. Science 310: 1321-1324 (2005). *

• De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22: 763-772 (2005). *

• de Lisle GW. Johne's disease in New Zealand: the past, present and a glimpse into the future. N. Z. Vet. J. 50: S53-S56 (2002).

• de Messias-Reason IJ, Boldt AB, Moraes Braga AC, Von Rosen Seeling Stahlke E, Dornelles L, Pereira-Ferrari L, Kremsner PG, Kun JF. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J. Infect. Dis. 196: 1379-1385 (2007). *

• De Paula ML, Braga FG, Coimbra ES, Carmo AM, Teixeira HC, Da Silva AD, Souza MA, Ferreira AP. Modulatory effects of 6-carboxymethylthiopurine on activated murine macrophages. Chem. Biol. Drug Des. 71: 563-567 (2008). *

• De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? Infect. Control Hosp. Epidemiol. 24: 477-482 (2003). *

• Delgado F, Estrada-Chavez C, Romano M, Paolicchi F, Blanco-Viera F, Capellino F, Chavez-Gris G, Pereira-Suarez AL. Expression of NRAMP1 and iNOS in Mycobacterium avium subsp. paratuberculosis naturally infected cattle. Comp. Immunol. Microbiol. Infect. Dis. Apr 3 [Epub ahead of print] (2009). *

• Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J. Immunol. 176: 1090-1097 (2006). *

• Dell'Isola B, Poyart C, Goulet O, Mougenot JF, Sadoun-Journo E, Brousse N, Schmitz J, Ricour C, Berche P. Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J. Infect. Dis. 169: 449-451 (1994).

• den Boon S, van Lill SW, Borgdorff MW, Verver S, Bateman ED, Lombard CJ, Enarson DA, Beyers N. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 60: 555-557 (2005). *

• den Dunnen J, Gringhuis SI, Geijtenbeek TB. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol. Immunother. 58: 1149-1157 (2009). *

• Deretic V, Delgado M, Vergne I, Master S, De Haro S, Ponpuak M, Singh S. Autophagy in immunity against Mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr. Top. Microbiol. Immunol. 335: 169-188 (2009).

• Desvignes L, Ernst JD. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31: 974-985 (2009). *

• Devilder MC, Allain S, Dousset C, Bonneville M, Scotet E. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and Plasmacytoid Dendritic Cells. J. Immunol. 183: 3625-3633 (2009).

• Dhawan SS, Finks AL, Wang BW. Mycobacterial coxitis masked by concomitant staphylococcal infection after infliximab for Crohn's disease. Joint Bone Spine 76: 107-108 (2009). *

• Dhiman R, Indramohan M, Barnes PF, Nayak RC, Paidipally P, Rao LV, Vankayalapati R. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J. Immunol. 183: 6639-6645 (2009).

• Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, Lenz LL, Cado D, Riley LW, Winoto A. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21: 877-889 (2004). *

• Dietlin TA, Cua DJ, Burke KA, Lund BT, van der Veen RC. Role of IL-23 in mobilization of immunoregulatory nitric oxide or superoxide producing Gr-1(+) cells from bone marrow. Free Radic. Biol. Med. 47: 357-363 (2009).

• Dietrich CG, Gartung C, Lorenzen J, Geier A, Wasmuth HE, Matern S, Lammert F. Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma. Ann. Hepatol. 3: 118-120 (2004). *

• Dimakou K, Papaioannides D, Latsi P, Katsimboula S, Korantzopoulos P, Orphanidou D. Disseminated tuberculosis complicating anti-TNF-alpha treatment. Int. J. Clin. Pract. 58: 1052-1055 (2004). *

• Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 21 Suppl. 2: S24-S34 (2003). *

• Dinser R, Fousse M, Sester U, Albrecht K, Singh M, Kohler H, Muller-Ladner U, Sester M. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) 47: 212-218 (2008). *

• Dissanayeke SR, Levin S, Pienaar S, Wood K, Eley B, Beatty D, Henderson H, Anderson S, Levin M. Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups. PLoS One 4: e6698 (2009). *

• Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, Fortune S, Behar SM, Remold HG. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10: 899-906 (2009). *

• Divangahi M, Yang T, Kugathasan K, McCormick S, Takenaka S, Gaschler G, Ashkar A, Stampfli M, Gauldie J, Bramson J, Takai T, Brown E, Yokoyama WM, Aoki N, Xing Z. Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol. 179: 4015-4026 (2007). *

• Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, Longhurst HJ, Kumararatne DS. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin. Infect. Dis. 38: e10-e14 (2004). *

• Dohlman CH, Grosskreutz CL, Chen TC, Pasquale LR, Rubin PA, Kim EC, Durand M. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J. Glaucoma Apr 15 [Epub ahead of print] (2009).

• Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br. J. Dermatol. 159: 1217-1228 (2008). *

• Donoghue HD, Holton J. Intestinal tuberculosis. Curr. Opin. Infect. Dis. 22: 490-496 (2009).

• Dos Santos Jr RR, Sartori A, Deperon Bonato VL, Coelho Castelo AA, Vilella CA, Zollner RL, Lopes Silva C. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression. Clin. Exp. Immunol. 149: 570-578 (2007). *

• Dow CT. Paratuberculosis and type I diabetes. Is this the trigger? Med. Hypotheses 67: 782-785 (2006).

• Doz E, Rose S, Court N, Front S, Vasseur V, Charron S, Gilleron M, Puzo G, Fremaux I, Delneste Y, Erard F, Ryffel B, Martin OR, Quesniaux VF. Mycobacterial phosphatidyl inositol mannosides negatively regulate host Toll-like receptor 4, MYD88-dependent proinflammatory cytokines and TRIF-dependent co-stimulatory molecules expression. J. Biol. Chem. 284: 23187-23196 (2009). *

• Doz E, Rose S, Nigou J, Gilleron M, Puzo G, Erard F, Ryffel B, Quesniaux VF. Acylation determines the Toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 282: 26014-26025 (2007). *

• Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell. Immunol. 258: 29-37 (2009). *

• Drebber U, Kasper HU, Ratering J, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases. Liver Int. 28: 828-834 (2008).

• Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, Kremer L, Adam E, Woerly G, Dombrowicz D, Capron M. TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113: 3235-3244 (2009). *

• Dubaniewicz A. Mycobacterium tuberclosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun. Rev. Nov 18 [Epub ahead of print] (2009).

• Dumonceau JM, Adler M, Cremer M, Van Gossum A. The role of infectious agents in Crohn's disease. Acta Gastroenterol. Belg. 57: 301-305 (1994).

• Dumonceau JM, Van Gossum A, Adler M, Fonteyne PA, Van Vooren JP, Deviere J, Portaels F. No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction. Dig. Dis. Sci. 41: 421-426 (1996).

• Dumonceau JM, Van Gossum A, Adler M, Van Vooren JP, Fonteyne PA, De Beenhouwer H, Portaels F. Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 16: 358-363 (1997).

• Durai M, Huang MN, Moudgil KD. Self heat-shock protein 65-mediated regulation of autoimmune arthritis. J. Autoimmun. 33: 208-213 (2009).

• Durai M, Kim HR, Bala K, Moudgil KD. T cells against the pathogenic and protective epitopes of heat-shock protein 65 are crossreactive and display functional similarity: novel aspect of regulation of autoimmune arthritis. J. Rheumatol. 34: 2134-2143 (2007).

• Eastwood MA, Choudari CP, Macintyre M, Richardson AJ, Stewart CS. Antibodies to Mycobacterium paratuberculosis. Gut 34: 1291 (1993). *

• Ebert EC, Bhatt BD, Liu S, Das KM. Induction of suppressor cells by Mycobacterium paratuberculosis antigen in inflammatory bowel disease. Clin. Exp. Immunol. 83: 320-325 (1991). *

• Eckstein TM, Chandrasekaran S, Mahapatra S, McNeil MR, Chatterjee D, Rithner CD, Ryan PW, Belisle JT, Inamine JM. A major cell wall lipopeptide of Mycobacterium avium subspecies paratuberculosis. J. Biol. Chem. 281: 5209-5215 (2006). *

• Economou M, Pappas G. New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations. Inflamm. Bowel Dis. 14: 709-720 (2008). *

• Ehlers S, Lehmann J, Mossmann H, Alber G, Holscher C. Interleukin-12p40 mediates transient protection against Mycobacterium avium infection in the absence of interleukin-12. Immunobiology 210: 217-227 (2005).

• Eishi Y. Seeking a causative agent of sarcoidosis. Nippon Rinsho 52: 1486-1491 (1994).

• El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, Konig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406 (2008). *

• El-Zaatari FA, Naser SA, Hulten K, Burch P, Graham DY. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr. Microbiol. 39: 115-119 (1999). *

• el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of Mycobacterium avium complex in sarcoidosis. J. Clin. Microbiol. 34: 2240-2245 (1996). *

• El-Zaatari FA, Osato MS, Graham DY. Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol. Med. 7: 247-252 (2001). *

• Elass E, Coddeville B, Guerardel Y, Kremer L, Maes E, Mazurier J, Legrand D. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett. 581: 1383-1390 (2007). *

• Ellingson JL, Cheville JC, Brees D, Miller JM, Cheville NF. Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. Clin. Med. Res. 1: 217-226 (2003). *

• Elsaghier A, Prantera C, Bothamley G, Wilkins E, Jindal S, Ivanyi J. Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins. Clin. Exp. Immunol. 89: 305-309 (1992). *

• Elsaghier A, Prantera C, Moreno C, Ivanyi J. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin. Exp. Immunol. 90: 503-508 (1992). *

• Eltholth MM, Marsh VR, Van Winden S, Guitian FJ. Contamination of food products with Mycobacterium avium paratuberculosis: a systematic review. J. Appl. Microbiol. 107: 1061-1071 (2009). *

• Engstrand L. Mycobacterium paratuberculosis and Crohn's disease. Scand. J. Infect. Dis. Suppl. 98: 27-29 (1995).

• Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig. Dis. 27: 555-559 (2009).

• Equils O, Shapiro A, Madak Z, Liu C, Lu D. Human immunodeficiency virus type 1 protease inhibitors block Toll-like receptor 2 (TLR2)- and TLR4-induced NF-kappaB activation. Antimicrob. Agents Chemother. 48: 3905-3911 (2004). *

• Erasmus DL, Victor TC, van Eeden PJ, Falck V, van Helden P. Mycobacterium paratuberculosis and Crohn's disease. Gut 36: 942 (1995). *

• Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J. Cyst. Fibros. Jan 11 [Epub ahead of print] (2010).

• Esther van de Vosse, Ottenhoff TH. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect. 8: 1167-1173 (2006). *

• Eum SY, Jeon BY, Min JH, Kim SC, Cho S, Park SK, Cho SN. Tumor necrosis factor-alpha and interleukin-10 in whole blood is associated with disease progression in pulmonary multidrug-resistant tuberculosis patients. Respiration 76: 331-337 (2008).

• EUROPEAN COMMISSION, DIRECTORATE-GENERAL HEALTH & CONSUMER PROTECTION, Directorate B - Scientific Health Opinions, Unit B3 - Management of scientific committees II. Possible links between Crohn’s disease and Paratuberculosis (http://europa.eu.int/comm/food/fs/sc/scah/out38_en.pdf). Report of the Scientific Committee on Animal Health and Animal Welfare Adopted 21 March 2000 (2000). *

• Everett B, Cameron B, Li H, Vollmer-Conna U, Davenport T, Hickie I, Wakefield D, Vernon S, Reeves WC, Lloyd AR. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun. 8: 699-702 (2007). *

• Ewer K, Cockle P, Gordon S, Mansoor H, Govaerts M, Walravens K, Marche S, Hewinson G, Vordermeier M. Antigen mining with iterative genome screens identifies novel diagnostics for the Mycobacterium tuberculosis complex. Clin. Vaccine Immunol. 13: 90-97 (2006). *

• Faller M, Niederweis M, Schulz GE. The structure of a mycobacterial outer-membrane channel. Science 303: 1189-1192 (2004). *

• Fallon JC, Patchett S, Gulmann C, Murphy GM. Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab. Clin. Exp. Dermatol. 33: 43-45 (2008). *

• Fang J, Fang D, Silver PB, Wen F, Li B, Ren X, Lin Q, Caspi RR, Su SB. The role of TLR2, TLR3, TLR4 and TLR9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest. Ophthalmol. Vis. Sci. Jan 27 [Epub ahead of print] (2010).

• Farhi D, Duriez P, Aractingi S, Cosnes J, Khosrotehrani K. Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports. J. Med. Case Reports 1: 109 (2007). *

• Favila-Humara LC, Chavez-Gris GG, Carrillo-Casas EM, Hernandez-Castro R. Mycobacterium avium subsp. paratuberculosis detection in individual and bulk tank milk samples from bovine herds and caprine flocks. Foodborne Pathog. Dis. Nov 13 [Epub ahead of print] (2009).

• Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).

• Felaco P, Castellani ML, De Lutiis MA, Felaco M, Pandolfi F, Salini V, De Amicis D, Vecchiet J, Tete S, Ciampoli C, Conti F, Cerulli G, Caraffa A, Antinolfi P, Cuccurullo C, Perrella A, Theoharides TC, Conti P, Toniato E, Kempuraj D, Shaik YB. IL-32: a newly-discovered proinflammatory cytokine. J. Biol. Regul. Homeost. Agents 23: 141-147 (2009).

• Feleszko W, Jaworska J, Hamelmann E. Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives). Eur. J. Pharmacol. 533: 308-318 (2006). *

• Felizardo M, Gomes A, Sousa M, Teixeira A, Freitas J, Tavares A, Vaz Patto J, Gomes M. Immunosuppression and tuberculosis. Rev. Port. Pneumol. 13: S23-S24 (2007).

• Feller M, Huwiler K, Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease - authors' reply. Lancet Infect. Dis. 8: 345-346 (2008).

• Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, Pfyffer GE, Jemmi T, Baumgartner A, Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 7: 607-613 (2007).

• Fend F, Langer R, Hann von Weyhern CW, Schulz S, Miethke T. Molecular diagnosis of mycobacterial infections. Verh. Dtsch. Ges. Pathol. 91: 135-139 (2007).

• Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093 (2006). *

• Feng CG, Zheng L, Jankovic D, Báfica A, Cannons JL, Watford WT, Chaussabel D, Hieny S, Caspar P, Schwartzberg PL, Lenardo MJ, Sher A. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4(+) T cell populations by preventing interferon-gamma-induced cell death. Nat. Immunol. 9: 1279-1287 (2008). *

• Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, Murdaca G, Zocchi MR. Vdelta1 T lymphocytes producing IFNgamma and IL-17 are expanded in HIV-1 infected patients and respond to Candida albicans. Blood 113: 6611-6618 (2009). *

• Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, Netea MG. Functional consequences of Toll-like receptor 4 polymorphisms. Mol. Med. 14: 346-352 (2008). *

• Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DM, van Crevel R, Ottenhoff TH, Van der Meer JW, Netea MG. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J. Leukoc. Biol. 82: 1011-1018 (2007). *

• Fiasse R, Latinne D. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy. Acta Gastroenterol. Belg. 69: 418-422 (2006).

• Fidler HM, Thurrell W, Johnson NM, Rook GA, McFadden JJ. Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut 35: 506-510 (1994). *

• Fieschi C, Allez M, Casanova JL. High risk of infectious disease caused by salmonellae and mycobacteria infections in patients with Crohn disease treated with anti-interleukin-12 antibody. Clin. Infect. Dis. 40: 1381 (2005). *

• Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18: 347-361 (2006). *

• Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73: 20-26 (2006). *

• Fletcher HA. Correlates of immune protection from tuberculosis. Curr. Mol. Med. 7: 319-325 (2007).

• Fletcher HA, Keyser A, Bowmaker M, Sayles PC, Kaplan G, Hussey G, Hill AV, Hanekom WA. Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth. BMC Med. Genomics 2: 10 (2009). *

• Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, Hair JR, Huey OS, Houben EN, Pieters J, Day C, Oehlmann W, Singh M, Smith KG, Lehner PJ. Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 314: 454-458 (2006). *

• Fonollosa A, Segura A, Giralt J, Garcia-Arumi J. Tuberculous uveitis after treatment with etanercept. Graefes Arch. Clin. Exp. Ophthalmol. 245: 1397-1399 (2007).

• Fonseca DM, Silva CL, Wowk PF, Paula MO, Ramos SG, Horn C, Marchal G, Bonato VL. Mycobacterium tuberculosis culture filtrate proteins plus CpG-ODN confer protection to BCG primed mice by inhibiting IL-4 secretion. Infect. Immun. 77: 5311-5321 (2009). *

• Forbes EK, Sander C, Ronan EO, McShane H, Hill AV, Beverley PC, Tchilian EZ. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. 181: 4955-4964 (2008). *

• Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr. Opin. Gastroenterol. 20: 16-21 (2004).

• Fortaleza GT, Brito Mde F, Santos JB, Figueiredo AR, Gomes P. Splenic tuberculosis during psoriasis treatment with infliximab. An. Bras. Dermatol. 84: 420-424 (2009).

• Fortea Ormaechea JI, Gisbert JP, Marin-Jimenez I. Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease. Gastroenterol. Hepatol. 32: 353-363 (2009).

• Foweraker J. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br. Med. Bull. 89: 93-110 (2009). *

• Fowler KH, Chapkin RS, McMurray DN. Effects of purified dietary n-3 ethyl esters on murine T lymphocyte function. J. Immunol. 151: 5186-5197 (1993).

• Frank DN. Mycobacterium avium subspecies paratuberculosis and Crohn's disease. Lancet Infect. Dis. 8: 345 (2008).

• Frank TS, Cook SM. Analysis of paraffin sections of Crohn's disease for Mycobacterium paratuberculosis using polymerase chain reaction. Mod. Pathol. 9: 32-35 (1996).

• Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database Syst. Rev. 2: CD005435 (2006). *

• Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 107: 1173-1181 (2001). *

• Freeman AF, Olivier KN, Rubio TT, Bartlett G, Ochi JW, Claypool RJ, Ding L, Kuhns DB, Holland SM. Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children. Pediatr. Pulmonol. 44: 1051-1056 (2009).

• Freeman H, Noble M. Lack of evidence for Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Inflamm. Bowel Dis. 11: 782-783 (2005). *

• Freeman HJ, Davis JE, Prest ME, Lawson EJ. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease. Can. J. Gastroenterol. 18: 687-690 (2004). *

• Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I, Jacobs M, Ryffel B, Quesniaux VF. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179: 1178-1189 (2007). *

• French MA. Immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis. 48: 101-107 (2009). *

• Fuchs I, Avnon L, Freud T, Abu-Shakra M. Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors. Clin. Rheumatol. 28: 167-172 (2009). *

• Fujita H, Eishi Y, Ishige I, Saitoh K, Takizawa T, Arima T, Koike M. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J. Gastroenterol. 37: 509-516 (2002). *

• Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115: 565-574 (2005). *

• Gan H, Ouyang Q, Bu H. Mycobacterium paratuberculosis in the intestine of patients with Crohn's disease. Zhonghua Nei Ke Za Zhi 36: 228-230 (1997).

• Gandotra S, Jang S, Murray PJ, Salgame P, Ehrt S. NOD2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75: 5127-5134 (2007). *

• Gao A, Mutharia L, Chen S, Rahn K, Odumeru J. Effect of pasteurization on survival of Mycobacterium paratuberculosis in milk. J. Dairy Sci. 85: 3198-3205 (2002). *

• Gao A, Odumeru J, Raymond M, Hendrick S, Duffield T, Mutharia L. Comparison of milk culture, direct and nested polymerase chain reaction (PCR) with fecal culture based on samples from dairy herds infected with Mycobacterium avium subsp. paratuberculosis. Can. J. Vet. Res. 73: 58-64 (2009). *

• Garcia-Alles LF, Versluis K, Maveyraud L, Vallina AT, Sansano S, Bello NF, Gober HJ, Guillet V, de la Salle H, Puzo G, Mori L, Heck AJ, De Libero G, Mourey L. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J. 25: 3684-3692 (2006). *

• Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis. 3: 148-155 (2003).

• Garip A, Diedrichs-Mohring M, Thurau SR, Deeg CA, Wildner G. Uveitis in a patient treated with Bacille-Calmette-Guerin possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 116: 2457-2462.e1-e2 (2009).

• Garlanda C, Di Liberto D, Vecchi A, La Manna MP, Buracchi C, Caccamo N, Salerno A, Dieli F, Mantovani A. Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J. Immunol. 179: 3119-3125 (2007). *

• Gaseitsiwe S, Valentini D, Mahdavifar S, Reilly M, Ehrnst A, Maeurer M. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501 and DRB1*0401. Clin. Vaccine Immunol. Oct 28 [Epub ahead of print] (2009). *

• Gearry RB, Aitken J, Roberts R, Ismail S, Keenan J, Barclay M. Mycobacterium avium paratuberculosis and Crohn's disease. J. Gastroenterol. Hepatol. 20: 1943 (2005). *

• Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, Matthys P. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 60: 390-395 (2009). *

• Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, Huygen K, Ottenhoff TH. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165: 6463-6471 (2000). *

• George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ. Res. 86: 1203-1210 (2000). *

• Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, Consolaro MR, De Marchi M, Giachino D, Robbiano A, Astegiano M, Sambataro A, Kastelein RA, Carra G, Trinchieri G. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205: 1447-1461 (2008). *

• Geurtsen J, Chedammi S, Mesters J, Cot M, Driessen NN, Sambou T, Kakutani R, Ummels R, Maaskant J, Takata H, Baba O, Terashima T, Bovin N, Vandenbroucke-Grauls CM, Nigou J, Puzo G, Lemassu A, Daffe M, Appelmelk BJ. Identification of mycobacterial alpha-glucan as a novel ligand for DC-SIGN: involvement of mycobacterial capsular polysaccharides in host immune modulation. J. Immunol. 183: 5221-5231 (2009).

• Ghadiali AH, Strother M, Naser SA, Manning EJ, Sreevatsan S. Mycobacterium avium subsp. paratuberculosis strains isolated from Crohn's disease patients and animal species exhibit similar polymorphic locus patterns. J. Clin. Microbiol. 42: 5345-5348 (2004). *

• Ghassemi M, Andersen BR, Roebuck KA, Rabbi MF, Plate JM, Novak RM. Mycobacterium avium complex activates nuclear factor kappaB via induction of inflammatory cytokines. Cell. Immunol. 191: 117-123 (1999). *

• Giardina AR, Accardo-Palumbo A, Ciccia F, Ferrante A, Principato A, Impastato R, Triolo G. Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis? Reumatismo 61: 21-26 (2009). *

• Gibbons DL, Haque SF, Copestake SL, Wells JW, Noble A, Smith AL, Hayday AC. Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol. 2: 144-155 (2009). *

• Gilad J. Antimycobacterial therapy for Crohn's disease. Am. J. Gastroenterol. 95: 2985-2986 (2000). *

• Gilbertson B, Germano S, Steele P, Turner S, de St Groth BF, Cheers C. Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. Infect. Immun. 72: 6884-6891 (2004). *

• Gilleron M, Nigou J, Nicolle D, Quesniaux V, Puzo G. The acylation state of Mycobacterial lipomannans modulates innate immunity response through Toll-like receptor 2. Chem. Biol. 13: 39-47 (2006). *

• Gillespie EE, Kotsanas D, Stuart RL. Microbiological monitoring of endoscopes: 5-year review. J. Gastroenterol. Hepatol. 23: 1069-1074 (2008). *

• Giron RM, Maiz L, Barrio I, Martinez MT, Salcedo A, Prados C. Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study. Arch. Bronconeumol. 44: 679-684 (2008).

• Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A. Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26: S12-S17 (2008).

• Gitnick G. Etiology of inflammatory bowel diseases: where have we been? Where are we going? Scand. J. Gastroenterol. Suppl. 175: 93-96 (1990).

• Gitnick G. Current views of the etiology of inflammatory bowel disease. Semin. Pediatr. Surg. 3: 2-7 (1994).

• Glanemann B, Schonenbrucher H, Bridger N, Abdulmawjood A, Neiger R, Bulte M. Detection of Mycobacterium avium subspecies paratuberculosis-specific DNA by PCR in intestinal biopsies of dogs. J. Vet. Intern. Med. 22: 1090-1094 (2008).

• Glasser AL, Darfeuille-Michaud A. Abnormalities in the handling of intracellular bacteria in Crohn's disease: a link between infectious etiology and host genetic susceptibility. Arch. Immunol. Ther. Exp. (Warsz.) 56: 237-244 (2008).

• Goic-Barisic I, Ledina D, Tonkic M, Luksic B, Barisic I. Lymphoid form of intestinal tuberculosis with miliary dissemination: case report. Acta Med. Croatica 60: 505-508 (2006).

• Gomez LM, Anaya JM, Martin J. Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum. Immunol. 66: 1242-1247 (2005).

• Gomez LM, Camargo JF, Castiblanco J, Ruiz-Narvaez EA, Cadena J, Anaya JM. Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens 67: 290-296 (2006). *

• Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126: 95-99 (2004). *

• Goodgame RW, Kimball K, Akram S, Ike E, Ou CN, Sutton F, Graham D. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease. Aliment. Pharmacol. Ther. 15: 1861-1866 (2001). *

• Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35 (2003).

• Goulart LR, Goulart IM. Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases. Arch. Dermatol. Res. 301: 123-137 (2009). *

• Graham DY, Markesich DC, Yoshimura HH. Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology 92: 436-442 (1987).

• Greenstein RJ. Is Crohn's disease caused by a Mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect. Dis. 3: 507-514 (2003).

• Greenstein RJ, Collins MT. Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet 364: 396-397 (2004). *

• Greenstein RJ, Su L, Haroutunian V, Shahidi A, Brown ST. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLoS ONE 2: e161 (2007). *

• Greenstein RJ, Su L, Juste RA, Brown ST. On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. PLoS ONE 3: e2496 (2008). *

• Greenstein RJ, Su L, Shahidi A, Brown ST. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS ONE 2: e516 (2007). *

• Greenstein RJ, Su L, Whitlock RH, Brown ST. Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture. Gut Pathog. 1: 4 (2009). *

• Grimes DS. Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Gut 52: 155 (2003). *

• Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10: 1081-1088 (2009). *

• Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26: 605-616 (2007). *

• Groenendaal H, Zagmutt FJ. Scenario analysis of changes in consumption of dairy products caused by a hypothetical causal link between Mycobacterium avium subspecies paratuberculosis and Crohn's disease. J. Dairy Sci. 91: 3245-3258 (2008).

• Grotzke JE, Harriff MJ, Siler AC, Nolt D, Delepine J, Lewinsohn DA, Lewinsohn DM. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog. 5: e1000374 (2009). *

• Grover A, Taylor J, Troudt J, Keyser A, Sommersted K, Schenkel A, Izzo AA. Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell. Microbiol. 10: 1390-1404 (2008). *

• Gu Q, Ouyang Q, Zhang WY, Li GD. A comparison of clinical and pathologic characteristics between Crohn's disease and intestinal tuberculosis. Zhonghua Nei Ke Za Zhi 48: 291-294 (2009).

• Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. Mechanisms of disease: the hygiene hypothesis revisited. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 275-284 (2006). *

• Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41: 773-781 (2004). *

• Gumber S, Taylor DL, Marsh IB, Whittington RJ. Growth pattern and partial proteome of Mycobacterium avium subsp. paratuberculosis during the stress response to hypoxia and nutrient starvation. Vet. Microbiol. 133: 344-357 (2009). *

• Gumber S, Whittington RJ. Analysis of the growth pattern, survival and proteome of Mycobacterium avium subsp. paratuberculosis following exposure to heat. Vet. Microbiol. 136: 82-90 (2009). *

• Guo JP, Backdahl L, Marta M, Mathsson L, Ronnelid J, Lorentzen JC. Profound and paradoxical impact on arthritis and autoimmunity of the rat antigen-presenting lectin-like receptor complex. Arthritis Rheum. 58: 1343-1353 (2008). *

• Gupta M, Subramanian V, Yadav J. Immunoproteomic identification of secretory and subcellular protein antigens and functional evaluation of the secretome fraction of Mycobacterium immunogenum, a newly recognized species of the M. chelonae-M. abscessus group. J. Proteome Res. 8: 2319-2330 (2009). *

• Guyot A, Begon E, Abramowitz L, Landry J, Marinho E, Descamps V, Crickx B. A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease. Ann. Dermatol. Venereol. 136: 806-810 (2009).

• Hagge DA, Saunders BM, Ebenezer GJ, Ray NA, Marks VT, Britton WJ, Krahenbuhl JL, Adams LB. Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am. J. Pathol. 174: 1379-1389 (2009).

• Haider D, Dhawahir-Scala FE, Strouthidis NG, Davies N. Acute panuveitis with hypopyon in Crohn's disease secondary to medical therapy; a case report. J. Med. Case Reports. 1: 42 (2007). *

• Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D. Inhibition of anti-tuberculosis T lymphocyte function with tumor necrosis factor antagonists. Arthritis Res. Ther. 8: R114 (2006). *

• Hampson SJ, Parker MC, Saverymuttu SH, Joseph AE, McFadden JJ, Hermon-Taylor J. Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients. Aliment. Pharmacol. Ther. 3: 343-352 (1989).

• Hanawa T, Osaki T, Manzoku T, Fukuda M, Kawakami H, Tomoda A, Kamiya S. In vitro antibacterial activity of Phx-3 against Helicobacter pylori. Biol. Pharm. Bull. 33: 188-191 (2010).

• Hansen R, Thomson JM, El-Omar EM, Hold GL. The role of infection in the aetiology of inflammatory bowel disease. J. Gastroenterol. Jan 15 [Epub ahead of print] (2010). *

• Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, Orange JS. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J. Allergy Clin. Immunol. 122: 1169-1177.e16 (2008). *

• Haraldsen G, Sollid LM, Bakke O, Farstad IN, Kvale D, Molberg, Norstein J, Stang E, Brandtzaeg P. Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology 114: 649-656 (1998). *

• Harfouch-Hammoud EI, Daher NA. Susceptibility to and severity of tuberculosis is genetically controlled by human leukocyte antigens. Saudi Med. J. 29: 1625-1629 (2008).

• Harris J, Hope JC, Keane J. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198: 1842-1850 (2008). *

• Harris JE, Lammerding AM. Crohn's disease and Mycobacterium avium subsp. paratuberculosis: current issues. J. Food Prot. 64: 2103-2110 (2001).

• Hartley RA. Mycobacterium avium-intracellulare infection presenting as a testicular mass in an immunocompromised patient: a case report. Cases J. 2: 8975 (2009). *

• Hasan Z, Jamil B, Khan J, Ali R, Khan MA, Nasir N, Yusuf MS, Jamil S, Irfan M, Hussain R. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand. J. Immunol. 69: 259-267 (2009). *

• Hasan Z, Tanveer M, Kanji A, Hasan Q, Ghebremichael S, Hasan R. Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian strain 1 and Beijing isolates. J. Clin. Microbiol. 44: 1763-1768 (2006). *

• Hawn TR, Dunstan SJ, Thwaites GE, Simmons CP, Thuong NT, Lan NT, Quy HT, Chau TT, Hieu NT, Rodrigues S, Janer M, Zhao LP, Hien TT, Farrar JJ, Aderem A. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis. 194: 1127-1134 (2006). *

• Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT, Chau TT, Rodrigues S, Nachman A, Janer M, Hien TT, Farrar JJ, Aderem A. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur. J. Immunol. 37: 2280-2289 (2007). *

• Hayashi D, Takii T, Fujiwara N, Fujita Y, Yano I, Yamamoto S, Kondo M, Yasuda E, Inagaki E, Kanai K, Fujiwara A, Kawarazaki A, Chiba T, Onozaki K. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains. FEMS Immunol. Med. Microbiol. 56: 116-128 (2009). *

• Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-grand) 49: 277-300 (2003).

• Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG, Kim RB. A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab. Dispos. 36: 500-507 (2008). *

• Hermon-Taylor J. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy. Dig. Liver Dis. 34: 9-12 (2002).

• Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday Scenario. Gut Pathog. 1: 15 (2009). *

• Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis in the causation of Crohn's disease. World J. Gastroenterol. 6: 630-632 (2000). *

• Hermon-Taylor J. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 49: 755-756 (2001). *

• Hermon-Taylor J, Barnes N, Clarke C, Finlayson C. Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease. BMJ 316: 449-453 (1998). *

• Hermon-Taylor J, Bull T. Crohn's disease caused by Mycobacterium avium subspecies paratuberculosis: a public health tragedy whose resolution is long overdue. J. Med. Microbiol. 51: 3-6 (2002). *

• Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can. J. Gastroenterol. 14: 521-539 (2000). *

• Hermon-Taylor J, Moss M, Tizard M, Malik Z, Sanderson J. Molecular biology of Crohn's disease mycobacteria. Baillieres Clin. Gastroenterol. 4: 23-42 (1990).

• Herthnek D, Nielsen SS, Lindberg A, Bolske G. A robust method for bacterial lysis and DNA purification to be used with real-time PCR for detection of Mycobacterium avium subsp. paratuberculosis in milk. J. Microbiol. Methods 75: 335-340 (2008).

• Hervas-Stubbs S, Majlessi L, Simsova M, Morova J, Rojas MJ, Nouze C, Brodin P, Sebo P, Leclerc C. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect. Immun. 74: 3396-3407 (2006). *

• Hida S, Miura NN, Adachi Y, Ohno N. Cell wall beta-glucan derived from Candida albicans acts as a trigger for autoimmune arthritis in SKG mice. Biol. Pharm. Bull. 30: 1589-1592 (2007). *

• Hida S, Nagi-Miura N, Adachi Y, Ohno N. beta-Glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis. Microbiol. Immunol. 50: 453-461 (2006). *

• Hines ME 2nd, Styer EL. Preliminary characterization of chemically generated Mycobacterium avium subsp. paratuberculosis cell wall deficient forms (spheroplasts). Vet. Microbiol. 95: 247-258 (2003). *

• Hirschel B. AIDS and gastrointestinal tract: a summary for gastroenterologists and surgeons. Schweiz. Med. Wochenschr. 120: 475-484 (1990).

• Hizawa K, Nagata Y, Kudo T, Taniguchi M, Matsumoto T, Iida M. A case of steroid-dependent ulcerative colitis complicated by skin infection of Mycobacterium szulgai. Nippon Shokakibyo Gakkai Zasshi 106: 1359-1363 (2009).

• Hoeve MA, de Boer T, Langenberg DM, Sanal O, Verreck FA, Ottenhoff TH. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur. J. Immunol. 33: 3393-3397 (2003). *

• Holland SM. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol. Res. 38: 342-346 (2007).

• Holscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167: 6957-6966 (2001). *

• Hong YH, Lee CK. Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma. Rheumatol. Int. 29: 569-573 (2009). *

• Honscheid A, Rink L, Haase H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr. Metab. Immune Disord. Drug Targets 9: 132-134 (2009).

• Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, Mascart F. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am. J. Respir. Crit. Care Med. 176: 409-416 (2007). *

• Huang J, Liao C, Wu L, Cao Y, Gao F. A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn's disease. Colorectal Dis. Dec 21 [Epub ahead of print] (2009). *

• Huang MN, Yu H, Moudgil KD. The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal. Semin. Arthritis Rheum. Dec 5 [Epub ahead of print] (2009). *

• Hubbard J, Surawicz CM. Etiological role of mycobacterium in Crohn's disease: an assessment of the literature. Dig. Dis. 17: 6-13 (1999).

• Huiras E, Preda V, Maurer T, Whitfeld M. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr. Opin. HIV AIDS 3: 453-460 (2008).

• Hulten K, Almashhrawi A, El-Zaatari FA, Graham DY. Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria. Dig. Dis. Sci. 45: 445-456 (2000). *

• Hulten K, El-Zimaity HM, Karttunen TJ, Almashhrawi A, Schwartz MR, Graham DY, El-Zaatari FA. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am. J. Gastroenterol. 96: 1529-1535 (2001). *

• Huszti Z, Bene L, Kovacs A, Fekete B, Fust G, Romics L, Singh M, Prohaszka Z. Low levels of antibodies against E. coli and mycobacterial 65kDa heat shock proteins in patients with inflammatory bowel disease. Inflamm. Res. 53: 551-555 (2004). *

• Hwang SA, Actor JK. Lactoferrin modulation of BCG-infected dendritic cell functions. Int. Immunol. 21: 1185-1197 (2009).

• Ibbotson JP, Lowes JR, Chahal H, Gaston JS, Life P, Kumararatne DS, Sharif H, Alexander-Williams J, Allan RN. Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 87: 224-230 (1992). *

• Iglesias Alzueta J, Matamoros Florí N. Common variable immunodeficiency. Review. Allergol. Immunopathol. (Madr.) 29: 113-118 (2001).

• Ikonomopoulos J, Balaskas C, Kantzoura B, Fragiadaki E, Pavlik I, Bartos M, Lukas JC, Gazouli M. Comparative evaluation of positive tests to Mycobacterium avium subsp. paratuberculosis in clinically healthy sheep and goats in South-West Greece using molecular techniques, serology, and culture. Vet. J. 174: 337-343 (2007). *

• Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Zacharatos PV, Kokotas SN, Evangelou K, Kotsinas AG, Tsakris AG, Manolis EN, Kittas CN. Sensitive differential detection of genetically related mycobacterial pathogens in archival material. Am. J. Clin. Pathol. 114: 940-950 (2000). *

• Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165: 6107-6115 (2000). *

• Inge LD, Wilson JW. Update on the treatment of tuberculosis. Am. Fam. Physician 78: 457-465 (2008).

• Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51: 1537-1540 (2007). *

• Irie T, Maeda Y, Aida T, Sumitani K, Nagumo M, Tachikawa T. Multiple granulomatous inflammation in the minor salivary glands: a proposed new entity, allergic granulomatous sialadenitis. Pathol. Int. 54: 850-853 (2004). *

• Ismail Y, Muhamad A. Protean manifestations of gastrointestinal tuberculosis. Med. J. Malaysia 58: 345-349 (2003).

• Issekutz AC, Sapru K. Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action. Int. Immunopharmacol. 8: 708-716 (2008).

• Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, Chensue SW, Kunkel SL. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J. Clin. Invest. 119: 33-46 (2009). *

• Jacobs M, Samarina A, Grivennikov S, Botha T, Allie N, Fremond C, Togbe D, Vasseur V, Rose S, Erard F, Monteiro A, Nedospasov S, Quesniaux V, Ryffel B. Review: reactivation of tuberculosis by tumor necrosis factor neutralization. Eur. Cytokine Netw. 18: 1-9 (2007).

• Jacobs M, Togbe D, Fremond C, Samarina A, Allie N, Botha T, Carlos D, Parida SK, Grivennikov S, Nedospasov S, Monteiro A, Le Bert M, Quesniaux V, Ryffel B. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect. 9: 623-628 (2007). *

• Jang S, Uzelac A, Salgame P. Distinct chemokine and cytokine gene expression pattern of murine dendritic cells and macrophages in response to Mycobacterium tuberculosis infection. J. Leukoc. Biol. 84: 1264-1270 (2008). *

• Jantchou P, Monnet E, Carbonnel F. Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy). Gastroenterol. Clin. Biol. 30: 859-867 (2006).

• Jaravata CV, Smith WL, Rensen GJ, Ruzante J, Cullor JS. Survey of ground beef for the detection of Mycobacterium avium paratuberculosis. Foodborne Pathog. Dis. 4: 103-106 (2007).

• Jason J, Archibald LK, Nwanyanwu OC, Sowell AL, Buchanan I, Larned J, Bell M, Kazembe PN, Dobbie H, Jarvis WR. Vitamin A levels and immunity in humans. Clin. Diagn. Lab. Immunol. 9: 616-621 (2002). *

• Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, Ronco P, Rondeau E, Fain O. Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) 86: 170-180 (2007).

• Javidan-Nejad C, Bhalla S. Bronchiectasis. Radiol. Clin. North Am. 47: 289-306 (2009).

• Jeevan A, Bonilla DL, McMurray DN. Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route. Immunology 128: e296-e305 (2009).

• Jesus Cremades M, Luiza de Souza-Galvao M, García JM, Menendez R. Respiratory infections research: a perspective from the tuberculosis and respiratory infections area (TIR). Arch. Bronconeumol. 45 Suppl. 1: 11-15 (2009).

• Jeyanathan M, Alexander DC, Turenne CY, Girard C, Behr MA. Evaluation of in situ methods used to detect Mycobacterium avium subsp. paratuberculosis in samples from patients with Crohn's disease. J. Clin. Microbiol. 44: 2942-2950 (2006). *

• Jeyanathan M, Boutros-Tadros O, Radhi J, Semret M, Bitton A, Behr MA. Visualization of Mycobacterium avium in Crohn's tissue by oil-immersion microscopy. Microbes Infect. 9: 1567-1573 (2007). *

• Jin J, Sun L, Jiao W, Zhao S, Li H, Guan X, Jiao A, Jiang Z, Shen A. SLC11A1 (formerly NRAMP1) gene polymorphisms associated with pediatric tuberculosis in China. Clin. Infect. Dis. 48: 733-738 (2009). *

• Jin JL, Zhang WH, Hu ZY, Chen S, Weng XH. A new multiplex allele-specific polymerase chain reaction assay for detection of rifampin-resistant Mycobacterium tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 28: 623-625 (2005).

• Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell. Microbiol. 9: 1087-1098 (2007). *

• Johansen IS. Rapid diagnoses of mycobacterial diseases, and their implication on clinical management. Dan. Med. Bull. 53: 28-45 (2006).

• Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 178: 7520-7524 (2007). *

• Johnson CM, Traherne JA, Jamieson SE, Tremelling M, Bingham S, Parkes M, Blackwell JM, Trowsdale J. Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease. Tissue Antigens 69: 236-241 (2007). *

• Jones PH, Farver TB, Beaman B, Cetinkaya B, Morgan KL. Crohn's disease in people exposed to clinical cases of bovine paratuberculosis. Epidemiol. Infect. 134: 49-56 (2006). *

• Jonsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J. Clin. Microbiol. 45: 1497-1504 (2007). *

• Joplin R. Infectious etiology of primary biliary cirrhosis? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 19-20. October 15-16 (2003). *

• Jordan PW, Stanley T, Donnelly FM, Elborn JS, McClurg RB, Millar BC, Goldsmith CE, Moore JE. Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods. Lett. Appl. Microbiol. 44: 459-466 (2007). *

• Jordan RW, Stanley T, Donnelly FM, Elborn JS, McClurg RB, Millar BC, Goldsmith CE, Rendall J, Moore JE. Non-tuberculous mycobacterial infection in adult patients with cystic fibrosis: comparison of three decontamination methods. Br. J. Biomed. Sci. 65: 28-30 (2008).

• Jordao L, Lengeling A, Bordat Y, Boudou F, Gicquel B, Neyrolles O, Becker PD, Guzman CA, Griffiths G, Anes E. Effects of omega-3 and -6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect. 10: 1379-1386 (2008). *

• Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik TH, Song CH, Jo EK. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect. Immun. 74: 2686-2696 (2006). *

• Jurado JO, Alvarez IB, Pasquinelli V, Martínez GJ, Quiroga MF, Abbate E, Musella RM, Chuluyan HE, Garcia VE. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J. Immunol. 181: 116-125 (2008). *

• Juste RA, Elguezabal N, Garrido JM, Pavon A, Geijo MV, Sevilla I, Cabriada JL, Tejada A, García-Campos F, Casado R, Ochotorena I, Izeta A, Greenstein RJ. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS ONE 3: e2537 (2008). *

• Juste RA, Elguezabal N, Pavon A, Garrido JM, Geijo M, Sevilla I, Cabriada JL, Tejada A, García-Campos F, Casado R, Ochotorena I, Izeta A. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int. J. Infect. Dis. 13: 247-254 (2009).

• Kahler AK, Persson AS, Sanchez F, Kallstrom H, Apt AS, Schurr E, Lavebratt C. A new coding mutation in the TNF-alpha leader sequence in tuberculosis-sensitive I/St mice causes higher secretion levels of soluble TNF-alpha. Genes Immun. 6: 620-627 (2005). *

• Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118: 233-239 (2006). *

• Kallinowski F, Wassmer A, Hofmann MA, Harmsen D, Heesemann J, Karch H, Herfarth C, Buhr HJ. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease. Hepatogastroenterology 45: 1552-1558 (1998).

• Kamath AT, Rochat AF, Christensen D, Agger EM, Andersen P, Lambert PH, Siegrist CA. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS ONE 4: e5771 (2009). *

• Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, Andersen P, Lambert PH, Siegrist CA. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS ONE 3: e3683 (2008). *

• Kamath AT, Valenti MP, Rochat AF, Agger EM, Lingnau K, von Gabain A, Andersen P, Lambert PH, Siegrist CA. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur. J. Immunol. 38: 1247-1256 (2008). *

• Kamm MA. Manipulation of enteric flora in clinical practice. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 36. May 7-8 (2004). *

• Kanazawa K, Haga Y, Funakoshi O, Nakajima H, Munakata A, Yoshida Y. Absence of Mycobacterium paratuberculosis DNA in intestinal tissues from Crohn's disease by nested polymerase chain reaction. J. Gastroenterol. 34: 200-206 (1999).

• Kang TJ, Yeum CE, Kim BC, You EY, Chae GT. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 112: 674-680 (2004). *

• Kapoor N, Narayana Y, Patil SA, Balaji KN. Nitric oxide is involved in Mycobacterium bovis Bacillus Calmette-Guerin-activated Jagged1 and Notch1 signaling. J. Immunol. Feb 10 [Epub ahead of print] (2010).

• Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radiol. 35: 154-167 (2000).

• Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr. Drug Targets Inflamm. Allergy 4: 273-279 (2005).

• Kasperbauer SH, Daley CL. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin. Respir. Crit. Care Med. 29: 569-576 (2008).

• Kassan H, Cohavy O, Rosenbaum JT, Braun J, Gordon LK. Uveitis seroreactivity to candidate pANCA antigens: mycobacterial HupB and histone H1(69-171). Ocul. Immunol. Inflamm. 13: 191-198 (2005).

• Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1: 20-30 (2001). *

• Kelchtermans H, Struyf S, De Klerck B, Mitera T, Alen M, Geboes L, Van Balen M, Dillen C, Put W, Gysemans C, Billiau A, Van Damme J, Matthys P. Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 (GCP-2) production. J. Leukoc. Biol. 81: 1044-1053 (2007). *

• Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM. IL-23 and IL-17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8: 369-377 (2007). *

• Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, Pearl JE, Ghilardi N, Desauvage FJ, Lund FE, Cooper AM. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203: 1805-1815 (2006). *

• Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175: 788-795 (2005). *

• Khare S, Nunes J, Figueiredo J, Lawhon S, Rossetti C, Gull T, Rice-Ficht A, Adams LG. Early phase morphological lesions and transcriptional responses of bovine ileum infected with Mycobacterium avium subsp. paratuberculosis. Vet. Pathol. 46: 717-728 (2009).

• Kim EY, Chi HH, Bouziane M, Gaur A, Moudgil KD. Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma. Clin. Immunol. 127: 98-106 (2008). *

• Kim HJ, Chung DH, Kim MJ, Jang JH, Kim YW, Han SK, Shim YS, Yim JJ. Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance. Int. J. Tuberc. Lung Dis. 12: 1071-1076 (2008).

• Kim HR, Kim EY, Cerny J, Moudgil KD. Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis. J. Immunol. 177: 6634-6641 (2006). *

• Kim HR, Rajaiah R, Wu QL, Satpute SR, Tan MT, Simon JE, Berman BM, Moudgil KD. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. J. Nutr. 138: 2111-2116 (2008). *

• Kim RD, Greenberg DE, Ehrmantraut ME, Ding L, Shea Y, Chernick M, Jolley C, Raffeld M, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Fitzgerald A, Darnell D, Decastro R, Porcella SF, Olivier KN, Moss J, Holland SM. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 178: 1066-1074 (2008). *

• Kim SK, Kim YM, Yeum CE, Jin SH, Chae GT, Lee SB. Rifampicin inhibits the LPS-induced expression of Toll-like receptor 2 via the suppression of NF-kappaB DNA-binding activity in RAW 264.7 cells. Korean J. Physiol. Pharmacol. 13: 475-482 (2009). *

• Kim SY, Shin AR, Kim HJ, Cho SN, Park JK, Shin SJ. Identification of Rv2041c, a novel immunogenic antigen from Mycobacterium tuberculosis with serodiagnostic potential. Scand. J. Immunol. 70: 457-464 (2009). *

• King P. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 67: 965-974 (2007).

• Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG, Cameron DJ, Bishop RF. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm. Bowel Dis. 15: 1643-1655 (2009). *

• Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270: 121-144 (2002).

• Klein R, Wiebel M, Engelhart S, Berg PA. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin. Exp. Immunol. 92: 308-316 (1993). *

• Kleinnijenhuis J, Joosten LA, van de Veerdonk FL, Savage N, van Crevel R, Kullberg BJ, van der Ven A, Ottenhoff TH, Dinarello CA, van der Meer JW, Netea MG. Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis. Eur. J. Immunol. 39: 1914-1922 (2009). *

• Klucar P, Barnes PF, Kong Y, Howard ST, Pang X, Huang FF, Tvinnereim AR, Samten B, Shams H. Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis. Vaccine 27: 1816-1824 (2009).

• Knosel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn's disease. Pathol. Res. Pract. 205: 223-230 (2009).

• Kobashi Y, Yoshida K, Niki Y, Oka M. Sibling cases of Mycobacterium avium complex disease associated with hematological disease. J. Infect. Chemother. 12: 331-334 (2006). *

• Kocian J, Kocianova J. Current views on the development and course of Crohn's disease. Cas. Lek. Cesk. 138: 486-490 (1999).

• Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128: 94-101 (2005). *

• Kolokotronis A, Avramidou E, Zaraboukas T, Mandraveli K, Alexiou S, Antoniades D. Oral tuberculosis associated with a treatment with anti-rheumatic drugs. J. Oral. Pathol. Med. 35: 123-125 (2006).

• Konno AY, Maricato J, Konno FT, Mariano M, Lopes JD. Peptides from Paracoccidioides brasiliensis GP43 inhibit macrophage functions and inflammatory response. Microbes Infect. 11: 92-99 (2009). *

• Koo HC, Park YH, Hamilton MJ, Barrington GM, Davies CJ, Kim JB, Dahl JL, Waters WR, Davis WC. Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves. Infect. Immun. 72: 6870-6883 (2004). *

• Korbel DS, Schneider B, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 10: 995-1004 (2008). *

• Korf H, Vander Beken S, Romano M, Steffensen KR, Stijlemans B, Gustafsson JA, Grooten J, Huygen K. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Invest. 119: 1626-1637 (2009). *

• Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J. Clin. Gastroenterol. 39: S59-S65 (2005).

• Kraft A, Kreuter M, Herth FJ, Wiebel M. Relapsing solitary pulmonary nodule in a patient with ulcerative colitis. Dtsch. Med. Wochenschr. 134: 511-514 (2009).

• Kreuzpaintner G, Das PK, Stronkhorst A, Slob AW, Strohmeyer G. Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease. Gut 37: 361-366 (1995). *

• Kreuzpaintner G, Kirschner P, Wallner A, Kolble R, Hesterberg R, Thomas L, Borchard F. Mycobacteria of Runyon groups I, II and IV do not play an aetiological role in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 7: 1177-1182 (1995).

• Krishnan MY, Manning EJ, Collins MT. Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis. J. Antimicrob. Chemother. 64: 1018-1023 (2009).

• Krishnan MY, Manning EJ, Collins MT. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J. Antimicrob. Chemother. 64: 310-316 (2009).

• Kruis W. Antibiotics and probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 75-78 (2004). *

• Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, Modlin RL. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181: 7115-7120 (2008). *

• Kuenstner JT. Mycobacterium avium subspecies paratuberculosis: a human pathogen causing most cases of Crohn's disease. Am. J. Gastroenterol. 101: 1157-1158 (2006). *

• Kumar M, Sundaramurthi JC, Mehra NK, Kaur G, Raja A. Cellular immune response to Mycobacterium tuberculosis-specific antigen culture filtrate protein-10 in south India. Med. Microbiol. Immunol. Nov 10 [Epub ahead of print] (2009). *

• Kumawat K, Pathak SK, Spetz AL, Kundu M, Basu J. Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factor alpha production and macrophage apoptosis. J. Biol. Chem. Jan 12 [Epub ahead of print] (2010). *

• Kundu M, Pathak SK, Kumawat K, Basu S, Chatterjee G, Pathak S, Noguchi T, Takeda K, Ichijo H, Thien CB, Langdon WY, Basu J. A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat. Immunol. 10: 918-926 (2009). *

• Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, Kaufmann SH. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178: 2661-2665 (2007). *

• Lafuse WP, Alvarez GR, Curry HM, Zwilling BS. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN-gamma-induced gene expression by TLR2-dependent and independent pathways. J. Interferon Cytokine Res. 26: 548-561 (2006).

• Lagranderie M, Abolhassani M, Vanoirbeek JA, Lima C, Balazuc AM, Vargaftig BB, Marchal G. Mycobacterium bovis Bacillus Calmette-Guerin killed by extended freeze-drying targeted plasmacytoid dendritic cells to regulate lung inflammation. J. Immunol. 184: 1062-1070 (2010).

• Laguna TA, Sagel SD, Sontag MK, Accurso FJ. The clinical course of a Mexican female with cystic fibrosis and the novel genotype S531P/S531P. J. Cyst. Fibros. 7: 454-456 (2008).

• Lala S, Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Rook GA, Keshav SA, Zumla A. The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis. BMC Infect. Dis. 7: 96 (2007). *

• Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, Blitz R, Branson K, Fine PE, Dockrell HM. Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine Nov 23 [Epub ahead of print] (2009).

• Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J. Rheumatol. 33: 817-819 (2006).

• Lamhonwah AM, Ackerley C, Onizuka R, Tilups A, Lamhonwah D, Chung C, Tao KS, Tellier R, Tein I. Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31. Biochem. Biophys. Res. Commun. 337: 1165-1175 (2005). *

• Lampropoulou V, Hoehlig K, Roch T, Neves P, Gomez EC, Sweenie CH, Hao Y, Freitas AA, Steinhoff U, Anderton SM, Fillatreau S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180: 4763-4773 (2008). *

• Lang T, Prina E, Sibthorpe D, Blackwell JM. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect. Immun. 65: 380-386 (1997). *

• Lange C, Hellmich B, Ernst M, Ehlers S. Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy. Nat. Clin. Pract. Rheumatol. 3: 528-534 (2007). *

• Laramore AP, Rubinas TC, Varnholt H. Mycobacterium avium complex in the liver. Ann. Hepatol. 8: 241 (2009).

• Larcombe LA, Orr PH, Lodge AM, Brown JS, Dembinski IJ, Milligan LC, Larcombe EA, Martin BD, Nickerson PW. Functional gene polymorphisms in Canadian Aboriginal populations with high rates of tuberculosis. J. Infect. Dis. 198: 1175-1179 (2008). *

• Lau CF, Wong AM, Yee KS, Loo CK, Hui PK, Lam KM. A case of colonic tuberculosis mimicking Crohn's disease. Hong Kong Med. J. 4: 63-66 (1998).

• Leandro AC, Rocha MA, Cardoso CS, Bonecini-Almeida MG. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz. J. Med. Biol. Res. 42: 312-322 (2009). *

• Lee J, Kim HR, Min JW, Park JS, Jin SM, Han SK, Shim YS, Yim JJ. Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans. J. Korean Med. Sci. 22: 667-671 (2007). *

• Lee J, Reinke EK, Zozulya AL, Sandor M, Fabry Z. Mycobacterium bovis Bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J. Immunol. 181: 6201-6212 (2008). *

• Lee JS, Shin SJ, Collins MT, Jung ID, Jeong YI, Lee CM, Shin YK, Kim D, Park YM. Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization. Infect. Immun. 77: 2979-2988 (2009). *

• Lefkowitch JH. Pathology of AIDS-related liver disease. Dig. Dis. 12: 321-330 (1994).

• Legrand F, Driss V, Woerly G, Loiseau S, Hermann E, Fournie JJ, Heliot L, Mattot V, Soncin F, Gougeon ML, Dombrowicz D, Capron M. A functional gammadeltaTCR/CD3 complex distinct from gammadelta T cells is expressed by human eosinophils. PLoS One 4: e5926 (2009). *

• Lehmann D, Ben-Nun A. Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J. Autoimmun. 5: 675-690 (1992).

• Lehmann FS. Pathophysiology of inflammatory bowel disease. Ther. Umsch. 60: 127-132 (2003).

• Lenarczyk A, Helsloot J, Farmer K, Peters L, Sturgess A, Kirkham B. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin. Exp. Immunol. 122: 41-48 (2000). *

• Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, Yahav Y, Rahav G. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg. Infect. Dis. 14: 378-384 (2008). *

• Li X, McKinstry KK, Swain SL, Dalton DK. IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 179: 939-949 (2007). *

• Lian Y, Yue J, Han M, Liu J, Liu L. Analysis of the association between BTNL2 polymorphism and tuberculosis in Chinese Han population. Infect. Genet. Evol. Feb 19 [Epub ahead of print] (2010).

• Liang FC, Wei YC, Jiang TH, Hsiehi MY, Wen YC, Chiou YS, Wu SH, Chen LC, Huang JL, Lee WI. Current classification and status of primary immunodeficiency diseases in Taiwan. Acta Paediatr. Taiwan 49: 3-8 (2008).

• Lidar M, Langevitz P, Shoenfeld Y. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr. Med. Assoc. J. 11: 558-563 (2009). *

• Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, Klein E, Flynn JL. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62: 340-350 (2010). *

• Lin PL, Plessner HL, Voitenok NN, Flynn JL. Tumor necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc. 12: 22-25 (2007). *

• Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810 (2009). *

• Lisby G, Andersen J, Engbaek K, Binder V. Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand. J. Gastroenterol. 29: 923-929 (1994).

• Little MA, Smyth L, Salama AD, Mukherjee S, Smith J, Haskard D, Nourshargh S, Cook HT, Pusey CD. Experimental autoimmune vasculitis. An animal model of antineutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am. J. Pathol. 174: 1212-1220 (2009). *

• Liu J, Fujiwara TM, Buu NT, Sanchez FO, Cellier M, Paradis AJ, Frappier D, Skamene E, Gros P, Morgan K, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am. J. Hum. Genet. 56: 845-853 (1995). *

• Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol. Med. 13: 117-124 (2007). *

• Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, Vazirnia A, Zhang X, Steinmeyer A, Zugel U, Hollis BW, Cheng G, Modlin RL. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 4: e5810 (2009). *

• Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773 (2006). *

• Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179: 2060-2063 (2007). *

• Lizardi-Cervera J, Soto Ramirez LE, Poo JL, Uribe M. Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: frequency and clinical manifestations. Ann. Hepatol. 4: 188-191 (2005). *

• Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662-4669 (2006). *

• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517 (2004). *

• Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum. Immunol. 67: 643-654 (2006).

• Lozano-Leon A, Barreiro-de Acosta M, Dominguez-Munoz JE. Absence of Mycobacterium avium subspecies paratuberculosis in Crohn's disease patients. Inflamm. Bowel Dis. 12: 1190-1192 (2006). *

• Lu Y, Kim BS, Pope RM. Clonal heterogeneity of synovial fluid T lymphocytes in inflammatory synovitis. Clin. Immunol. Immunopathol. 63: 28-33 (1992).

• Luft FC. NOD takes its Toll but stays in the CARDs in Crohn's disease. J. Mol. Med. 83: 577-578 (2005). *

• Lund BM, Gould GW, Rampling AM. Pasteurization of milk and the heat resistance of Mycobacterium avium subsp. paratuberculosis: a critical review of the data. Int. J. Food Microbiol. 77: 135-145 (2002).

• Luo Y, Han R, Evanoff DP, Chen X. Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against bladder cancer cells. Clin. Exp. Immunol. Feb 10 [Epub ahead of print] (2010). *

• Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 226: 112-131 (2008). *

• Lykouras D, Sampsonas F, Kaparianos A, Karkoulias K, Tsoukalas G, Spiropoulos K. Human genes in TB infection: their role in immune response. Monaldi Arch. Chest Dis. 69: 24-31 (2008).

• Ma X, Cheung C, Krausz KW, Shah Y, Wang T, Idle JR, Gonzalez FJ. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4. Drug Metab. Dispos. 36: 2506-2512 (2008). *

• Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM. Full-exon resequencing reveals Toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2: e1318 (2007). *

• MacDonald TT, Murch SH. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin. Gastroenterol. 8: 1-34 (1994).

• Machado FS, Aliberti J. Role of lipoxin in the modulation of immune response during infection. Int. Immunopharmacol. 8: 1316-1319 (2008).

• Macintyre CR. New developments in BCG vaccine: implications for tuberculosis control. Epidemiol. Infect. 135: 177-180 (2007).

• MacLennan C, Fieschi C, Lammas DA, Picard C, Dorman SE, Sanal O, MacLennan JM, Holland SM, Ottenhoff TH, Casanova JL, Kumararatne DS. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 190: 1755-1757 (2004). *

• MacLennan C, Lammas DA, Kumararatne DS. Anti-interleukin-12 antibody treatment for Crohn disease: potential risk of invasive disease due to mycobacteria and salmonellae infection. Clin. Infect. Dis. 40: 1381-1382 (2005). *

• Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR. Does melatonin play a disease-promoting role in rheumatoid arthritis? J. Neuroimmunol. 158: 106-111 (2005).

• Maglione PJ, Xu J, Casadevall A, Chan J. Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J. Immunol. 180: 3329-3338 (2008). *

• Mahon RN, Rojas RE, Fulton SA, Franko J, Harding CV, Boom WH. Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T cell activation by interfering with proximal T cell receptor signaling. Infect. Immun. 77: 4574-4583 (2009). *

• Mai HN, Hijikata M, Inoue Y, Suzuki K, Sakatani M, Okada M, Kimura K, Kobayashi N, Toyota E, Kudo K, Nagai H, Kurashima A, Kajiki A, Oketani N, Hayakawa H, Tanaka G, Shojima J, Matsushita I, Sakurada S, Tokunaga K, Keicho N. Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene. Int. J. Tuberc. Lung Dis. 11: 808-813 (2007).

• Maiden MC. Putting leprosy on the map. Nat. Genet. 41: 1264-1266 (2009). *

• Maimon N, Brunton J, Chan AK, Marras TK. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax 62: 739-740 (2007). *

• Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouze C, Ladant D, Cole ST, Sebo P, Leclerc C. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect. Immun. 74: 2128-2137 (2006). *

• Majoor CJ, Schreurs AJ, Weers-Pothoff G. Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. Thorax 59: 631-632 (2004). *

• Malhotra D, Relhan V, Reddy BS, Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: revisited. Hum. Genet. 116: 413-415 (2005). *

• Malik S, Abel L, Tooker H, Poon A, Simkin L, Girard M, Adams GJ, Starke JR, Smith KC, Graviss EA, Musser JM, Schurr E. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc. Natl. Acad. Sci. U.S.A. 102: 12183-12188 (2005). *

• Marcenaro E, Ferranti B, Falco M, Moretta L, Moretta A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int. Immunol. 20: 1155-1167 (2008).

• Marengo EB, Commodaro AG, Peron JP, de Moraes LV, Portaro FC, Belfort R, Rizzo LV, Sant'anna OA. Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice. PLoS One 4: e7912 (2009). *

• Marinic I, Gagro A, Rabatic S. Regulatory T cells. Acta Med. Croatica 60: 447-456 (2006).

• Markesich DC, Sawai ET, Butel JS, Graham DY. Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins. Dig. Dis. Sci. 36: 454-460 (1991).

• Marquina-Castillo B, García-Garcia L, Ponce-de-Leon A, Jimenez-Corona ME, Bobadilla-Del Valle M, Cano-Arellano B, Canizales-Quintero S, Martinez-Gamboa A, Kato-Maeda M, Robertson B, Young D, Small P, Schoolnik G, Sifuentes-Osornio J, Hernandez-Pando R. Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model. Immunology 128: 123-133 (2009). *

• Marquis JF, Lacourse R, Ryan L, North RJ, Gros P. Genetic and functional characterization of the mouse Trl3 locus in defense against tuberculosis. J. Immunol. 182: 3757-3767 (2009).

• Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N, Packe GE, Davidson RN, Griffiths CJ, Wilkinson RJ. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest. 117: 1988-1994 (2007). *

• Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, Davidson RN, Sorensen OE, Kampmann B, Griffiths CJ, Wilkinson RJ. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 178: 7190-7198 (2007). *

• Martino A, Badell E, Abadie V, Balloy V, Chignard M, Mistou MY, Combadiere B, Combadiere C, Winter N. Mycobacterium bovis Bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. Jan 18 [Epub ahead of print] (2010).

• Martins de Sousa E, Bonfim de Bortoli F, Amaral EP, Batista AC, Kipnis TL, Cardoso AM, Kipnis A, Junqueira-Kipnis AP. Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice. Infect. Immun. Feb 1 [Epub ahead of print] (2010). *

• Maschmeyer G, Haas A. Infectious complications related to nucleoside analogs and monoclonal antibodies. Dtsch. Med. Wochenschr. 131: 2414-2419 (2006).

• Mason A, Nair S. Primary biliary cirrhosis: new thoughts on pathophysiology and treatment. Curr. Gastroenterol. Rep. 4: 45-51 (2002).

• Mason CM, Porretta E, Zhang P, Nelson S. CD4(+) CD25(+) transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin. Exp. Immunol. 148: 537-545 (2007). *

• Matejuk A, Afentoulis M. Association of CD45(dim)VLA-4 (+) cells with the NKT cell lineage and their selective expression of IL-13, IP-15, and CCR3 transcripts. Arch. Immunol. Ther. Exp. (Warsz.) 54: 183-191 (2006).

• Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsubouchi H, Sasaki H, Shimokawa Y, Komatsu M. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med. 3: e466 (2006). *

• Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51: 1139-1147 (2007). *

• Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, Lawson GH, Rowland AC, Berkhoff GA, Barthold SW. Agglutinins to bacteria in Crohn's disease. Gut 21: 376-380 (1980). *

• Matthys P. The effect of interferon-gamma in collagen-induced arthritis in mice shows a mechanism of expanding Mac-1+ blood cells during its pathogenesis. Verh. K. Acad. Geneeskd. Belg. 67: 125-137 (2005).

• Mattoch IW, Pham N, Robbins JB, Bogomilsky J, Tandon M, Kohler S. Reactive eccrine syringofibroadenoma arising in peristomal skin: an unusual presentation of a rare lesion. J. Am. Acad. Dermatol. 58: 691-696 (2008).

• Matulis G, Juni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases - performance of a Mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann. Rheum. Dis. 67: 84-90 (2008).

• Mayanja-Kizza H, Wu M, Aung H, Liu S, Luzze H, Hirsch C, Toossi Z. The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis. Scand. J. Immunol. 69: 516-520 (2009). *

• McFadden J, Collins J, Beaman B, Arthur M, Gitnick G. Mycobacteria in Crohn's disease: DNA probes identify the wood pigeon strain of Mycobacterium avium and Mycobacterium paratuberculosis from human tissue. J. Clin. Microbiol. 30: 3070-3073 (1992). *

• McFadden JJ, Butcher PD, Chiodini R, Hermon-Taylor J. Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species. J. Clin. Microbiol. 25: 796-801 (1987). *

• Meconi S, Vercellone A, Levillain F, Payre B, Al Saati T, Capilla F, Desreumaux P, Darfeuille-Michaud A, Altare F. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cell. Microbiol. 9: 1252-1261 (2007). *

• Medici V, Rossaro L, Balasubramanian S, Cohen SH. Chapter 12. Innate and adaptive immune responses to bacterial and parasite infections: clinicopathological consequences. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 153-162 (2007). *

• Medjahed H, Gaillard JL, Reyrat JM. Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol. Jan 7 [Epub ahead of print] (2010). *

• Medjahed H, Reyrat JM. Construction of defined glycopeptidolipid mutants in Mycobacterium abscessus: comparison of genetic tools. Appl. Environ. Microbiol. 75: 1331-1338 (2009). *

• Mehta S, Fantry L. Gastrointestinal infections in the immunocompromised host. Curr. Opin. Gastroenterol. 21: 39-43 (2005).

• Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170: 1406-1415 (2003). *

• Mendez-Samperio P. Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease. Int. J. Infect. Dis. Sep 15 [Epub ahead of print] (2009).

• Mendez-Samperio P, Belmont L, Miranda E. Mycobacterium bovis BCG Toll-like receptors 2 and 4 cooperation increases the innate epithelial immune response. Arch. Med. Res. 39: 33-39 (2008).

• Mendoza JL, Lana R, Diaz-Rubio M. Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J. Gastroenterol. 15: 417-422 (2009). *

• Menon KVN, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am. J. Gastroenterol. 99: 255-260 (2004). *

• Metcalf C. Crohn’s disease: an overview. Nurs. Stand. 16: 45-52 (2002). *

• Metcalf JV, Howel D, James OF, Bhopal R. Primary biliary cirrhosis: epidemiology helping the clinician. BMJ 312: 1181-1182 (1996). *

• Mia MY, Kim EY, Satpute SR, Moudgil KD. The dynamics of articular leukocyte trafficking and the immune response to self heat-shock protein 65 influence arthritis susceptibility. J. Clin. Immunol. 28: 420-431 (2008). *

• Miguel Gomez L, Anaya JM, Ramon Vilchez J, Cadena J, Hinojosa R, Velez L, Angel Lopez-Nevot M, Martin J. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb.) 87: 288-294 (2007).

• Miletic T, Kovacevic-Jovanovic V, Vujic V, Stanojevic S, Mitic K, Lazarevic-Macanovic M, Dimitrijevic M. Reactive oxygen species (ROS), but not nitric oxide (NO), contribute to strain differences in the susceptibility to experimental arthritis in rats. Immunobiology 212: 95-105 (2007).

• Miller EA, Ernst JD. Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J. Clin. Invest. 119: 1079-1082 (2009). *

• Minegishi Y. Hyper-IgE syndrome. Curr. Opin. Immunol. 21: 487-492 (2009).

• Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int. Immunol. 21: 105-112 (2009). *

• Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755 (2006). *

• Miniello S, Testini M, Piccinni G, Urgesi G, Lissidini G, Tomasicchio N, Centonze A, Bonomo GM. The uncertain primary diagnosis of inflammatory bowel diseases. Panminerva Med. 44: 233-236 (2002).

• Miranda A, Amadeu TP, Schueler G, Alvarenga FB, Duppre N, Ferreira H, Nery JA, Sarno EN. Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology 51: 649-656 (2007).

• Mishina D, Katsel P, Brown ST, Gilberts EC, Greenstein RJ. On the etiology of Crohn disease. Proc. Natl. Acad. Sci. U.S.A. 93: 9816-9820 (1996). *

• Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North RJ, Gros P. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun. 1: 467-477 (2000). *

• Miyazaki J, Kawai K, Oikawa T, Johraku A, Hattori K, Shimazui T, Akaza H. Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guerin through Toll-like receptor signalling. BJU Int. 97: 860-854 (2006).

• Moalem S, Weinberg ED, Percy ME. Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival. Biometals 17: 135-139 (2004).

• Mobius P, Luyven G, Hotzel H, Kohler H. High genetic diversity among Mycobacterium avium subsp. paratuberculosis strains of German cattle herds shown by combination of IS900 RFLP analysis and MIRU-VNTR typing. J. Clin. Microbiol. 46: 972-981 (2008). *

• Mobley JL. Using epidemiology and archaeology to unearth new drug targets for rheumatoid arthritis therapy. Drug Discov. Today 11: 4-7 (2006).

• Mobley JL. Is rheumatoid arthritis a consequence of natural selection for enhanced tuberculosis resistance? Med. Hypotheses 62: 839-843 (2004).

• Modlin RL. The innate immune response in leprosy. Curr. Opin. Immunol. Jan 6 [Epub ahead of print] (2010).

• Mohammadzadeh A, Farnia P, Ghazvini K, Behdani M, Rashed T, Ghanaat J. Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis. J. Med. Microbiol. 55: 1657-1659 (2006). *

• Moisan J, Thuraisingam T, Henault J, Sanctis JD, Radzioch D. Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands. FEMS Immunol. Med. Microbiol. 47: 138-147 (2006). *

• Molle V, Soulat D, Jault JM, Grangeasse C, Cozzone AJ, Prost JF. Two FHA domains on an ABC transporter, Rv1747, mediate its phosphorylation by PknF, a Ser/Thr protein kinase from Mycobacterium tuberculosis. FEMS Microbiol. Lett. 234: 215-223 (2004). *

• Moller M, Kwiatkowski R, Nebel A, van Helden PD, Hoal EG, Schreiber S. Allelic variation in BTNL2 and susceptibility to tuberculosis in a South African population. Microbes Infect. 9: 522-528 (2007). *

• Moller M, Nebel A, Kwiatkowski R, van Helden PD, Hoal EG, Schreiber S. Host susceptibility to tuberculosis: CARD15 polymorphisms in a South African population. Mol. Cell. Probes 21: 148-151 (2007).

• Molloy D, Sayana MK, Keane J, Mehigan B. Anal fistula: an unusual presentation of tuberculosis in a migrant health care professional. Ir. J. Med. Sci. 178: 527-529 (2009). *

• Monnet D, Moachon L, Dougados M, Brezin AP. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat. Clin. Pract. Rheumatol. 2: 393-397 (2006). *

• Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 127: 1-6 (2008). *

• Mootoo A, Stylianou E, Arias MA, Reljic R. TNF-alpha in tuberculosis: a cytokine with a split personality. Inflamm. Allergy Drug Targets 8: 53-62 (2009).

• Mor A, Clifton BO, Kishimoto M, Izmirly PM, Greenberg J, Reddy S, Rosenthal PB. Methotrexate combined with isoniazid therapy for latent tuberculosis is well tolerated in rheumatoid arthritis patients: experience from an urban arthritis clinic. Ann. Rheum. Dis. 67: 462-465 (2008).

• Morahan G, Kaur G, Singh M, Rapthap CC, Kumar N, Katoch K, Mehra NK, Huang D. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 69 Suppl. 1: S234-S236 (2007).

• Morand JJ. What's new in clinical dermatology? Ann. Dermatol. Venereol. 136S7: S393-S406 (2009).

• Moreira LO, Smith AM, Defreitas AA, Qualls JE, El Kasmi KC, Murray PJ. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2. Vaccine 26: 5808-5813 (2008). *

• Morgante P, Lopez B, Barrera L, Ritacco V, de Kantor IN. Humoral response to mycobacteria in patients with Crohn disease. Medicina (B. Aires) 54: 97-102 (1994).

• Moss MT, Sanderson JD, Tizard ML, Hermon-Taylor J, el-Zaatari FA, Markesich DC, Graham DY. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut 33: 1209-1213 (1992). *

• Mossalayi MD, Vouldoukis I, Mamani-Matsuda M, Kauss T, Guillon J, Maugein J, Moynet D, Rambert J, Desplat V, Mazier D, Vincendeau P, Malvy D. CD23 mediates anti-mycobacterial activity of human macrophages. Infect. Immun. 77: 5537-5542 (2009). *

• Mota P, Diogo N, Pina J. Multi-drug resistant tuberculosis in a respiratory infectious diseases unit - results from five years. Rev. Port. Pneumol. 11: S44-S45 (2005).

• Motiwala AS, Janagama HK, Paustian ML, Zhu X, Bannantine JP, Kapur V, Sreevatsan S. Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes. Infect. Immun. 74: 6046-6056 (2006). *

• Motiwala AS, Li L, Kapur V, Sreevatsan S. Current understanding of the genetic diversity of Mycobacterium avium subsp. paratuberculosis. Microbes Infect. 8: 1406-1418 (2006).

• Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw WP, Bannantine JP, Kapur V, Sreevatsan S. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. J. Clin. Microbiol. 41: 2015-2026 (2003). *

• Mougous JD, Senaratne RH, Petzold CJ, Jain M, Lee DH, Schelle MW, Leavell MD, Cox JS, Leary JA, Riley LW, Bertozzi CR. A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 103: 4258-4263 (2006). *

• Mpofu CM, Campbell BJ, Subramanian S, Marshall-Clarke S, Hart CA, Cross A, Roberts CL, McGoldrick A, Edwards SW, Rhodes JM. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 133: 1487-1498 (2007). *

• Mucha R, Bhide MR, Chakurkar EB, Novak M, Mikula I Sr. Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle. Vet. Immunol. Immunopathol. 128: 381-388 (2009). *

• Mufti AH, Toye BW, McKendry RR, Angel JB. Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. Diagn. Microbiol. Infect. Dis. 53: 233-238 (2005).

• Mukai T, Maeda Y, Tamura T, Matsuoka M, Tsukamoto Y, Makino M. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein. J. Immunol. 183: 6561-6568 (2009).

• Muller S, Schaffer T, Schoepfer AM, Hilty A, Bodmer T, Seibold F. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. World J. Gastroenterol. 14: 3650-3661 (2008). *

• Munoz S, Rivas-Santiago B, Enciso JA. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand. J. Immunol. 70: 256-263 (2009). *

• Mura M, Bull TJ, Evans H, Sidi-Boumedine K, McMinn L, Rhodes G, Pickup R, Hermon-Taylor J. Replication and long-term persistence of bovine and human strains of Mycobacterium avium subsp. paratuberculosis within Acanthamoeba polyphaga. Appl. Environ. Microbiol. 72: 854-859 (2006). *

• Murakami S, Takeno M, Kirino Y, Kobayashi M, Watanabe R, Kudo M, Ihata A, Ueda A, Ohno S, Watanuki Y, Kaneko T, Ishigatsubo Y. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis (Edinb.) 89: 136-141 (2009).

• Murphy JT, Sommer S, Kabara EA, Verman N, Kuelbs MA, Saama P, Halgren R, Coussens PM. Gene expression profiling of monocyte-derived macrophages following infection with Mycobacterium avium subspecies avium and Mycobacterium avium subspecies paratuberculosis. Physiol. Genomics 28: 67-75 (2006). *

• Murray A, Oliaro J, Schlup MM, Chadwick VS. Mycobacterium paratuberculosis and inflammatory bowel disease: frequency distribution in serial colonoscopic biopsies using the polymerase chain reaction. Microbios. 83: 217-228 (1995).

• Musicki K, Briscoe H, Britton WJ, Saunders BM. LIGHT contributes to early but not late control of Mycobacterium tuberculosis infection. Int. Immunol. Feb 25 [Epub ahead of print] (2010).

• Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med. Princ. Pract. 18: 385-392 (2009).

• Mustafa AS. Th1 cell reactivity and HLA-DR binding prediction for promiscuous recognition of MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis. Scand. J. Immunol. 69: 213-222 (2009). *

• Mustafa AS, Al-Attiyah R, Hanif SN, Shaban FA. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells. Clin. Vaccine Immunol. 15: 916-924 (2008). *

• Mustafa AS, Shaban F. Mapping of Th1-cell epitope regions of Mycobacterium tuberculosis protein MPT64 (Rv1980c) using synthetic peptides and T-cell lines from M. tuberculosis-infected healthy humans. Med. Princ. Pract. 19: 122-128 (2010).

• Mutlu GM, Mutlu EA, Bellmeyer A, Rubinstein I. Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am. J. Med. 119: 639-646 (2006). *

• Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 28: 563-566 (2000). *

• Nagayama Y, McLachlan SM, Rapoport B, Oishi K. Graves' hyperthyroidism and the hygiene hypothesis in a mouse model. Endocrinology 145: 5075-5079 (2004). *

• Nagro CJ, Kolla RV, Rickert RC. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis. J. Immunol. 175: 5379-5389 (2005). *

• Nakamura RM, Barry M. Serologic markers in inflammatory bowel disease (IBD). MLO Med. Lab. Obs. 33: 8-15; quiz 16-19 (2001).

• Nakamura RM, Matsutani M, Barry M. Advances in clinical laboratory tests for inflammatory bowel disease. Clin. Chim. Acta 335: 9-20 (2003). *

• Nakase H, Nishio A, Tamaki H, Matsuura M, Asada M, Chiba T, Okazaki K. Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn's disease. Inflamm. Bowel Dis. 12: 62-69 (2006). *

• Nakazato S, Takase H, Yanagihara Y, Issekutz TB, Issekutz AC, Takai M, Kyogoku M. Effect of G-1 column (Adacolumn) therapy in rats with adjuvant arthritis on the migration and immunoreactivity of peripheral and splenic leukocytes. Mod. Rheumatol. 15: 249-257 (2005).

• Naser S, Shafran I, El-Zaatari F. Mycobacterium avium subsp. paratuberculosis in Crohn's disease is serologically positive. Clin. Diagn. Lab. Immunol. 6: 282 (1999). *

• Naser SA. Mycobacterium in Crohn's disease is hard to digest. Gastroenterology 129: 1359-1360 (2005). *

• Naser SA, Collins MT. Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn's disease. Inflamm. Bowel Dis. 11: 1123 (2005). *

• Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364: 1039-1044 (2004). *

• Naser SA, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am. J. Gastroenterol. 95: 1094-1095 (2000). *

• Naser SA, Shafran I, Schwartz D, El-Zaatari F, Biggerstaff J. In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy. Mol. Cell Probes. 16: 41-48 (2002). *

• Navarro Lopez V, Ramos JM, Meseguer V, Perez Arellano JL, Serrano R, Garcia Ordonez MA, Peralta G, Boix V, Pardo J, Conde A, Salgado F, Gutierrez F; GTI-SEMI Group. Microbiology and outcome of iliopsoas abscess in 124 patients. Medicine (Baltimore) 88: 120-130 (2009).

• Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Zerva L, Spandidos DA. Mycobacterium thermoresistibile: case report of a rarely isolated mycobacterium from Europe and review of literature. Indian J. Med. Microbiol. 27: 264-267 (2009). *

• Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 3: e277 (2006). *

• Newton SM, Mackie SL, Martineau AR, Wilkinson KA, Kampmann B, Fisher C, Dutta S, Levin M, Wilkinson RJ, Pasvol G. Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin. Vaccine Immunol. 15: 506-512 (2008). *

• Nguyen Duc C, Pha Hai B, Pham Van T, Ton That B, Huguier M. Acute intestinal tuberculosis. Ann. Chir. 131: 306-310 (2006).

• Nicolo C, Sali M, Di Sante G, Geloso MC, Signori E, Penitente R, Uniyal S, Rinaldi M, Ingrosso L, Fazio VM, Chan BM, Delogu G, Ria F. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis. J. Immunol. 184: 222-235 (2010).

• Nielsen SE, Nielsen OH, Vainer B, Claesson MH. Inflammatory bowel disease - do microorganisms play a role? Ugeskr. Laeger. 164: 5947-5950 (2002).

• Nilsson E, Larsson A, Olesen HV, Wejaker PE, Kollberg H. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr. Pulmonol. 43: 892-899 (2008).

• Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302 (2002). *

• No authors listed. Crohn's disease: new evidence of mycobacterial involvement. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 68 (2004). *

• No authors listed. Identification of Rv2041c, a novel immunogenic antigen from Mycobacterium tuberculosis with serodiagnostic potential. Scand. J. Immunol. 70: 621 (2009).

• No authors listed. Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins. Scand. J. Immunol. 71: 61 (2010).

• No authors listed. In this issue. Eur. J. Immunol. 38: 605-606 (2008).

• Nobrega C, Roque S, Nunes-Alves C, Coelho A, Medeiros I, Castro AG, Appelberg R, Correia-Neves M. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J. Immunol. 184: 351-358 (2010).

• Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 60: 565-582 (2005). *

• O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to Bacillus Calmette-Guerin. J. Neurosci. 29: 4200-4209 (2009).

• O'Donohue J, Fidler H, Garcia-Barcelo M, Nouri-Aria K, Williams R, McFadden J. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J. Hepatol. 28: 433-438 (1998). *

• O'Donohue J, McFarlane B, Bomford A, Yates M, Williams R. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J. Hepatol. 21: 887-999 (1994).

• O'Donohue J, Workman MR, Rolando N, Yates M, Philpott-Howard J, Williams R. Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases. Eur. J. Clin. Microbiol. Infect. Dis. 16: 743-746 (1997).

• O'Kane CM, Boyle JJ, Horncastle DE, Elkington PT, Friedland JS. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J. Immunol. 178: 3767-3776 (2007). *

• O'Shaughnessy MC, Vetsika EK, Inglis JJ, Carleson J, Haigh R, Kidd BL, Winyard PG. The effect of substance P on nitric oxide release in a rheumatoid arthritis model. Inflamm. Res. 55: 236-240 (2006). *

• O'Shea FD, Haroon N, Salonen DC, Inman RD. Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis. Nat. Clin. Pract. Rheumatol. 5: 171-173 (2009).

• Ofodile ON. Cardiovascular disease could be contained based on currently available data! Dose Response 4: 225-254 (2006).

• Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 23: 219-223 (2004). *

• Ohkusa T, Sato N. Antibacterial and antimycobacterial treatment for inflammatory bowel disease. J. Gastroenterol. Hepatol. 20: 340-351 (2005). *

• Okada M, Shirakawa T. Frontier of Mycobacterium research - host vs. Mycobacterium. Kekkaku 80: 613-629 (2005).

• Okubo H, Iwamoto M, Yoshio T, Okazaki H, Kato T, Bandoh M, Minota S. Rapidly aggravated Mycobacterium avium infection in a patient with rheumatoid arthritis treated with infliximab. Mod. Rheumatol. 15: 62-64 (2005).

• Oliveira JB, Notarangelo LD, Fleisher TA. Applications of flow cytometry for the study of primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol. 8: 499-509 (2008).

• Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, Rose S, Fremond C, Quesniaux VF, Szymkowski DE, Garcia I. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette-Guerin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. J. Infect. Dis. 199: 1053-1063 (2009). *

• Olleros ML, Vesin D, Martinez-Soria E, Allenbach C, Tacchini-Cottier F, Pache JC, Marchal G, Rahman J, Fernandez C, Izui S, Garcia I. Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guerin and Mycobacterium tuberculosis clearance. Immunology 122: 350-361 (2007). *

• Olsen I, Tollefsen S, Aagaard C, Reitan LJ, Bannantine JP, Andersen P, Sollid LM, Lundin KE. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS ONE 4: e5641 (2009). *

• Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scand. J. Immunol. 53: 198-203 (2001). *

• Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against MPP14, a 14 kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Acta Vet. Scand. 44: 287 (2003).

• Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113: 725-733 (2004). *

• Orange JS, Levy O, Brodeur SR, Krzewski K, Roy RM, Niemela JE, Fleisher TA, Bonilla FA, Geha RS. Human nuclear factor kappaB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J. Allergy Clin. Immunol. 114: 650-656 (2004). *

• Oswald-Richter K, Sato H, Hajizadeh R, Shepherd BE, Sidney J, Sette A, Newman LS, Drake WP. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J. Clin. Immunol. Jun 18 [Epub ahead of print] (2009). *

• Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb.) 85: 53-64 (2005).

• Ou-Yang HF, Hu XB, Ti XY, Shi JR, Li SJ, Qi HW, Wu CG. Suppression of allergic airway inflammation in a mouse model by Der p2 recombined BCG. Immunology 128: e343-e352 (2009). *

• Oudkerk Pool M, Bouma G, Meuwissen SG, von Blomberg BM, van de Merwe JP, Deville WL, Fonk JC, Pena AS. Serological markers to differentiate between ulcerative colitis and Crohn's disease. J. Clin. Pathol. 48: 346-350 (1995). *

• Overduin P, Schouls L, Roholl P, van der Zanden A, Mahmmod N, Herrewegh A, van Soolingen D. Use of multilocus variable-number tandem-repeat analysis for typing Mycobacterium avium subsp. paratuberculosis. J. Clin. Microbiol. 42: 5022-5028 (2004). *

• Paccagnini D, Sieswerda L, Rosu V, Masala S, Pacifico A, Gazouli M, Ikonomopoulos J, Ahmed N, Zanetti S, Sechi LA. Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One 4: e7109 (2009). *

• Pacheco AG, Cardoso CC, Moraes MO. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum. Genet. 123: 477-484 (2008). *

• Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22: 292-301 (2009).

• Paidipally P, Periasamy S, Barnes PF, Dhiman R, Indramohan M, Griffith DE, Cosman D, Vankayalapati R. NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen. J. Immunol. 183: 1940-1945 (2009).

• Paige C, Bishai WR. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Cell. Microbiol. Dec 21 [Epub ahead of print] (2009). *

• Palma C, Iona E, Ebensen T, Guzman CA, Cassone A. The Toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages. Open Microbiol. J. 3: 47-52 (2009). *

• Park HY, Kwon YS, Ki CS, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ. Interleukin-12 receptor beta1 polymorphisms and nontuberculous mycobacterial lung diseases. Lung 186: 241-245 (2008).

• Park JH, Seo GY, Lee JS, Kim TH, Yoo DH. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial. J. Rheumatol. 36: 2158-2163 (2009).

• Park S, Kim EJ, Lee SH, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ. Vitamin D-receptor polymorphisms and non-tuberculous mycobacterial lung disease in Korean patients. Int. J. Tuberc. Lung Dis. 12: 698-700 (2008).

• Parkash O, Singh BP, Pai M. Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans. Scand. J. Immunol. 70: 345-357 (2009). *

• Parrish NM, Ko CG, Dick JD, Jones PB, Ellingson JL. Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis. Clin. Med. Res. 2: 107-114 (2004). *

• Parrish NM, Radcliff RP, Brey BJ, Anderson JL, Clark DL Jr, Koziczkowski JL, Ko CG, Goldberg ND, Brinker DA, Carlson RA, Dick JD, Ellingson JL. Absence of Mycobacterium avium subsp. paratuberculosis in Crohn's patients. Inflamm. Bowel Dis. 15: 558-565 (2009). *

• Parrish SC, Myers J, Lazarus A. Nontuberculous mycobacterial pulmonary infections in non-HIV patients. Postgrad. Med. 120: 78-86 (2008).

• Paschoal IA, de Oliveira Villalba W, Bertuzzo CS, Cerqueira EM, Pereira MC. Cystic fibrosis in adults. Lung 185: 81-87 (2007).

• Pasquinelli V, Townsend JC, Jurado JO, Alvarez IB, Quiroga MF, Barnes PF, Samten B, García VE. IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. J. Infect. Dis. 199: 661-665 (2009). *

• Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne D. Genetically determined susceptibility to mycobacterial infection. J. Clin. Pathol. 61: 1006-1012 (2008).

• Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, Kaisho T, Kundu M, Basu J. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8: 610-618 (2007). *

• Pathak SK, Basu S, Bhattacharyya A, Pathak S, Kundu M, Basu J. Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J. Biol. Chem. 280: 42794-42800 (2005). *

• Patterson DS, Allen WM. Chronic mycobacterial enteritis in ruminants as a model of Crohn's disease. Proc. R. Soc. Med. 65: 998-1001 (1972). *

• Pedraza-Sanchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordonez M, Gonzalez-Hernandez Y, Sada-Diaz E, de Beaucoudrey L, Casanova JL, Torres-Rojas M. Bacille Calmette-Guerin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int. J. Infect. Dis. Feb 18 [Epub ahead of print] (2010).

• Peen E, Enestrom S, Skogh T. Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver. Gut 38: 135-140 (1996). *

• Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, Wang J, Li BQ. Interleukin 17-producing gammadelta T cells increased in patients with active pulmonary tuberculosis. Cell. Mol. Immunol. 5: 203-208 (2008). *

• Peng Y, Han G, Shao H, Wang Y, Kaplan HJ, Sun D. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48: 4153-4161 (2007). *

• Pereira AC, Brito-de-Souza VN, Cardoso CC, Dias-Baptista IM, Parelli FP, Venturini J, Villani-Moreno FR, Pacheco AG, Moraes MO. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun. 10: 174-180 (2009). *

• Pereira J. Comparative analyses between tuberculids and extrapulmonary tuberculosis - another face for Mycobacterium tuberculosis. Rev. Port. Pneumol. 12: S31-S32 (2006).

• Perlmutter A, Mittal A, Menter A. Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians. Br. J. Dermatol. 160: 8-15 (2009). *

• Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 1060-1065 (2003).

• Persson YA, Blomgran-Julinder R, Rahman S, Zheng L, Stendahl O. Mycobacterium tuberculosis-induced apoptotic neutrophils trigger a pro-inflammatory response in macrophages through release of heat shock protein 72, acting in synergy with the bacteria. Microbes Infect. 10: 233-240 (2007). *

• Peyrin-Biroulet L, Neut C, Colombel JF. Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology 132: 2594-2598 (2007). *

• Phillips R, Sarfo FS, Guenin-Mace L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with Buruli ulcer disease. J. Infect. Dis. 200: 1675-1684 (2009). *

• Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, Dupuis S, Soudais C, Al-Mohsen IZ, Genin E, Lammas D, Kumararatne DS, Leclerc T, Rafii A, Frayha H, Murugasu B, Wah LB, Sinniah R, Loubser M, Okamoto E, Al-Ghonaium A, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am. J. Hum. Genet. 70: 336-348 (2002). *

• Picciotto A, Gesu GP, Schito GC, Testa R, Varagona G, Celle G. Antimycobacterial chemotherapy in inflammatory bowel disease. Biomed. Pharmacother. 43: 141-143 (1989).

• Picco P, Gattorno M, Vignola S, Barabino A, Marazzi MG, Bondi E, Pistoia V, Buoncompagni A. Clinical and biological characteristics of immunopathological disease-related erythema nodosum in children. Scand. J. Rheumatol. 28: 27-32 (1999).

• Pickup RW, Rhodes G, Arnott S, Sidi-Boumedine K, Bull TJ, Weightman A, Hurley M, Hermon-Taylor J. Mycobacterium avium subsp. paratuberculosis in the catchment area and water of the river Taff in South Wales, United Kingdom, and its potential relationship to clustering of Crohn's disease cases in the city of Cardiff. Appl. Environ. Microbiol. 71: 2130-2139 (2005). *

• Pierce ES. Possible transmission of Mycobacterium avium subspecies paratuberculosis through potable water: lessons from an urban cluster of Crohn's disease. Gut Pathog. 1: 17 (2009). *

• Pierce ES. Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog. 5: e1000234 (2009). *

• Pinedo PJ, Buergelt CD, Donovan GA, Melendez P, Morel L, Wu R, Langaee TY, Rae DO. Association between CARD15/NOD2 gene polymorphisms and paratuberculosis infection in cattle. Vet. Microbiol. 134: 346-352 (2009). *

• Pinedo PJ, Buergelt CD, Donovan GA, Melendez P, Morel L, Wu R, Langaee TY, Rae DO. Candidate gene polymorphisms (BoIFNG, TLR4, SLC11A1) as risk factors for paratuberculosis infection in cattle. Prev. Vet. Med. 91: 189-196 (2009).

• Pinedo PJ, Wang C, Li Y, Rae DO, Wu R. Risk haplotype analysis for bovine paratuberculosis. Mamm. Genome 20: 124-129 (2009). *

• Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr. Opin. Gastroenterol. 24: 440-447 (2008). *

• Poggi A, Catellani S, Musso A, Zocchi MR. Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation. Curr. Med. Chem. 16: 4743-4749 (2009).

• Pokkali S, Rajavelu P, Sudhakar R, Das SD. Phenotypic modulation in Mycobacterium tuberculosis infected neutrophil during tuberculosis. Indian J. Med. Res. 130: 185-192 (2009). *

• Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A. Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology 131: 85-96 (2006). *

• Poon AH, Laprise C, Lemire M, Hudson TJ, Schurr E. NRAMP1 is not associated with asthma, atopy, and serum immunoglobulin E levels in the French Canadian population. Genes Immun. 6: 519-527 (2005). *

• Portugal I, Barreiro L, Vultos T, Macedo R, Furtado C, Fonseca Antunes A, Brum L. Molecular epidemiology of Mycobacterium tuberculosis in Lisbon. Rev. Port. Pneumol. 14: 239-259 (2008).

• Pott J, Basler T, Duerr CU, Rohde M, Goethe R, Hornef MW. Internalization-dependent recognition of Mycobacterium avium subsp. paratuberculosis by intestinal epithelial cells. Cell. Microbiol. 11: 1802-1815 (2009). *

• Pound MW, Tart SB, Okoye O. Multidrug-resistant Ewingella americana: a case report and review of the literature. Ann. Pharmacother. 41: 2066-2070 (2007).

• Powell JJ. Microparticles - a link between modern life and inflammatory bowel disease? Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 49. May 7-8 (2004). *

• Prabhu Anand S, Selvaraj P, Narayanan PR. Effect of 1,25 dihydroxyvitamin D(3) on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 45: 105-110 (2009).

• Pradeep JD, Clunie GP, Gaffney K, Innes NJ, Brooksby A, Bradley P, Gulati A. Screening for Mycobacterium tuberculosis prior to anti-TNF therapy - an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. Rheumatology (Oxford) 48: 195 (2009). *

• Pradhan VD, Badakere SS, Ghosh K, Pawar AR. Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J. Med. Sci. 58: 283-288 (2004). *

• Prantera C. Mycobacteria and Crohn's disease: the endless story. Dig. Liver Dis. 39: 452-454 (2007).

• Prantera C, Berto E, Scribano ML. Mycobacteria and subgroups of patients in Crohn's disease. Ital. J. Gastroenterol. 23: 49-51 (1991).

• Prantera C, Bothamley G, Levenstein S, Mangiarotti R, Argentieri R. Crohn's disease and mycobacteria: two cases of Crohn's disease with high anti-mycobacterial antibody levels cured by dapsone therapy. Biomed. Pharmacother. 43: 295-299 (1989).

• Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am. J. Gastroenterol. 89: 513-518 (1994).

• Prantera C, Scribano ML. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Curr. Opin. Gastroenterol. 25: 329-333 (2009).

• Prantera C, Scribano ML. Crohn's disease: the case for bacteria. Ital. J. Gastroenterol. Hepatol. 31: 244-246 (1999).

• Pulickal AS, Hambleton S, Callaghan MJ, Moore CE, Goulding J, Goodsall A, Baretto R, Lammas DA, Anderson ST, Levin M, Pollard AJ. Biliary cirrhosis in a child with inherited interleukin-12 deficiency. J. Trop. Pediatr. 54: 269-271 (2008).

• Pulimood AB, Peter S, Rook GW, Donoghue HD. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am. J. Clin. Pathol. 129: 846-851 (2008). *

• Purwantini E, Mukhopadhyay B. Conversion of NO2 to NO by reduced coenzyme F420 protects mycobacteria from nitrosative damage. Proc. Natl. Acad. Sci. U.S.A. 106: 6333-6338 (2009). *

• Qie YQ, Wang JL, Liu W, Shen H, Chen JZ, Zhu BD, Xu Y, Zhang XL, Wang HH. More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4. Scand. J. Immunol. 69: 342-350 (2009). *

• Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, Hunt R, Estep J, Haynes BF, Jacobs Jr WR, Letvin NL, Du G, Chen ZW. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J. Infect. Dis. 198: 1514-1519 (2008). *

• Quack I, Sellin L, Buchner NJ, Theegarten D, Rump LC, Henning BF. Eosinophilic gastroenteritis in a young girl - long term remission under Montelukast. BMC Gastroenterol. 5: 24 (2005). *

• Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, Yeremeev V, Bihl F, Erard F, Botha T, Drennan M, Soler MN, Le Bert M, Schnyder B, Ryffel B. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6: 946-959 (2004). *

• Quesniaux VF, Jacobs M, Allie N, Grivennikov S, Nedospasov SA, Garcia I, Olleros ML, Shebzukhov Y, Kuprash D, Vasseur V, Rose S, Court N, Vacher R, Ryffel B. TNF in host resistance to tuberculosis infection. Curr. Dir. Autoimmun. 11: 157-179 (2010).

• Quinones MP, Jimenez F, Martinez H, Estrada CA, Willmon O, Dudley M, Kuziel WA, Melby PC, Reddick RL, Ahuja SK, Ahuja SS. CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium. J. Mol. Med. 84: 503-512 (2006). *

• Quintero-Macias L, Santos-Mendoza T, Donis-Maturano L, Silva-Sanchez A, Aguilar D, Orozco H, Gicquel B, Estrada-Garcia I, Flores-Romo L, Hernandez-Pando R. T-cell responses and in vivo cytotoxicity in the target organ and the regional lymphoid tissue during airborne infection with the virulent Mycobacterium tuberculosis MT103 and its lipid mutant fadD26. Scand. J. Immunol. 71: 20-28 (2010). *

• Quirke P. Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 49: 757-760 (2001). *

• Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin. Exp. Immunol. 153: 19-30 (2008). *

• Rachman H, Kaufmann SH. Exploring functional genomics for the development of novel intervention strategies against tuberculosis. Int. J. Med. Microbiol. 297: 559-567 (2007).

• Radaeva TV, Kondratieva EV, Sosunov VV, Majorov KB, Apt A. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model. Tuberculosis (Edinb.) 88: 576-585 (2008).

• Radhakrishnan DK, Yau Y, Corey M, Richardson S, Chedore P, Jamieson F, Dell SD. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr. Pulmonol. 44: 1100-1106 (2009).

• Radomski N, Thibault VC, Karoui C, de Cruz K, Cochard T, Gutierrez C, Supply P, Biet F, Boschiroli ML. Genotypic diversity of Mycobacterium avium subspecies from human and animal origins, studied by MIRU-VNTR and IS1311 RFLP typing methods. J. Clin. Microbiol. Jan 27 [Epub ahead of print] (2010). *

• Rajaiah R, Lee DY, Ma Z, Fan AY, Lao L, Fong HH, Berman BM, Moudgil KD. Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation. J. Ethnopharmacol. 123: 40-44 (2009).

• Raman K, Bhat AG, Chandra N. A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis. Mol. Biosyst. 6: 516-530 (2010).

• Ramos JM, Garcia-Sepulcre MF, Rodriguez JC, Padilla S, Gutierrez F. Mycobacterium marinum infection complicated by anti-tumor necrosis factor therapy. J. Med. Microbiol. Feb 4 [Epub ahead of print] (2010).

• Rampini SK, Selchow P, Keller C, Ehlers S, Bottger EC, Sander P. LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest. Microbiology 154: 2991-3001 (2008). *

• Rand L, Green JA, Saraiva L, Friedland JS, Elkington PT. Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade. J. Immunol. 182: 5865-5872 (2009).

• Randhawa AK, Ziltener HJ, Stokes RW. CD43 controls the intracellular growth of Mycobacterium tuberculosis through the induction of TNF-alpha-mediated apoptosis. Cell. Microbiol. 10: 2105-2117 (2008). *

• Ravzi S, Saiman L. Nontuberculous mycobacteria in cystic fibrosis. Pediatr. Infect. Dis. J. 26: 263-264 (2007).

• Ray JC, Wang J, Chan J, Kirschner DE. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J. Theor. Biol. 252: 24-38 (2008). *

• Reddacliff LA, Beh K, McGregor H, Whittington RJ. A preliminary study of possible genetic influences on the susceptibility of sheep to Johne's disease. Aust. Vet. J. 83: 435-441 (2005).

• Reeders JW, Yee J, Gore RM, Miller FH, Megibow AJ. Gastrointestinal infection in the immunocompromised (AIDS) patient. Eur. Radiol. 14 Suppl. 3: E84-E102 (2004).

• Rees JR, Longstaff A, Rigby HL, Smith DL, Dixon AR. An unusual cause for a colonic stricture: a case of Mycobacterium xenopi mimicking malignancy. Postgrad. Med. J. 79: 705-706 (2003). *

• Reid DM, Gow NA, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr. Opin. Immunol. 21: 30-37 (2009).

• Reiling N, Ehlers S, Holscher C. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunol. Lett. 116: 15-23 (2008).

• Reiling N, Schneider D, Ehlers S. Mycobacterium tuberculosis-induced cell death of primary human monocytes and macrophages is not significantly modulated by tumor necrosis factor-targeted biologicals. J. Investig. Dermatol. Symp. Proc. 12: 26-33 (2007). *

• Reljic R. IFN-gamma therapy of tuberculosis and related infections. J. Interferon Cytokine Res. 27: 353-364 (2007).

• Remus N, Alcais A, Abel L. Human genetics of common mycobacterial infections. Immunol. Res. 28: 109-129 (2003).

• Ren YR, Pan F, Parvez S, Fleig A, Chong CR, Xu J, Dang Y, Zhang J, Jiang H, Penner R, Liu JO. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS ONE 3: e4009 (2008). *

• Ren Z, Turton J, Borody T, Pang G, Clancy R. Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease. J. Gastroenterol. Hepatol. 23: 310-314 (2008). *

• Rhoades ER, Archambault AS, Greendyke R, Hsu FF, Streeter C, Byrd TF. Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. J. Immunol. 183: 1997-2007 (2009).

• Rhodes J, Freedman AR. Measles, Mycobacterium paratuberculosis and Crohn's disease. Ital. J. Gastroenterol. Hepatol. 31: 255-257 (1999).

• Ribeiro FM, Szyper-Kravitz M, Klumb EM, Lannes G, Ribeiro FR, Albuquerque EM, Shoenfeld Y. Can lupus flares be associated with tuberculosis infection? Clin. Rev. Allergy Immunol. Jun 24 [Epub ahead of print] (2009). *

• Richeldi L, Ewer K, Losi M, Hansell DM, Roversi P, Fabbri LM, Lalvani A. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann. Intern. Med. 140: 709-713 (2004). *

• Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffe M, Brosch R, Risler JL, Gaillard JL. Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. PLoS One 4: e5660 (2009). *

• Rittner HL, Hackel D, Voigt P, Mousa S, Stolz A, Labuz D, Schafer M, Schaefer M, Stein C, Brack A. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog 5: e1000362 (2009). *

• Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 195: 870-878 (2007). *

• Rocchi R, Kimura H, Tzou SC, Suzuki K, Rose NR, Pinchera A, Ladenson PW, Caturegli P. Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness. Proc. Natl. Acad. Sci. U.S.A. 104: 6019-6024 (2007). *

• Rocha-Ramirez LM, Estrada-Garcia I, Lopez-Marin LM, Segura-Salinas E, Mendez-Aragon P, Van Soolingen D, Torres-Gonzalez R, Chacon-Salinas R, Estrada-Parra S, Maldonado-Bernal C, Lopez-Macias C, Isibasi A. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb.) 88: 212-220 (2008). *

• Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, Brayshaw SJ, Huitt GA, Iseman MD, Saavedra MT, Taussig LM, Wagener JS, Accurso FJ, Nick JA. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am. J. Respir. Crit. Care Med. 171: 621-626 (2005). *

• Rodrigues DH, Sachs D, Teixeira AL. Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arq. Neuropsiquiatr. 67: 78-81 (2009).

• Rodrigues MF, Barsante MM, Alves CC, Souza MA, Ferreira AP, Amarante-Mendes GP, Teixeira HC. Apoptosis of macrophages during pulmonary Mycobacterium bovis infection: correlation with intracellular bacillary load and cytokine levels. Immunology 128: e691-e699 (2009).

• Rodriguez-Palmero M, Franch A, Castell M, Pelegri C, Perez-Cano FJ, Kleinschnitz C, Stoll G, Hunig T, Castellote C. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. J. Rheumatol. 33: 110-118 (2006).

• Roediger WE. A new hypothesis for the aetiology of Crohn's disease - evidence from lipid metabolism and intestinal tuberculosis. Postgrad. Med. J. 67: 666-671 (1991). *

• Roholl PJ, Herrewegh A, van Soolingen D. Positive IS900 in situ hybridization signals as evidence for role of Mycobacterium avium subsp. paratuberculosis in etiology of Crohn's disease. J. Clin. Microbiol. 40: 3112 (2002). *

• Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical tissue from patients with Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm. Bowel Dis. 11: 116-125 (2005). *

• Rondelli FM, Mahuad CV, Gentiletti A, Goni M, Pons-Estel B, Bottasso O, Stanford JL, Bay ML. Altered production of IFN-gamma and other inflammation-related cytokines by mycobacteria-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients. Cell. Mol. Biol. (Noisy-le-grand) 52: 59-64 (2006).

• Rook GA. Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 7: 327-337 (2007).

• Rook GA. The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans. R. Soc. Trop. Med. Hyg. 101: 1072-1074 (2007). *

• Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, Brunet LR. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin. Immunopathol. 25: 237-255 (2004). *

• Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5: 661-667 (2005). *

• Rook GA, Martinelli R, Brunet LR. Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr. Opin. Allergy Clin. Immunol. 3: 337-342 (2003).

• Rook GAW. Microecology, hygiene and mucosal immunology. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 33. May 7-8 (2004). *

• Rose NR. The adjuvant effect in infection and autoimmunity. Clin. Rev. Allergy Immunol. 34: 279-282 (2008). *

• Rosenblatt RL. Lung transplantation in cystic fibrosis. Respir. Care 54: 777-787 (2009).

• Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol. Rev. 203: 38-47 (2005).

• Rossi G, Nigro G, Tattoli I, Vincenzetti S, Mariani P, Magi GE, Renzoni G, Taccini E, Bernardini ML. Adhesion molecules and cytokine profile in ileal tissue of sheep infected with Mycobacterium avium subsp. paratuberculosis. Microbes Infect. 11: 698-706 (2009). *

• Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc. Am. Thorac. Soc. 4: 453-456 (2007). *

• Rosu V, Ahmed N, Paccagnini D, Gerlach G, Fadda G, Hasnain SE, Zanetti S, Sechi LA. Specific immunoassays confirm association of Mycobacterium avium subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus. PLoS ONE 4: e4386 (2009). *

• Rothfuchs AG, Egen JG, Feng CG, Antonelli LR, Bafica A, Winter N, Locksley RM, Sher A. In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli. J. Immunol. 182: 6915-6925 (2009).

• Rottman M, Soudais C, Vogt G, Renia L, Emile JF, Decaluwe H, Gaillard JL, Casanova JL. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med. 5: e26 (2008). *

• Roupie V, Rosseels V, Piersoel V, Zinniel DK, Barletta RG, Huygen K. Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at early but not at late stage of infection. Infect. Immun. 76: 2099-2105 (2008). *

• Roux AL, Catherinot E, Rippoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, Guterriez C, Vincent V, Fauroux B, Rottman M, Guillemot D, Gaillard JL, Herrmann JL; for the OMA group. Multicenter French prevalence study of non tuberculous mycobacteria in cystic fibrosis. J. Clin. Microbiol. 47: 4124-4128 (2009). *

• Roux S, Apetoh L, Chalmin F, Ladoire S, Mignot G, Puig PE, Lauvau G, Zitvogel L, Martin F, Chauffert B, Yagita H, Solary E, Ghiringhelli F. CD4CD25 Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer. J. Clin. Invest. 118: 3751-3761 (2008). *

• Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P. Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 37: 660-667 (1995). *

• Rudiger T, Hartmann M, Muller-Hermelink HK, Marx A. Inflammatory reactions of the spleen. Pathologe 29: 121-128 (2008).

• Rumsey J, Valentine JF, Naser SA. Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. Med. Sci. Monit. 12: BR130-BR139 (2006). *

• Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr. Opin. Gastroenterol. 22: 209-214 (2006). *

• Ryan P, Aarons S, Bennett MW, Lee G, O'Sullivan GC, O'Connell J, Shanahan F. Mycobacterium paratuberculosis detected by nested PCR in intestinal granulomas isolated by LCM in cases of Crohn's disease. Methods Mol. Biol. 193: 205-211 (2002).

• Ryan P, Bennett MW, Aarons S, Lee G, Collins JK, O'Sullivan GC, O'Connell J, Shanahan F. PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection. Gut 51: 665-670 (2002). *

• Ryan P, Kelly RG, Lee G, Collins JK, O'Sullivan GC, O'Connell J, Shanahan F. Bacterial DNA within granulomas of patients with Crohn's disease. Detection by laser capture microdissection and PCR. Am. J. Gastroenterol. 99: 1539-1543 (2004). *

• Ryffel B, Fremond C, Jacobs M, Parida S, Botha T, Schnyder B, Quesniaux V. Innate immunity to mycobacterial infection in mice: critical role for Toll-like receptors. Tuberculosis (Edinb.) 85: 395-405 (2005).

• Ryffel B, Jacobs M, Parida S, Botha T, Togbe D, Quesniaux V. Toll-like receptors and control of mycobacterial infection in mice. Novartis Found. Symp. 279: 127-139 (2006).

• Ryu YJ, Kim EJ, Lee SH, Kim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ. Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. Eur. Respir. J. 30: 736-742 (2007).

• Sahiratmadja E, Baak-Pablo R, de Visser AW, Alisjahbana B, Adnan I, van Crevel R, Marzuki S, van Dissel JT, Ottenhoff TH, van de Vosse E. Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis (Edinb.) 87: 303-311 (2007).

• Sahrbacher U, Naumann L, Reischl U, Schoolmerich J, Gluck T. Reduced TH-1 cytokine release in an adult patient with chronic relapsing Mycobacterium malmoense infection. Infection 35: 282-286 (2007). *

• Sakane T, Miura K. Research for basic and clinical aspects of Behcet's disease - recent advance and future. Nippon Rinsho 54: 870-884 (1996).

• Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS. Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J. Infect. Dis. 194: 486-492 (2006). *

• Salliot C, Desplaces N, Boisrenoult P, Koeger AC, Beaufils P, Vincent V, Mamoudy P, Ziza JM. Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in France. Clin. Infect. Dis. 43: 987-993 (2006). *

• Saltini C, Pallante M, Puxeddu E, Contini S, Voorter CE, Drent M, Amicosante M. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25: 100-116 (2008).

• Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J. Infect. 55: 484-487 (2007).

• Samten B, Wang X, Barnes PF. Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses. Tuberculosis (Edinb.) 89 Suppl. 1: S74-S76 (2009).

• Sanchez Carazo JL, Mahiques Santos L, Oliver Martinez V. Safety of etanercept in psoriasis: a critical review. Drug Saf. 29: 675-685 (2006).

• Sanchez-Valle JA, Martinez-Ordaz JL, Blanco-Benavides R. Tuberculous psoas abscess in a patient with HIV. Cir. Cir. 72: 405-407 (2004).

• Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33: 890-896 (1992). *

• Santos-Junior RR, Sartori A, Franco MD, Filho OG, Coelho-Castelo AA, Bonato VL, Cabrera WH, Ibanez OM, Silva CL. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum. Gene Ther. 16: 1338-1345 (2005).

• Santos-Junior RR, Sartori A, Lima DS, Souza PR, Coelho-Castelo AA, Bonato VL, Silva CL. DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. J. Immune Based Ther. Vaccines 7: 4 (2009).

• Saraceno R, Chimenti S. How to manage infections in the era of biologics? Dermatol. Ther. 21: 180-186 (2008). *

• Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, Nisini R. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect. Dis. 9: 99 (2009). *

• Sartor RB. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr. Opin. Gastroenterol. 19: 358-365 (2003).

• Sartor RB. Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 54: 896-898 (2005). *

• Sasikala M, Reddy DN, Pratap N, Sharma SK, Balkumar PR, Sekaran A, Banerjee R, Reddy DB. Absence of Mycobacterium avium ss paratuberculosis-specific IS900 sequence in intestinal biopsy tissues of Indian patients with Crohn's disease. Indian J. Gastroenterol. Jan 4 [Epub ahead of print] (2010). *

• Sasikala M, Reddy DN, Pratap N, Sharma SK, Balkumar PR, Sekaran A, Banerjee R, Reddy DB. Absence of Mycobacterium avium ss paratuberculosis-specific IS900 sequence in intestinal biopsy tissues of Indian patients with Crohn's disease. Indian J. Gastroenterol. 28: 169-174 (2009). *

• Satpute SR, Rajaiah R, Polumuri SK, Moudgil KD. Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses. Arthritis Rheum. 60: 103-113 (2009). *

• Satpute SR, Soukhareva N, Scott DW, Moudgil KD. Mycobacterial Hsp65-IgG-expressing tolerogenic B cells confer protection against adjuvant-induced arthritis in Lewis rats. Arthritis Rheum. 56: 1490-1496 (2007). *

• Scandurra GM, Williams RB, Triccas JA, Pinto R, Gicquel B, Slobedman B, Cunningham A, Britton WJ. Effect of phthiocerol dimycocerosate deficiency on the transcriptional response of human macrophages to Mycobacterium tuberculosis. Microbes Infect. 9: 87-95 (2007). *

• Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis infection in irritable bowel syndrome and comparison with Crohn's and Johne's diseases: common neural and immune pathogenicity. J. Clin. Microbiol. 45: 3883-3890 (2007). *

• Schafer G, Guler R, Murray G, Brombacher F, Brown GD. The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PLoS One 4: e8448 (2009). *

• Schmid M, Fellermann K, Wehkamp J, Herrlinger K, Stange EF. The role of defensins in the pathogenesis of inflammatory bowel disease. Z. Gastroenterol. 42: 333-338 (2004).

• Schneider BE, Korbel D, Hagens K, Koch M, Raupach B, Enders J, Kaufmann SH, Mittrucker HW, Schaible UE. A role of interleukin 18 for protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol. Nov 30 [Epub ahead of print] (2009). *

• Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, Brown GD, Wells C, Lang R. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. Feb 17 [Epub ahead of print] (2010).

• Schoos J. Paratuberculosis in cattle. Reflections on the interactions with Crohn disease in humans. A literature review. Bull. Soc. Sci. Med. Grand Duche Luxemb. 3: 327-339 (2005).

• Schreiber T, Ehlers S, Heitmann L, Rausch A, Mages J, Murray PJ, Lang R, Holscher C. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183: 1301-1312 (2009).

• Schroder NW, Schumann RR. Non-LPS targets and actions of LPS binding protein (LBP). J. Endotoxin Res. 11: 237-242 (2005). *

• Schurr E, Alcais A, Singh M, Mehra N, Abel L. Mycobacterial infections: PARK2 and PACRG associations in leprosy. Tissue Antigens 69 Suppl. 1: 231-233 (2007). *

• Schwartz D, Shafran I, Romero C, Piromalli C, Biggerstaff J, Naser N, Chamberlin W, Naser SA. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin. Microbiol. Infect. 6: 303-307 (2000).

• Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G, Hassan HY, Wilkinson RJ, Walzl G, Gelderbloem SJ, Mahomed H, Hussey GD, Hanekom WA. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180: 1962-1970 (2008). *

• Sechi LA, Ahmed N, Felis GE, Dupre I, Cannas S, Fadda G, Bua A, Zanetti S. Immunogenicity and cytoadherence of recombinant heparin binding haemagglutinin (HBHA) of Mycobacterium avium subsp. paratuberculosis: functional promiscuity or a role in virulence? Vaccine 24: 236-243 (2006). *

• Sechi LA, Felis GE, Ahmed N, Paccagnini D, Usai D, Ortu S, Molicotti P, Zanetti S. Genome and transcriptome scale portrait of sigma factors in Mycobacterium avium subsp. paratuberculosis. Infect. Genet. Evol. 7: 424-432 (2007).

• Sechi LA, Gazouli M, Ikonomopoulos J, Lukas JC, Scanu AM, Ahmed N, Fadda G, Zanetti S. Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J. Clin. Microbiol. 43: 5275-5277 (2005). *

• Sechi LA, Gazouli M, Sieswerda LE, Molicotti P, Ahmed N, Ikonomopoulos J, Scanu AM, Paccagnini D, Zanetti S. Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J. Gastroenterol. 12: 7161-7164 (2006). *

• Sechi LA, Mura M, Tanda E, Lissia A, Fadda G, Zanetti S. Mycobacterium avium sub. paratuberculosis in tissue samples of Crohn's disease patients. New Microbiol. 27: 75-77 (2004).

• Sechi LA, Mura M, Tanda F, Lissia A, Solinas A, Fadda G, Zanetti S, Manuela M, Francesco T, Amelia L, Antonello S, Giovanni F, Stefania Z. Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization. J. Clin. Microbiol. 39: 4514-4517 (2001). *

• Sechi LA, Rosu V, Pacifico A, Fadda G, Ahmed N, Zanetti S. Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis. Clin. Vaccine Immunol. 15: 320-326 (2008).

• Sechi LA, Ruehl A, Ahmed N, Usai D, Paccagnini D, Felis GE, Zanetti S. Mycobacterium avium subspecies paratuberculosis infects and multiplies in enteric glial cells. World J. Gastroenterol. 13: 5731-5735 (2007). *

• Sechi LA, Scanu AM, Molicotti P, Cannas S, Mura M, Dettori G, Fadda G, Zanetti S. Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am. J. Gastroenterol. 100: 1529-1536 (2005). *

• Sedlackova L, Velek J, Vavrincova P, Hromadnikova I. Peripheral blood mononuclear cell responses to heat shock proteins and their derived synthetic peptides in juvenile idiopathic arthritis patients. Inflamm. Res. 55: 153-159 (2006). *

• Selby W. Pathogenesis and therapeutic aspects of Crohn's disease. Vet. Microbiol. 77: 505-511 (2000). *

• Selby W, Pavli P, Crotty B, Florin T, Radford-Smith G, Gibson P, Mitchell B, Connell W, Read R, Merrett M, Ee H, Hetzel D; Antibiotics in Crohn’s Disease Study Group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132: 2313-2319 (2007). *

• Selby WS. Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease. Lancet 364: 1013-1014 (2004). *

• Seldenrijk CA, Drexhage HA, Meuwissen SG, Meijer CJ. T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease. Gut 31: 529-535 (1990). *

• Sellami MK, Zitouni M, Zouiten F, Laadhar L, Ben Chaabane T, Makni S. Tuberculosis, primary biliary cirrhosis and autoimmunity (apropos of a case in Tunisia). Bull. Soc. Pathol. Exot. 94: 330-331 (2001).

• Sellner J, Hemmer B, Muhlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. Oct 21 [Epub ahead of print] (2009).

• Selvaraj P, Prabhu Anand S, Harishankar M, Alagarasu K. Plasma 1,25 dihydroxy vitamin D(3) level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis. J. Clin. Immunol. 29: 470-478 (2009). *

• Selvaraj P, Vidyarani M, Alagarasu K, Prabhu Anand S, Narayanan PR. Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J. Clin. Immunol. 28: 306-313 (2008). *

• Semret M, Turenne CY, Behr MA. Insertion sequence IS900 revisited. J. Clin. Microbiol. 44: 1081-1083 (2006). *

• Senior K. Does a mycobacterial infection cause Crohn's disease? Lancet Infect. Dis. 8: 671 (2008).

• Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452 (2008). *

• Settbas Y, Alper M, Akcan Y, Gurbuz Y, Oksuz S. Massive gastrointestinal tuberculosis in a young patient without immunosuppression. World J. Gastroenterol. 9: 2382-2384 (2003). *

• Sevilla I, Garrido JM, Geijo M, Juste RA. Pulsed-field gel electrophoresis profile homogeneity of Mycobacterium avium subsp. paratuberculosis isolates from cattle and heterogeneity of those from sheep and goats. BMC Microbiol. 7: 18 (2007). *

• Sevilla I, Li L, Amonsin A, Garrido JM, Geijo MV, Kapur V, Juste RA. Comparative analysis of Mycobacterium avium subsp. paratuberculosis isolates from cattle, sheep and goats by short sequence repeat and pulsed-field gel electrophoresis typing. BMC Microbiol. 8: 204 (2008). *

• Sewell DL, Reinke EK, Hogan LH, Sandor M, Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett. 82: 101-110 (2002).

• Shaffer JL, Hughes S, Linaker BD, Baker RD, Turnberg LA. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 25: 203-205 (1984). *

• Shafran I, Burgunder P. Potential pathogenic role of Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Inflamm. Bowel Dis. 14: 1753-1755 (2008). *

• Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig. Liver Dis. 34: 22-28 (2002).

• Shafran I, Piromalli C, Decker JW, Sandoval J, Naser SA, El-Zaatari FA. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Dig. Dis. Sci. 47: 2079-2081 (2002). *

• Shahabi S, Hassan ZM, Jazani NH. Any beneficial effects of mycobacteria on multiple sclerosis and experimental autoimmune encephalitis may include stimulation of the sympathetic nervous system. Med. Hypotheses 67: 164-168 (2006).

• Shahabi S, Hassan ZM, Jazani NH, Ebtekar M. Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med. Hypotheses 67: 900-903 (2006).

• Shanahan F, O'Mahony J. The mycobacteria story in Crohn's disease. Am. J. Gastroenterol. 100: 1537-1538 (2005). *

• Shankar H, Singh SV, Singh PK, Singh AV, Sohal JS, Greenstein RJ. Presence, characterization, and genotype profiles of Mycobacterium avium subspecies paratuberculosis from unpasteurized individual and pooled milk, commercial pasteurized milk, and milk products in India by culture, PCR, and PCR-REA methods. Int. J. Infect. Dis. Jul 1 [Epub ahead of print] (2009).

• Shapira Y, Agmon-Levin N, Shoenfeld Y. Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin. Rev. Allergy Immunol. Jun 20 [Epub ahead of print] (2009). *

• Sharma S, Sharma M, Bose M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol. Cell Biol. 87: 226-234 (2009). *

• Sharma SK, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130: 261-272 (2006). *

• Shehan JM, Sarma DP. Mycobacterium mucogenicum: report of a skin infection associated with etanercept. Dermatol. Online J. 14: 5 (2008). *

• Sherer Y, Cerinic MM, Bartoli F, Blagojevic J, Conforti ML, Gilburd B, Ehrenfeld M, Shoenfeld Y. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann. N. Y. Acad. Sci. 1108: 259-267 (2007). *

• Sheridan JM, Bull TJ, Hermon-Taylor J. Use of bioinformatics to predict a function for the GS element in Mycobacterium avium subspecies paratuberculosis. J. Mol. Microbiol. Biotechnol. 5: 57-66 (2003).

• Shi C, Zhang H, Zhang T, Wang X, Bai B, Zhao Y, Zhang C, Xu Z. New alternative vaccine component against Mycobacterium tuberculosis - heat shock protein 16.3 or its T-cell epitope. Scand. J. Immunol. 70: 465-474 (2009). *

• Shim TS, Turner OC, Orme IM. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 83: 367-371 (2003).

• Shin AR, Kim HJ, Cho SN, Collins MT, Manning EJ, Naser SA, Shin SJ. Identification of seroreactive proteins in the culture filtrate antigen of Mycobacterium avium ssp. paratuberculosis human isolates to sera from Crohn's disease patients. FEMS Immunol. Med. Microbiol. Oct 1 [Epub ahead of print] (2009). *

• Shin SJ, Collins MT. Thiopurine drugs (azathioprine and 6-mercaptopurine) inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob. Agents Chemother. 52: 418-426 (2008). *

• Shin SJ, Wu CW, Steinberg H, Talaat AM. Identification of novel virulence determinants in Mycobacterium paratuberculosis by screening a library of insertional mutants. Infect. Immun. 74: 3825-3833 (2006). *

• Shiratsuch H, Basson MD. Caspase activation may be associated with Mycobacterium avium pathogenicity. Am. J. Surg. 186: 547-551 (2003). *

• Shojima J, Tanaka G, Keicho N, Tamiya G, Ando S, Oka A, Inoue Y, Suzuki K, Sakatani M, Okada M, Kobayashi N, Toyota E, Kudo K, Kajiki A, Nagai H, Kurashima A, Oketani N, Hayakawa H, Takemura T, Nakata K, Ito H, Morita T, Matsushita I, Hijikata M, et al. Identification of MICA as a susceptibility gene for pulmonary Mycobacterium avium complex infection. J. Infect. Dis. 199: 1707-1715 (2009). *

• Shovman O, Sherer Y, Gilbourd B, Gerli R, Bocci EB, delle Monache F, Luccioli F, Shoenfeld Y. Low levels of heat shock proteins-60 and -65 autoantibodies in Sjogren's syndrome. Isr. Med. Assoc. J. 7: 778-780 (2005). *

• Shrestha N, Ida JA, Lubinski AS, Pallin M, Kaplan G, Haslett PA. Regulation of acquired immunity by gammadelta T-cell/dendritic-cell interactions. Ann. N. Y. Acad. Sci. 1062: 79-94 (2005). *

• Sibartie S, Scully P, Keohane J, O'Neill S, O'Mahony J, O'Hanlon D, Kirwan WO, O'Mahony L, Shanahan F. Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm. Bowel Dis. 16: 296-304 (2010). *

• Sieswerda LE, Bannatyne RM. Mapping the effects of genetic susceptibility and Mycobacterium avium subsp. paratuberculosis infection on Crohn's disease: strong but independent. J. Clin. Microbiol. 44: 1204-1205 (2006). *

• Silva CL, Bonato VL, dos Santos-Junior RR, Zarate-Blades CR, Sartori A. Recent advances in DNA vaccines for autoimmune diseases. Expert Rev. Vaccines 8: 239-252 (2009).

• Silva LC, Silveira GG, Arnone M, Romiti R, Geluk A, Franken KC, Duarte AJ, Takahashi MD, Benard G. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area. Arch. Dermatol. Res. Jul 16 [Epub ahead of print] (2009). *

• Silver RF, Walrath J, Lee H, Jacobson BA, Horton H, Bowman MR, Nocka K, Sypek JP. Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv. Am. J. Respir. Cell. Mol. Biol. 40: 491-504 (2009). *

• Sim E, Lack N, Wang CJ, Long H, Westwood I, Fullam E, Kawamura A. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Toxicology 254: 170-183 (2008). *

• Simons MP, Leidal KG, Nauseef WM, Griffith TS. TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules. J. Leukoc. Biol. 83: 621-629 (2008). *

• Singh AV, Singh SV, Makharia GK, Singh PK, Sohal JS. Presence and characterization of Mycobacterium avium subspecies paratuberculosis from clinical and suspected cases of Crohn's disease and in the healthy human population in India. Int. J. Infect. Dis. 12: 190-197 (2008).

• Singh R, Manjunatha U, Boshoff HI, Ha YH, Niyomrattanakit P, Ledwidge R, Dowd CS, Lee IY, Kim P, Zhang L, Kang S, Keller TH, Jiricek J, Barry CE 3rd. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322: 1392-1395 (2008). *

• Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN. Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg. Med. Chem. Lett. 17: 3706-3711 (2007). *

• Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313: 1438-1441 (2006). *

• Singh SV, Singh PK, Singh AV, Sohal JS, Subodh S, Narayanasamy K. Non-chemical method of DNA recovery and characterization of Mycobacterium avium subspecies paratuberculosis using IS 900 PCR. Indian J. Exp. Biol. 45: 812-816 (2007).

• Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW Jr. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol. 9: 25 (2008). *

• Singh UP, Singh S, Singh R, Karls RK, Quinn FD, Potter ME, Lillard JW Jr. Influence of Mycobacterium avium paratuberculosis on colitis development and specific immune responses during disease. Infect. Immun. 75: 3722-3728 (2007). *

• Sinsimer D, Fallows D, Peixoto B, Krahenbuhl J, Kaplan G, Manca C. Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect. Immun. 78: 293-300 (2010). *

• Slana I, Liapi M, Moravkova M, Kralova A, Pavlik I. Mycobacterium avium subsp. paratuberculosis in cow bulk tank milk in Cyprus detected by culture and quantitative IS900 and F57 real-time PCR. Prev. Vet. Med. 89: 223-226 (2009).

• Slot M, Theunissen R, Van Paassen P, Damoiseaux J, Cohen Tervaert JW. Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study. J. Autoimmune Dis. 3: 4 (2006). *

• Smit JJ, Folkerts G, Nijkamp FP. Mycobacteria, genes and the 'hygiene hypothesis'. Curr. Opin. Allergy Clin. Immunol. 4: 57-62 (2004).

• Smit JJ, Van Loveren H, Hoekstra MO, Karimi K, Folkerts G, Nijkamp FP. The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J. Immunol. 171: 754-760 (2003). *

• Smith I, Nathan C, Peavy HH; NHLBI Working Group. Progress and new directions in genetics of tuberculosis: an NHLBI working group report. Am. J. Respir. Crit. Care Med. 172: 1491-1496 (2005). *

• Smith JW, Chalupa P, Shabaz Hasan M. Infectious arthritis: clinical features, laboratory findings and treatment. Clin. Microbiol. Infect. 12: 309-314 (2006). *

• Smith MS, Wakefield AJ. Viral association with Crohn's disease. Ann. Med. 25: 557-561 (1993).

• Smyth D, Rehman R, Remund K, Egan J. Remitting seronegative symmetrical synovitis with pitting oedema associated with rifampicin. Ir. J. Med. Sci. May 9 [Epub ahead of print] (2009). *

• Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, Hawkridge A, Hussey GD, Maecker H, Kaplan G, Hanekom WA. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180: 3569-3577 (2008). *

• Soderlin M, Blomkvist C, Dahl P, Forsberg P, Fohlman J. Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports. Lakartidningen 102: 3794-3796, 3799-3800 (2005).

• Sohal JS, Sheoran N, Narayanasamy K, Brahmachari V, Singh S, Subodh S. Genomic analysis of local isolate of Mycobacterium avium subspecies paratuberculosis. Vet. Microbiol. 134: 375-382 (2009).

• Sohal JS, Singh SV, Semret M, Subodh S, Sheoran N, Narayanasamy K, Singh PK, Singh AV, Maitra A. Mycobacterium avium subspecies paratuberculosis diagnosis and geno-typing: genomic insights. Microbiol. Res. 164: 330-337 (2009).

• Sohal JS, Singh SV, Singh PK, Singh AV. On the evolution of 'Indian Bison type' strains of Mycobacterium avium subspecies paratuberculosis. Microbiol. Res. May 11 [Epub ahead of print] (2009).

• Sohl S, Treudler R, Gebhardt C, Harth W, Helbig D, Simon JC. Brownish plaques on both sides of the nose. Hautarzt. 59: 1008-1010 (2008).

• Solomon DH. The comparative safety and effectiveness of TNF-alpha antagonists. J. Manag. Care Pharm. 13: S7-S18 (2007).

• Sommer S, Pudrith CB, Colvin CJ, Coussens PM. Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages. Vet. Immunol. Immunopathol. 128: 44-52 (2009). *

• Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, Kwon OJ. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am. J. Roentgenol. 191: 1070 (2008). *

• Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201: 755-767 (2005). *

• Sood R, Bhadauriya T, Rao M, Gautam R, Malhotra S, Barman TK, Upadhyay DJ, Rattan A. Antimycobacterial activities of oxazolidinones: a review. Infect. Disord. Drug Targets 6: 343-354 (2006).

• Sorrentino D, Avellini C, Zearo E. Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. Inflamm. Bowel Dis. 10: 438-440 (2004). *

• Spagnolo P, Richeldi L, du Bois RM. Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. Semin. Respir. Crit. Care Med. 29: 610-619 (2008).

• Spahn TW, Heimann H, Duchmann R, van der Zee R, Meyer zum Buschenfelde KH, Lohse AW. Cellular and humoral immunity to the 60-kD heat shock protein in inflammatory bowel disease. Digestion 58: 469-475 (1997).

• Spencer CT, Abate G, Blazevic A, Hoft DF. Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity. J. Immunol. 181: 4471-4484 (2008). *

• Spickler AR. Paratuberculosis (Johne’s disease) and Crohn’s disease. OIE; Institute for International Cooperation in Animal Biologics; An OIE Collaborating Center, Iowa State University, College of Veterinary Medicine, p 1-8 (2004). *

• Spohn G, Guler R, Johansen P, Keller I, Jacobs M, Beck M, Rohner F, Bauer M, Dietmeier K, Kundig TM, Jennings GT, Brombacher F, Bachmann MF. A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis. J. Immunol. 178: 7450-7457 (2007). *

• Srivastava V, Manchanda M, Gupta S, Singla R, Behera D, Das G, Natarajan K. Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection. J. Biol. Chem. 284: 25532-25541 (2009). *

• Stabel JR. Johne's disease and milk: do consumers need to worry? J. Dairy Sci. 83: 1659-1663 (2000). *

• Stabel JR. Johne's disease: a hidden threat. J. Dairy Sci. 81: 283-288 (1998). *

• Stabel JR, Lambertz A. Efficacy of pasteurization conditions for the inactivation of Mycobacterium avium subsp. paratuberculosis in milk. J. Food Prot. 67: 2719-2726 (2004).

• Stainsby KJ, Lowes JR, Allan RN, Ibbotson JP. Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects. Gut 34: 371-374 (1993). *

• Stas P, D'Hoore A, Van Assche G, Geboes K, Steenkiste E, Penninckx F, Rutgeerts P, Vermeire S. Miliary tuberculosis following infliximab therapy for Crohn disease: a case report and review of the literature. Acta Gastroenterol. Belg. 69: 217-220 (2006).

• Stenger S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann. Rheum. Dis. 64 Suppl. 4: iv24-iv28 (2005). *

• Stephan R, Schumacher S, Tasara T, Grant IR. Prevalence of Mycobacterium avium subspecies paratuberculosis in Swiss raw milk cheeses collected at the retail level. J. Dairy Sci. 90: 3590-3595 (2007).

• Sterling TR. New approaches to the treatment of latent tuberculosis. Semin. Respir. Crit. Care Med. 29: 532-541 (2008).

• Stern JN, Keskin DB, Romero V, Zuniga J, Encinales L, Li C, Awad C, Yunis EJ. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol. Res. 45: 1-12 (2009). *

• Stevens TR, Winrow VR, Blake DR, Rampton DS. Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis. Clin. Exp. Immunol. 90: 271-274 (1992). *

• Stevenson K, Alvarez J, Bakker D, Biet F, de Juan L, Denham S, Dimareli Z, Dohmann K, Gerlach GF, Heron I, Kopecna M, May L, Pavlik I, Sharp JM, Thibault V, Willemsen P, Zadoks R, Greig A. Occurrence of Mycobacterium avium subspecies paratuberculosis across host species and European countries with evidence for transmission between wildlife and domestic ruminants. BMC Microbiol. 9: 212 (2009). *

• Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, Te Meerman GJ, Tappero JW, Ashford DA, van der Steege G. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun. 7: 185-189 (2006). *

• Stockton JC, Howson JM, Awomoyi AA, McAdam KP, Blackwell JM, Newport MJ. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS Immunol. Med. Microbiol. 41: 157-160 (2004). *

• Stokkers PC, de Heer K, Leegwater AC, Reitsma PH, Tytgat GN, van Deventer SJ. Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-gamma receptor 1. Int. J. Colorectal Dis. 14: 13-17 (1999). *

• Storer E. An atypical panniculitis. Australas. J. Dermatol. 47: A58 (2006).

• Su SB, Silver PB, Grajewski RS, Agarwal RK, Tang J, Chan CC, Caspi RR. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 175: 6303-6310 (2005). *

• Suarez Fernandez G. Paratuberculose enteritis and Crohn's disease. An. R. Acad. Nac. Med. (Madr.) 124: 221-234 (2007).

• Suenaga K, Yokoyama Y, Nishimori I, Sano S, Morita M, Okazaki K, Onishi S. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig. Dis. Sci. 44: 1202-1207 (1999). *

• Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y. Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am. J. Gastroenterol. 90: 76-80 (1995).

• Sugawara I. Study on the roles of cytokines involved in mycobacterial infection. Kekkaku 77: 585-588 (2002).

• Sullivan LC, Hoare HL, McCluskey J, Rossjohn J, Brooks AG. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27: 413-420 (2006). *

• Suresh N, Singh UB, Arora J, Pant H, Seth P, Sola C, Rastogi N, Samantaray JC, Pande JN. rpoB gene sequencing and spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates from India. Infect. Genet. Evol. 6: 474-483 (2006).

• Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39: 723-729 (2009). *

• Sweet L, Schorey JS. Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner. J. Leukoc. Biol. 80: 415-423 (2006). *

• Sweet L, Zhang W, Torres-Fewell H, Serianni A, Boggess W, Schorey J. Mycobacterium avium glycopeptidolipids require specific acetylation and methylation patterns for signaling through Toll-like receptor 2. J. Biol. Chem. 283: 33221-33231 (2008). *

• Swetman Andersen CA, Rosenkrands I, Olsen AW, Nordly P, Christensen D, Lang R, Kirschning C, Gomes JM, Bhowruth V, Minnikin DE, Besra GS, Follmann F, Andersen P, Agger EM. Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 183: 2294-2302 (2009).

• Szewczuk MR, Depew WT. Evidence for T lymphocyte reactivity to the 65 kilodalton heat shock protein of mycobacterium in active Crohn's disease. Clin. Invest. Med. 15: 494-505 (1992).

• Szkaradkiewicz A, Chudzicka-Strugala I, Zwozdziak B, Marciniak R, Wasilewska A, Drews M. Mycobacterium avium subsp. paratuberculosis in inflammatory bowel diseases. Przegl. Epidemiol. 61: 85-90 (2007).

• Szteyn J, Wiszniewska-Laszczych A, Ruszczynska A. Effectiveness of Mycobacterium paratuberculosis isolation from raw milk by means of direct isolation of DNA and classic culture. Pol. J. Vet. Sci. 11: 25-28 (2008).

• Takeno M, Murakami S, Ishigatsubo Y. Tuberculosis associated with anti-TNF therapy. Nippon Rinsho 65: 1308-1313 (2007).

• Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect. Dis. 8: 390-398 (2008).

• Tan HH, Tan A, Theng C, Ng SK. Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a dermatology clinic in Singapore. Ann. Acad. Med. Singapore 33: 532-536 (2004). *

• Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, Ansari A, Gershwin ME. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J. Hepatol. 31: 664-671 (1999). *

• Tanaka G, Shojima J, Matsushita I, Nagai H, Kurashima A, Nakata K, Toyota E, Kobayashi N, Kudo K, Keicho N. Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms. Eur. Respir. J. 30: 90-96 (2007). *

• Tanaka K, Wilks M, Coates PJ, Farthing MJ, Walker-Smith JA, Tabaqchali S. Mycobacterium paratuberculosis and Crohn's disease. Gut 32: 43-45 (1991). *

• Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, Podack ER, Yoshikai Y. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. J. Immunol. 181: 6316-6327 (2008). *

• Tanne A, Ma B, Boudou F, Tailleux L, Botella H, Badell E, Levillain F, Taylor ME, Drickamer K, Nigou J, Dobos KM, Puzo G, Vestweber D, Wild MK, Marcinko M, Sobieszczuk P, Stewart L, Lebus D, Gicquel B, Neyrolles O. A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis. J. Exp. Med. 206: 2205-2220 (2009). *

• Tasaka S, Hasegawa N, Nishimura T, Yamasawa W, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Hirose H, Ishizaka A. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration Jul 29 [Epub ahead of print] (2009).

• Taylor DL, Zhong L, Begg DJ, de Silva K, Whittington RJ. Toll-like receptor genes are differentially expressed at the sites of infection during the progression of Johne's disease in outbred sheep. Vet. Immunol. Immunopathol. 124: 132-151 (2008).

• Taylor GA, Feng CG, Sher A. p47 GTPases: regulators of immunity to intracellular pathogens. Nat. Rev. Immunol. 4: 100-109 (2004). *

• Teo JW, Thayalan P, Beer D, Yap AS, Nanjundappa M, Ngew X, Duraiswamy J, Liung S, Dartois V, Schreiber M, Hasan S, Cynamon M, Ryder NS, Yang X, Weidmann B, Bracken K, Dick T, Mukherjee K. Peptide deformylase inhibitors as potent antimycobacterial agents. Antimicrob. Agents Chemother. 50: 3665-3673 (2006). *

• Teo SK, Resztak KE, Scheffler MA, Kook KA, Zeldis JB, Stirling DI, Thomas SD. Thalidomide in the treatment of leprosy. Microbes Infect. 4: 1193-1202 (2002). *

• Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin. Infect. Dis. 41 Suppl. 7: S408-S415 (2005). *

• Thacker TC, Palmer MV, Waters WR. T-cell mRNA expression in response to Mycobacterium bovis BCG vaccination and Mycobacterium bovis infection of white-tailed deer. Clin. Vaccine Immunol. 16: 1139-1145 (2009).

• Thayer WR. The use of antimycobacterial agents in Crohn's disease. J. Clin. Gastroenterol. 15: 5-7 (1992).

• Thayer WR Jr, Coutu JA, Chiodini RJ, Van Kruiningen HJ, Merkal RS. Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease. Dig. Dis. Sci. 29: 1080-1055 (1984).

• Theus S, Theus J, Cottler-Fox M. UC blood infection with clinical strains of Mycobacterium tuberculosis: a novel model. Cytotherapy 9: 647-653 (2007).

• Thibault VC, Grayon M, Boschiroli ML, Hubbans C, Overduin P, Stevenson K, Gutierrez MC, Supply P, Biet F. New variable-number tandem-repeat markers for typing Mycobacterium avium subsp. paratuberculosis and M. avium strains: comparison with IS900 and IS1245 restriction fragment length polymorphism typing. J. Clin. Microbiol. 45: 2404-2410 (2007). *

• Thomas Dow C. Cows, Crohn's and more: is Mycobacterium paratuberculosis a superantigen? Med. Hypotheses 71: 858-861 (2008).

• Thomas GA, Swift GL, Green JT, Newcombe RG, Braniff-Mathews C, Rhodes J, Wilkinson S, Strohmeyer G, Kreuzpainter G. Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study. Gut 42: 497-500 (1998). *

• Thomas JE, Taoka CR, Gibbs BT, Fraser SL. Fatal pulmonary Mycobacterium abscessus infection in a patient using etanercept. Hawaii Med. J. 65: 12-15 (2006).

• Thorel MF. Relationship between Mycobacterium avium, M. paratuberculosis and mycobacteria associated with Crohn's disease. Ann. Rech. Vet. 20: 417-429 (1989).

• Thorn ST, Brown MA, Yanes JJ, Sherrill DL, Pugmire J, Anderson KA, Klotz SA. Pulmonary nocardiosis in cystic fibrosis. J. Cyst. Fibros. 8: 316-320 (2009).

• Thukral C, Travassos WJ, Peppercorn MA. The role of antibiotics in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 8: 223-228 (2005).

• Thuong NT, Dunstan SJ, Chau TT, Thorsson V, Simmons CP, Quyen NT, Thwaites GE, Thi Ngoc Lan N, Hibberd M, Teo YY, Seielstad M, Aderem A, Farrar JJ, Hawn TR. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog. 4: e1000229 (2008). *

• Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, Quy HT, Hieu NT, Aderem A, Hien TT, Farrar JJ, Dunstan SJ. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun. 8: 422-428 (2007). *

• Thuraisingam T, Sam H, Moisan J, Zhang Y, Ding A, Radzioch D. Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. J. Invest. Dermatol. 126: 890-901 (2006). *

• Tiwari S, Choi HP, Matsuzawa T, Pypaert M, Macmicking JD. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat. Immunol. 10: 907-918 (2009). *

• Tjarnlund A, Guirado E, Julian E, Cardona PJ, Fernandez C. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Microbes Infect. 8: 1790-1800 (2006). *

• Tjarnlund A, Rodriguez A, Cardona PJ, Guirado E, Ivanyi J, Singh M, Troye-Blomberg M, Fernandez C. Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice. Int. Immunol. 18: 807-816 (2006). *

• Tong L, Moudgil KD. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res. Ther. 9: R70 (2007). *

• Toracchio S, El-Zimaity HM, Urmacher C, Katz S, Graham DY. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas. Scand. J. Gastroenterol. 43: 1108-1111 (2008). *

• Torres M, Ramachandra L, Rojas RE, Bobadilla K, Thomas J, Canaday DH, Harding CV, Boom WH. Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages. Infect. Immun. 74: 1621-1630 (2006). *

• Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, Gustafson P, Manneh K, Lisse I, Sirugo G, Bennett S, Aaby P, McAdam KP, Bah-Sow O, Lienhardt C, Kramnik I, Hill AV. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc. Natl. Acad. Sci. U.S.A. 103: 10364-10368 (2006). *

• Toussirot E, Berthelot JM, Pertuiset E, Bouvard B, Gaudin P, Wendling D, Le Noach J, Lohse A, Lecuyer E, Cri L. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J. Rheumatol. 36: 2421-2427 (2009).

• Toussirot E, Streit G, Wendling D. Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review. Recent Pat. Inflamm. Allergy Drug Discov. 1: 39-47 (2007).

• Traunmuller F. Etiology of Crohn's disease: do certain food additives cause intestinal inflammation by molecular mimicry of mycobacterial lipids? Med. Hypotheses 65: 859-864 (2005).

• Treede I, Braun A, Sparla R, Kuhnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Fullekrug J, Stremmel W, Griffiths G, Ehehalt R. Anti-inflammatory effects of phosphatidylcholine. J. Biol. Chem. 282: 27155-27164 (2007). *

• Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun. 6: 358-363 (2005). *

• Tsoulfa G, Rook GA, Van-Embden JD, Young DB, Mehlert A, Isenberg DA, Hay FC, Lydyard PM. Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann. Rheum. Dis. 48: 118-123 (1989).

• Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J. Pathol. 193: 102-109 (2001). *

• Tucker ON, Healy V, Jeffers M, Keane FB. Granulomatous appendicitis. Surgeon 1: 286-289 (2003).

• Tundup S, Pathak N, Ramanadham M, Mukhopadhyay S, Murthy KJ, Ehtesham NZ, Hasnain SE. The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response. PLoS ONE 3: e3586 (2008). *

• Tuohy KA, Steinman TI. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn's disease. Am. J. Kidney Dis. 45: e3-e6 (2005).

• Tzen CY, Wu TY, Tzen CY, Tzen CY, Wu TY, Tzen CY, Tzen CY, Wu TY, Tzen CY. Detection of mycobacteria in Crohn's disease by a broad spectrum polymerase chain reaction. J. Formos. Med. Assoc. 105: 290-298 (2006).

• Um SW, Ki CS, Kwon OJ, Koh WJ. HLA antigens and nontuberculous mycobacterial lung disease in Korean patients. Lung 187: 136-140 (2009).

• Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, Matsuzaki G. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178: 3786-3796 (2007). *

• Uyan ZS, Ersu R, Oktem S, Cakir E, Koksalan OK, Karadag B, Karakoc F, Dagli E. Mycobacterium abscessus infection in a cystic fibrosis patient: a difficult to treat infection. Int. J. Tuberc. Lung Dis. 14: 250-251 (2010).

• Uzel G. The range of defects associated with nuclear factor kappaB essential modulator. Curr. Opin. Allergy Clin. Immunol. 5: 513-518 (2005).

• Uzoigwe JC, Khaitsa ML, Gibbs PS. Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol. Infect. 135: 1057-1068 (2007).

• van Beelen AJ, Teunissen MB, Kapsenberg ML, de Jong EC. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7: 374-381 (2007). *

• Van Caekenberghe D. Crohn's disease, sulfasalazine, and mycobacteria. J. Lab. Clin. Med. 114: 63-65 (1989).

• van de Vosse E, Lichtenauer-Kaligis EG, van Dissel JT, Ottenhoff TH. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 54: 817-829 (2003). *

• van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect. Dis. 9: 688-698 (2009).

• van de Vosse E, Verhard EM, de Paus RA, van Dissel JT. Antisense-mediated exon skipping to correct IL-12Rbeta1 deficiency in T cells. Blood 113: 4548-4555 (2009). *

• van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. Salmonella induced IL-23 and IL-1beta allow for IL-12 production by monocytes and Mvarphi1 through induction of IFN-gamma in CD56 NK/NK-like T cells. PLoS One 4: e8396 (2009). *

• van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E. Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1. Mol. Immunol. Dec 14 [Epub ahead of print] (2009). *

• van der Windt GJ, Wieland CW, Wiersinga WJ, Florquin S, van der Poll T. Osteopontin is not crucial to protective immunity during murine tuberculosis. Immunology 128: e766-e776 (2009). *

• van Eden W, Wagenaar-Hilbers JP, Wauben MH. Adjuvant arthritis in the rat. Curr. Protoc. Immunol. Chapter 15: Unit 15.4 (2001).

• van Ingen J, Boeree MJ, Dekhuijzen PR, van Soolingen D. Mycobacterial disease in patients with rheumatic disease. Nat. Clin. Pract. Rheumatol. 4: 649-656 (2008).

• van Ingen J, de Zwaan R, Dekhuijzen RP, Boeree MJ, van Soolingen D. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. J. Infect. 59: 324-331 (2009).

• van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709 (2003).

• Van Kruiningen HJ. Is Mycobacterium paratuberculosis or any other infectious agent involved in the pathogenesis of IBD? Inflamm. Bowel Dis. 14 Suppl. 2: S88-S89 (2008). *

• Van Kruiningen HJ. Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm. Bowel Dis. 5: 183-191 (1999).

• Van Kruiningen HJ, Ruiz B, Gumprecht L. Experimental disease in young chickens induced by a Mycobacterium paratuberculosis isolate from a patient with Crohn's disease. Can. J. Vet. Res. 55: 199-202 (1991).

• Vanderborght PR, Pacheco AG, Moraes ME, Antoni G, Romero M, Verville A, Thai VH, Huong NT, Ba NN, Schurr E, Sarno EN, Moraes MO. HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients. Genes Immun. 8: 320-324 (2007). *

• Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, Jackson-Sillah D, Crampin A, Sichali L, Bah B, Gustafson P, Aaby P, McAdam KP, Bah-Sow O, Lienhardt C, Sirugo G, Fine P, Hill AV. CD209 genetic polymorphism and tuberculosis disease. PLoS ONE 3: e1388 (2008). *

• Vannuffel P, Dieterich C, Naerhuyzen B, Gilot P, Coene M, Fiasse R, Cocito C. Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin. Diagn. Lab. Immunol. 1: 241-243 (1994).

• Vasiliauskas E. Recent advances in the diagnosis and classification of inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 493-500 (2003).

• Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. J. Rheumatol. 35: 1271-1276 (2008).

• Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7: 1151-1156 (2006). *

• Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M, Bekers O, Claessen AM, Drent M, van den Bosch JM, Grutters JC. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin. Exp. Immunol. 149: 453-462 (2007). *

• Venkataswamy MM, Baena A, Goldberg MF, Bricard G, Im JS, Chan J, Reddington F, Besra GS, Jacobs WR Jr, Porcelli SA. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 183: 1644-1656 (2009).

• Venos ES, Knodel MH, Radford CL, Berger BJ. Branched-chain amino acid aminotransferase and methionine formation in Mycobacterium tuberculosis. BMC Microbiol. 4: 39 (2004). *

• Verhave JC, van Altena R, Wijnands MJ, Roerdink HT. Tuberculous peritonitis during infliximab therapy. Neth. J. Med. 66: 77-80 (2008). *

• Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. U.S.A. 101: 4560-4565 (2004). *

• Vidyarani M, Selvaraj P, Raghavan S, Narayanan PR. Regulatory role of 1,25-dihydroxyvitamin D(3) and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis. Exp. Mol. Pathol. 86: 69-73 (2009). *

• Vilagut L, Pares A, Rodes J, Vila J, Vinas O, Gines A, Jimenez de Anta MT. Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis? J. Hepatol. 24: 125 (1996). *

• Vilagut L, Vila J, Vinas O, Pares A, Gines A, Jimenez de Anta MT, Rodes J. Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J. Hepatol. 21: 673-677 (1994).

• Voelter V, Rufer N, Reynard S, Greub G, Brookes R, Guillaume P, Grosjean F, Fagerberg T, Michelin O, Rowland-Jones S, Pinilla C, Leyvraz S, Romero P, Appay V. Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor. Int. Immunol. 20: 1087-1096 (2008).

• Volk BA, Gerok W. Current insights on the pathogenesis of chronic inflammatory bowel diseases. Schweiz. Rundsch. Med. Prax. 81: 863-865 (1992).

• von Bernuth H, Puel A, Ku CL, Yang K, Bustamante J, Chang HH, Picard C, Casanova JL. Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation. Clin. Infect. Dis. 41 Suppl. 7: S436-S439 (2005). *

• von Meyenn F, Schaefer M, Weighardt H, Bauer S, Kirschning CJ, Wagner H, Sparwasser T. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guerin by Flt3-ligand generated dendritic cells. Immunobiology 211: 557-565 (2006).

• Vordermeier HM, Villarreal-Ramos B, Cockle PJ, Macaulay M, Rhodes SG, Thacker T, Gilbert SC, McShane H, Hill AV, Xing RZ, Hewinson RG. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77: 3364-3373 (2009). *

• Waddell L, Rajic A, Sargeant J, Parker S, Deckert A, McEwen S. The methodological soundness of literature reviews addressing three potential zoonotic public health issues. Zoonoses Public Health 56: 477-489 (2009).

• Waddell LA, Rajic A, Sargeant J, Harris J, Amezcua R, Downey L, Read S, McEwen SA. The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can. J. Public Health 99: 145-155 (2008).

• Wagner TE, Huseby ES, Huseby JS. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor. Am. J. Med. 112: 67-69 (2002). *

• Wahab AA, Janahi IA, Marafia MM, El-Shafie S. Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation. J. Trop. Pediatr. 50: 229-233 (2004). *

• Wallace C, Fitness J, Hennig B, Sichali L, Mwaungulu L, Ponnighaus JM, Warndorff DK, Clayton D, Fine PE, Hill AV. Linkage analysis of susceptibility to leprosy type using an IBD regression method. Genes Immun. 5: 221-225 (2004). *

• Wallis RS. Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade. Arthritis Rheum. 58: 947-952 (2008). *

• Wallis RS. Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma. J. Investig. Dermatol. Symp. Proc. 12: 16-21 (2007). *

• Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin. Infect. Dis. 38: 1261-1265 (2004). *

• Wallis RS, Kyambadde P, Johnson JL, Horter L, Kittle R, Pohle M, Ducar C, Millard M, Mayanja-Kizza H, Whalen C, Okwera A. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS 18: 257-264 (2004).

• Walmsley RS, Ibbotson JP, Chahal H, Allan RN. Antibodies against Mycobacterium paratuberculosis in Crohn's disease. QJM 89: 217-321 (1996).

• Wang B, Henao-Tamayo M, Harton M, Ordway-Rodrigues D, Shanley C, Basaraba RJ, Orme IM. A Toll-like receptor-2 directed fusion protein vaccine against tuberculosis. Clin. Vaccine Immunol. 14: 902-906 (2007). *

• Wang X, Barnes PF, Dobos-Elder KM, Townsend JC, Chung YT, Shams H, Weis SE, Samten B. ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells. J. Immunol. 182: 3668-3677 (2009).

• Wasilenko ST, Mason GE, Mason AL. Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic? Liver Int. 29: 779-782 (2009). *

• Watanabe Y, Watari E, Matsunaga I, Hiromatsu K, Dascher CC, Kawashima T, Norose Y, Shimizu K, Takahashi H, Yano I, Sugita M. BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components. Vaccine 24: 5700-5707 (2006). *

• Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J. Clin. Gastroenterol. 14: 302-308 (1992).

• Weichold FF, Mueller S, Kortsik C, Hitzler WE, Wulf MJ, Hone DM, Sadoff JC, Maeurer MJ. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8(+) T-cell response in patients with pulmonary tuberculosis. Genes Immun. 8: 334-343 (2007). *

• Wells JE, Bosilevac JM, Kalchayanand N, Arthur TM, Shackelford SD, Wheeler TL, Koohmaraie M. Prevalence of Mycobacterium avium subsp. paratuberculosis in ileocecal lymph nodes and on hides and carcasses from cull cows and fed cattle at commercial beef processing plants in the United States. J. Food Prot. 72: 1457-1462 (2009).

• Welsh KJ, Abbott AN, Hwang SA, Indrigo J, Armitige LY, Blackburn MR, Hunter RL Jr, Actor JK. A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Microbiology 154: 1813-1824 (2008). *

• Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455: 1109-1113 (2008). *

• Werling D, Piercy J, Coffey TJ. Expression of Toll-like receptors (TLR) by bovine antigen-presenting cells - potential role in pathogen discrimination? Vet. Immunol. Immunopathol. 112: 2-11 (2006). *

• Westall FC. Comments to: integrating theories of the etiology of Crohn's disease on the etiology of Crohn's disease: questioning the hypotheses. Med. Sci. Monit. 12: LE5-LE6 (2006). *

• Whan L, Ball HJ, Grant IR, Rowe MT. Occurrence of Mycobacterium avium subsp. paratuberculosis in untreated water in Northern Ireland. Appl. Environ. Microbiol. 71: 7107-7112 (2005). *

• Whittaker LA, Teneback C. Atypical mycobacterial and fungal infections in cystic fibrosis. Semin. Respir. Crit. Care Med. 30: 539-546 (2009).

• Whittington RJ, Marsh IB, Reddacliff LA. Survival of Mycobacterium avium subsp. paratuberculosis in dam water and sediment. Appl. Environ. Microbiol. 71: 5304-5308 (2005). *

• Whittington RJ, Reddacliff LA, Marsh I, McAllister S, Saunders V. Temporal patterns and quantification of excretion of Mycobacterium avium subsp paratuberculosis in sheep with Johne's disease. Aust. Vet. J. 78: 34-37 (2000).

• Whittington RJ, Waldron A, Warne D. Thermal inactivation profiles of Mycobacterium avium subsp. paratuberculosis in lamb skeletal muscle homogenate fluid. Int. J. Food Microbiol. Oct 21 [Epub ahead of print] (2009). *

• Wiart A, Jepson A, Banya W, Bennett S, Whittle H, Martin NG, Hill AV. Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Twin Res. 7: 578-588 (2004).

• Wiker HG. MPB70 and MPB83 - major antigens of Mycobacterium bovis. Scand. J. Immunol. 69: 492-499 (2009). *

• Williams SL, Harris NB, Barletta RG. Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis. J. Clin. Microbiol. 37: 304-309 (1999). *

• Windish HP, Lin PL, Mattila JT, Green AM, Onuoha EO, Kane LP, Flynn JL. Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis. J. Leukoc. Biol. 86: 713-725 (2009). *

• Winthrop KL, Chiller T. Preventing and treating biologic-associated opportunistic infections. Nat. Rev. Rheumatol. 5: 405-410 (2009).

• Wolf NA, Amouzegar TK, Swanborg RH. Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 185: 115-122 (2007).

• Woodford N, Ellington MJ. The emergence of antibiotic resistance by mutation. Clin. Microbiol. Infect. 13: 5-18 (2007).

• Wozniak TM, Ryan AA, Britton WJ. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 177: 8684-8692 (2006). *

• Wozniak TM, Ryan AA, Triccas JA, Britton WJ. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect. Immun. 74: 557-565 (2006). *

• Wren BW, Colby SM, Cubberley RR, Pallen MJ. Degenerate PCR primers for the amplification of fragments from genes encoding response regulators from a range of pathogenic bacteria. FEMS Microbiol. Lett. 78: 287-291 (1992).

• Wright RC. Mycobacterium tuberculosis in pasteurized milk. Br. Med. J. 2: 108 (1967). *

• Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, Krensky AM, Clayberger C. IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin. Immunol. 126: 202-210 (2008). *

• Wu CW, Glasner J, Collins M, Naser S, Talaat AM. Whole-genome plasticity among Mycobacterium avium subspecies: insights from comparative genomic hybridizations. J. Bacteriol. 188: 711-723 (2006). *

• Wu CW, Livesey M, Schmoller SK, Manning EJ, Steinberg H, Davis WC, Hamilton MJ, Talaat AM. Invasion and persistence of Mycobacterium avium subsp. paratuberculosis during early stages of Johne's disease in calves. Infect. Immun. 75: 2110-2119 (2007). *

• Wu CW, Schmoller SK, Bannantine JP, Eckstein TM, Inamine JM, Livesey M, Albrecht R, Talaat AM. A novel cell wall lipopeptide is important for biofilm formation and pathogenicity of Mycobacterium avium subspecies paratuberculosis. Microb. Pathog. 46: 222-230 (2009). *

• Xu Y, Liu XD, Gong X, Eissa NT. Signaling pathway of autophagy associated with innate immunity. Autophagy 4: 110-112 (2008).

• Xue R, Wang S, Wang C, Zhu T, Li F, Sun H. HFIP-induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1. Biopolymers 84: 329-339 (2006). *

• Yancoski J, Rocco C, Bernasconi A, Oleastro M, Bezrodnik L, Vratnica C, Haerynck F, Rosenzweig SD. A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian susceptibility to mycobacterial diseases in European descendants. Infect. Genet. Evol. 9: 574-580 (2009).

• Yang CS, Lee JS, Song CH, Hur GM, Lee SJ, Tanaka S, Akira S, Paik TH, Jo EK. Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2. Cell. Microbiol. 9: 382-396 (2007). *

• Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282: 36223-36229 (2007). *

• Yang YS, Kim SJ, Kim JW, Koh EM. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis in Koreans. J. Korean Med. Sci. 15: 83-87 (2000). *

• Yim JJ, Ding L, Schaffer AA, Park GY, Shim YS, Holland SM. A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences. FEMS Immunol. Med. Microbiol. 40: 163-169 (2004). *

• Yim JJ, Kim HJ, Kwon OJ, Koh WJ. Association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a Korean population. Hum. Immunol. 69: 572-576 (2008).

• Yim JJ, Lee HW, Lee HS, Kim YW, Han SK, Shim YS, Holland SM. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. 7: 150-155 (2006). *

• Yim K, Nazeer SH, Kiska D, Rose FB, Brown D, Cynamon MH. Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept. Scand. J. Infect. Dis. 36: 150-154 (2004). *

• Yokoi T, Amakawa R, Tanijiri T, Sugimoto H, Torii Y, Amuro H, Son Y, Tajima K, Liu YJ, Ito T, Fukuhara S. Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLP-activated dendritic cells. Int. Immunol. 20: 1321-1329 (2008).

• Yoshikai Y. Immunological protection against Mycobacterium tuberculosis infection. Crit. Rev. Immunol. 26: 515-526 (2006).

• Yoshinaga Y, Kanamori T, Ota Y, Miyoshi T, Kagawa H, Yamamura M. Clinical characteristics of Mycobacterium tuberculosis infection among rheumatoid arthritis patients. Mod. Rheumatol. 14: 143-148 (2004).

• Yun JW, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Cha HS, Koh EM, Koh WJ. Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. J. Korean Med. Sci. 22: 779-783 (2007). *

• Zaidi S, Elidemir O, Heinle JS, McKenzie ED, Schecter MG, Kaplan SL, Dishop MK, Kearney DL, Mallory GB. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl. Infect. Dis. 11: 243-248 (2009).

• Zanetti S, Molicotti P, Cannas S, Ortu S, Ahmed N, Sechi LA. In vitro activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis. Ann. Clin. Microbiol. Antimicrob. 5: 27 (2006). *

• Zarate-Blades CR, Bonato VL, da Silveira EL, E Paula MO, Junta CM, Sandrin-Garcia P, Fachin AL, Mello SS, Cardoso RS, de Sa Galetti FC, Coelho-Castelo AA, Ramos SG, Donadi EA, Sakamoto-Hojo ET, da Silva Passos GA, Silva CL. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy. J. Gene Med. 11: 66-78 (2009).

• Zaunders JJ, Munier ML, Seddiki N, Pett S, Ip S, Bailey M, Xu Y, Brown K, Dyer WB, Kim M, de Rose R, Kent SJ, Jiang L, Breit SN, Emery S, Cunningham AL, Cooper DA, Kelleher AD. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J. Immunol. 183: 2827-2836 (2009).

• Zenaro E, Donini M, Dusi S. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN. J. Leukoc. Biol. 86: 1393-1401 (2009). *

• Zhang F, Liu H, Chen S, Wang C, Zhu C, Zhang L, Chu T, Liu D, Yan X, Liu J. Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population. BMC Med. Genet. 10: 133 (2009). *

• Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan XX, Yang HT, Rong-De Yang, Chu TS, Zhang C, Zhang L, Han JW, Yu GQ, Quan C, Yu YX, Zhang Z, Shi BQ, Zhang LH, Cheng H, Wang CY, Lin Y, et al. Genomewide association study of leprosy. N. Engl. J. Med. 361: 2609-2618 (2009). *

• Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-a/b, IFN-g, and IFN-l in host defense. Immunol. Rev. 226: 29-40 (2008). *

• Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 31: 761-771 (2009).

• Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front. Biosci. 9: 1136-1156 (2004).

• Zhong L, Di Fiore L, Taylor D, Begg D, de Silva K, Whittington RJ. Identification of differentially expressed genes in ileum, intestinal lymph node and peripheral blood mononuclear cells of sheep infected with Mycobacterium avium subsp. paratuberculosis using differential display polymerase chain reaction. Vet. Immunol. Immunopathol. 131: 177-189 (2009). *

• Zhu A, Lu Y, Jin L, Wu J, Li T, Liu J. Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice. Sheng Wu Gong Cheng Xue Bao 24: 640-645 (2008).

• Ziedalski TM, Kao PN, Henig NR, Jacobs SS, Ruoss SJ. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 130: 995-1002 (2006). *

• Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, Isogai E. Immunology and functional genomics of Behcet's disease. Cell. Mol. Life Sci. 60: 1903-1922 (2003). *

• Zlacka D, Vavrincova P, Hien Nguyen TT, Hromadnikova I. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. J. Autoimmun. 27: 81-88 (2006).

• Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SJ, Kovacs JA, Davey RT, Lane HC, Masur H, Sereti I. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 112: 287-294 (2008). *

• Zorzella SF, Seger J, Martins DR, Pelizon AC, Sartori A. Resistance to experimental autoimmune encephalomyelitis development in Lewis rats from a conventional animal facility. Mem. Inst. Oswaldo Cruz. 102: 931-936 (2007). *

• Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA. Intranasal immunization promotes Th17 immune responses. J. Immunol. 183: 6933-6938 (2009).

Number of references = 1205

www psc-literature.org